*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 457 ALA A 68 ALA~? 16.38 O2 GOL B3003 A 458 ALA A 67 ALA~? 20.70 O2 GOL B3003 B 193 ALA A 72 ALA~? 17.50 O2 GOL B3003 B 194 GLY A 73 GLY~? 19.36 O2 GOL B3003 coo 43.27 124.32 20.47 43.79 125.29 21.53 -69.22 -15.24 -11.24 -69.18 -16.81 -11.21 coo 39.57 123.53 20.89 38.42 124.25 20.20 -66.30 -12.87 -11.78 -65.83 -13.06 -13.25 coo 47.95 129.15 20.31 47.81 128.95 18.79 -74.48 -13.14 -9.37 -74.19 -14.60 -8.89 coo 50.40 126.23 20.48 50.46 127.00 20.75 -74.18 -11.03 -6.20 -74.35 -10.76 -6.94 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 457 ALA B 68 ALA~? 9.46 O2 GOL B3003 A 458 ALA B 67 ALA~? 13.93 O2 GOL B3003 B 193 ALA B 72 ALA~? 11.73 C1 GOL B3003 B 194 GLY B 73 GLY~? 15.91 C1 GOL B3003 coo 43.27 124.32 20.47 43.79 125.29 21.53 -58.71 -24.38 -1.50 -60.25 -24.49 -1.51 coo 39.57 123.53 20.89 38.42 124.25 20.20 -56.73 -21.14 -0.96 -57.02 -20.76 0.55 coo 47.95 129.15 20.31 47.81 128.95 18.79 -56.11 -29.30 -3.54 -57.59 -29.20 -3.91 coo 50.40 126.23 20.48 50.46 127.00 20.75 -54.34 -28.77 -6.80 -53.98 -28.87 -6.06 1pix_c02 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 2 hits 1pix_c02 naa= 4 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 193 ALA A 72 ALA~? 17.50 O2 GOL B3003 A 194 GLY A 73 GLY~? 19.36 O2 GOL B3003 B 457 ALA A 68 ALA~? 16.38 O2 GOL B3003 B 458 ALA A 67 ALA~? 20.70 O2 GOL B3003 coo 61.89 87.20 13.50 62.59 88.00 12.38 -74.48 -13.14 -9.37 -74.19 -14.60 -8.89 coo 59.34 89.99 13.88 59.24 89.18 13.73 -74.18 -11.03 -6.20 -74.35 -10.76 -6.94 coo 65.50 91.13 17.77 64.65 89.88 18.00 -69.22 -15.24 -11.24 -69.18 -16.81 -11.21 coo 68.56 91.15 20.03 69.95 90.68 19.64 -66.30 -12.87 -11.78 -65.83 -13.06 -13.25 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 193 ALA B 72 ALA~? 11.73 C1 GOL B3003 A 194 GLY B 73 GLY~? 15.91 C1 GOL B3003 B 457 ALA B 68 ALA~? 9.46 O2 GOL B3003 B 458 ALA B 67 ALA~? 13.93 O2 GOL B3003 coo 61.89 87.20 13.50 62.59 88.00 12.38 -56.11 -29.30 -3.54 -57.59 -29.20 -3.91 coo 59.34 89.99 13.88 59.24 89.18 13.73 -54.34 -28.77 -6.80 -53.98 -28.87 -6.06 coo 65.50 91.13 17.77 64.65 89.88 18.00 -58.71 -24.38 -1.50 -60.25 -24.49 -1.51 coo 68.56 91.15 20.03 69.95 90.68 19.64 -56.73 -21.14 -0.96 -57.02 -20.76 0.55 1pix_c03 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 2 hits 1pix_c03 naa= 4 ULMN 4 2nac_c01 NAD-DEPENDENT FORMATE DEHYDROGENASE user 1 4 # 1 B 146 ASN B 119 ASN^? 14.64 O3 GOL B3003 B 284 ARG B 85 ARG^? 26.71 C1 GOL B3003 B 313 GLN B 144 GLN^? 30.53 O3 GOL B3003 B 332 HIS B 84 HIS^? 25.00 C1 GOL B3003 coo 12.98 20.52 25.52 11.52 19.26 24.60 -64.01 -38.08 -11.10 -64.51 -37.27 -12.99 coo 3.62 10.14 26.36 6.20 11.40 25.00 -53.06 -34.97 -19.15 -50.61 -33.06 -19.14 coo -1.48 15.70 29.87 0.52 15.06 29.74 -51.37 -43.82 -18.42 -50.77 -43.69 -20.51 coo 3.21 17.70 29.79 4.27 16.89 28.18 -51.82 -41.33 -13.55 -52.15 -43.40 -13.65 2nac_c01 source 2nac NAD-DEPENDENT FORMATE DEHYDROGENASE (E.C.1.2.1: 1 hits 2nac_c01 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 102 ASP.? 31.57 O2 GOL B3003 A 100 ARG A 49 ARG~? 28.59 O2 GOL B3003 A 116 GLN A 33 GLN^? 32.15 O2 GOL B3003 coo 32.24 20.09 5.34 30.38 19.04 5.27 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 26.40 25.34 6.28 26.15 22.33 7.25 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 coo 26.74 21.94 13.78 27.57 20.97 12.08 -63.71 -3.20 -17.25 -63.44 -1.34 -16.21 12as_c00 source 12as ASPARAGINE SYNTHETASE : 1 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP A 102 ASP.? 31.57 O2 GOL B3003 B 100 ARG A 49 ARG~? 28.59 O2 GOL B3003 B 116 GLN A 33 GLN^? 32.15 O2 GOL B3003 coo 32.18 48.37 12.48 33.96 49.46 12.97 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 39.04 43.25 11.37 38.30 45.35 13.56 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 coo 37.43 42.63 19.41 36.76 44.08 17.97 -63.71 -3.20 -17.25 -63.44 -1.34 -16.21 12as_c01 source 12as ASPARAGINE SYNTHETASE : 1 hits 12as_c01 naa= 3 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 1 3 # 1 B 13 HIS A 60 HIS~? 18.77 O2 GOL B3003 B 40 LYS A 48 LYS.? 30.42 O2 GOL B3003 B 114 HIS A 55 HIS.? 23.22 O2 GOL B3003 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 2 3 # 2 B 13 HIS B 60 HIS~? 17.21 O2 GOL B3003 B 40 LYS B 48 LYS.? 23.67 O2 GOL B3003 B 114 HIS B 55 HIS.? 21.07 O2 GOL B3003 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -56.50 -11.36 6.48 -60.31 -8.26 9.60 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -70.49 -6.63 0.68 -71.77 -8.29 0.64 1a4y_c00 source 1a4y RIBONUCLEASE INHIBITOR : 2 hits 1a4y_c00 naa= 3 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 1 3 # 1 E 13 HIS A 60 HIS~? 18.77 O2 GOL B3003 E 40 LYS A 48 LYS.? 30.42 O2 GOL B3003 E 114 HIS A 55 HIS.? 23.22 O2 GOL B3003 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 2 3 # 2 E 13 HIS B 60 HIS~? 17.21 O2 GOL B3003 E 40 LYS B 48 LYS.? 23.67 O2 GOL B3003 E 114 HIS B 55 HIS.? 21.07 O2 GOL B3003 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -56.50 -11.36 6.48 -60.31 -8.26 9.60 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -70.49 -6.63 0.68 -71.77 -8.29 0.64 1a4y_c01 source 1a4y RIBONUCLEASE INHIBITOR : 2 hits 1a4y_c01 naa= 3 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 1 3 # 1 252 THR A 92 THR^? 7.25 O3 GOL B3003 350 PHE A 134 PHE^? 16.11 C2 GOL B3003 357 CYH A 65 CYH~? 13.02 O2 GOL B3003 coo 17.85 20.47 14.62 16.85 19.84 12.80 -71.10 -25.35 -7.58 -71.95 -27.31 -7.64 coo 7.92 21.96 13.27 8.57 20.30 15.42 -66.66 -20.84 -15.05 -67.17 -20.21 -12.35 coo 8.82 20.77 7.90 10.59 19.75 9.80 -65.23 -17.87 -9.94 -64.55 -20.54 -9.18 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 2 3 # 2 252 THR B 92 THR^? -4.12 O3 GOL B3003s 350 PHE B 134 PHE^? 7.35 O2 GOL B3003 357 CYH B 65 CYH~? 9.67 O2 GOL B3003 coo 17.85 20.47 14.62 16.85 19.84 12.80 -68.62 -27.37 -4.77 -70.50 -28.47 -4.70 coo 7.92 21.96 13.27 8.57 20.30 15.42 -64.55 -22.36 2.54 -63.98 -22.76 -0.20 coo 8.82 20.77 7.90 10.59 19.75 9.80 -61.86 -20.74 -2.77 -64.56 -20.53 -3.49 1akd_c01 source 1akd CYTOCHROME P450CAM : 2 hits 1akd_c01 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 102 ASP.? 31.57 O2 GOL B3003 227 GLU A 36 GLU^? 32.45 C3 GOL B3003 289 ASP A 130 ASP.? 32.43 C2 GOL B3003 coo -0.62 65.95 29.97 0.31 67.47 31.05 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 3.96 55.76 41.24 4.83 57.69 41.17 -77.05 -4.23 -19.20 -78.34 -5.25 -20.55 coo 9.42 68.07 30.27 7.35 68.27 30.10 -68.90 -15.75 -28.47 -68.86 -13.69 -28.85 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 130 ASP.? 32.43 C2 GOL B3003 227 GLU A 36 GLU^? 32.45 C3 GOL B3003 289 ASP A 102 ASP.? 31.57 O2 GOL B3003 coo -0.62 65.95 29.97 0.31 67.47 31.05 -68.90 -15.75 -28.47 -68.86 -13.69 -28.85 coo 3.96 55.76 41.24 4.83 57.69 41.17 -77.05 -4.23 -19.20 -78.34 -5.25 -20.55 coo 9.42 68.07 30.27 7.35 68.27 30.10 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 102 ASP.? 23.17 O2 GOL B3003 227 GLU B 36 GLU^? 22.14 C1 GOL B3003 289 ASP B 130 ASP.? 19.87 O1 GOL B3003 coo -0.62 65.95 29.97 0.31 67.47 31.05 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 3.96 55.76 41.24 4.83 57.69 41.17 -46.92 -30.82 5.73 -47.47 -32.26 7.22 coo 9.42 68.07 30.27 7.35 68.27 30.10 -58.56 -23.75 15.92 -56.48 -23.58 15.94 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 130 ASP.? 19.87 O1 GOL B3003 227 GLU B 36 GLU^? 22.14 C1 GOL B3003 289 ASP B 102 ASP.? 23.17 O2 GOL B3003 coo -0.62 65.95 29.97 0.31 67.47 31.05 -58.56 -23.75 15.92 -56.48 -23.58 15.94 coo 3.96 55.76 41.24 4.83 57.69 41.17 -46.92 -30.82 5.73 -47.47 -32.26 7.22 coo 9.42 68.07 30.27 7.35 68.27 30.10 -54.64 -15.40 9.63 -53.71 -13.49 9.90 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 4 hits 1amy_c06 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 110 SER.? 25.77 C3 GOL B3003 A 292 ASP A 130 ASP.? 32.43 C2 GOL B3003 A 322 HIS A 84 HIS^? 26.32 C3 GOL B3003 coo 36.34 32.23 39.60 36.43 34.62 39.93 -84.29 -14.36 -16.63 -83.54 -15.93 -18.35 coo 19.73 19.18 41.39 21.50 18.65 40.34 -68.90 -15.75 -28.47 -68.86 -13.69 -28.85 coo 41.69 45.14 46.60 41.78 47.19 46.18 -87.33 -9.64 0.04 -89.27 -10.38 -0.27 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER B 2 SER~? 23.90 C1 GOL B3003 A 292 ASP B 102 ASP.? 23.17 O2 GOL B3003 A 322 HIS B 84 HIS^? 25.00 C1 GOL B3003 coo 36.34 32.23 39.60 36.43 34.62 39.93 -45.76 -29.24 -6.32 -45.70 -31.69 -6.64 coo 19.73 19.18 41.39 21.50 18.65 40.34 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 41.69 45.14 46.60 41.78 47.19 46.18 -51.82 -41.33 -13.55 -52.15 -43.40 -13.65 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER B 110 SER.? 15.91 O1 GOL B3003 A 292 ASP B 130 ASP.? 19.87 O1 GOL B3003 A 322 HIS B 84 HIS^? 25.00 C1 GOL B3003 coo 36.34 32.23 39.60 36.43 34.62 39.93 -55.38 -39.72 3.17 -56.58 -39.47 5.29 coo 19.73 19.18 41.39 21.50 18.65 40.34 -58.56 -23.75 15.92 -56.48 -23.58 15.94 coo 41.69 45.14 46.60 41.78 47.19 46.18 -51.82 -41.33 -13.55 -52.15 -43.40 -13.65 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 3 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER B 2 SER~? 23.90 C1 GOL B3003 B 292 ASP B 102 ASP.? 23.17 O2 GOL B3003 B 322 HIS B 84 HIS^? 25.00 C1 GOL B3003 coo 35.42 71.28 22.94 36.24 69.06 22.37 -45.76 -29.24 -6.32 -45.70 -31.69 -6.64 coo 24.74 78.07 5.59 24.32 79.03 7.46 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 48.81 64.16 26.34 49.30 62.16 26.73 -51.82 -41.33 -13.55 -52.15 -43.40 -13.65 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER B 110 SER.? 15.91 O1 GOL B3003 B 292 ASP B 130 ASP.? 19.87 O1 GOL B3003 B 322 HIS B 84 HIS^? 25.00 C1 GOL B3003 coo 35.42 71.28 22.94 36.24 69.06 22.37 -55.38 -39.72 3.17 -56.58 -39.47 5.29 coo 24.74 78.07 5.59 24.32 79.03 7.46 -58.56 -23.75 15.92 -56.48 -23.58 15.94 coo 48.81 64.16 26.34 49.30 62.16 26.73 -51.82 -41.33 -13.55 -52.15 -43.40 -13.65 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 2 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 85 ARG^? 23.00 O2 GOL B3003 B 342 ASP A 77 ASP~? 25.15 O2 GOL B3003 B 531 ARG A 89 ARG^? 14.22 C3 GOL B3003 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -81.56 -10.21 5.97 -79.12 -9.20 7.55 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -77.20 -20.48 3.22 -78.65 -19.76 5.86 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG B 85 ARG^? 26.71 C1 GOL B3003 B 342 ASP B 77 ASP~? 23.19 C1 GOL B3003 B 531 ARG B 89 ARG^? 19.99 O3 GOL B3003 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -53.06 -34.97 -19.15 -50.61 -33.06 -19.14 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -63.05 -31.09 -16.52 -61.54 -30.22 -19.07 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 2 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 85 ARG^? 23.00 O2 GOL B3003 A 342 ASP A 77 ASP~? 25.15 O2 GOL B3003 A 531 ARG A 89 ARG^? 14.22 C3 GOL B3003 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -81.56 -10.21 5.97 -79.12 -9.20 7.55 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -77.20 -20.48 3.22 -78.65 -19.76 5.86 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG B 85 ARG^? 26.71 C1 GOL B3003 A 342 ASP B 77 ASP~? 23.19 C1 GOL B3003 A 531 ARG B 89 ARG^? 19.99 O3 GOL B3003 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -53.06 -34.97 -19.15 -50.61 -33.06 -19.14 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -63.05 -31.09 -16.52 -61.54 -30.22 -19.07 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 2 hits 1asy_c01 naa= 3 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 A 18 HIS A 84 HIS^? 26.32 C3 GOL B3003 A 91 ARG A 85 ARG^? 23.00 O2 GOL B3003 A 129 SER A 143 SER^? 21.60 C3 GOL B3003 coo 24.39 47.01 49.70 26.42 47.04 49.21 -87.33 -9.64 0.04 -89.27 -10.38 -0.27 coo 25.98 44.20 42.23 28.53 42.98 43.43 -81.56 -10.21 5.97 -79.12 -9.20 7.55 coo 30.00 49.76 45.68 28.73 48.72 47.47 -85.41 -13.56 3.43 -83.66 -13.28 5.07 1b6t_c00 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 1 hits 1b6t_c00 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 127 TYR^? 25.18 O3 GOL B3003 A 230 ASP A 129 ASP.? 33.59 C2 GOL B3003 A 273 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 9.23 21.44 106.88 10.18 19.34 105.31 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 1.45 22.80 104.16 2.58 21.02 104.01 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 2.97 11.64 107.87 6.59 15.13 107.03 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR B 127 TYR^? 12.67 O1 GOL B3003 A 230 ASP B 129 ASP.? 21.97 O1 GOL B3003 A 273 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 9.23 21.44 106.88 10.18 19.34 105.31 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 1.45 22.80 104.16 2.58 21.02 104.01 -59.59 -18.37 15.65 -59.22 -18.41 17.77 coo 2.97 11.64 107.87 6.59 15.13 107.03 -67.78 -15.41 8.33 -71.72 -12.47 6.85 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 127 TYR^? 25.18 O3 GOL B3003 B 230 ASP A 129 ASP.? 33.59 C2 GOL B3003 B 273 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 11.81 13.41 73.03 10.00 13.03 75.12 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 19.17 11.01 76.14 17.26 10.42 76.77 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 11.10 2.31 76.60 10.24 7.24 75.62 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR B 127 TYR^? 12.67 O1 GOL B3003 B 230 ASP B 129 ASP.? 21.97 O1 GOL B3003 B 273 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 11.81 13.41 73.03 10.00 13.03 75.12 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 19.17 11.01 76.14 17.26 10.42 76.77 -59.59 -18.37 15.65 -59.22 -18.41 17.77 coo 11.10 2.31 76.60 10.24 7.24 75.62 -67.78 -15.41 8.33 -71.72 -12.47 6.85 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c05 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP B 77 ASP~? 23.19 C1 GOL B3003 16 HIS A 55 HIS.? 23.22 O2 GOL B3003 67 GLY B 12 GLY~? 31.77 O2 GOL B3003 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -38.54 -18.65 2.88 -38.97 -18.90 2.23 1be1_c02 source 1be1 GLUTAMATE MUTASE : 1 hits 1be1_c02 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 43 GLU^? 29.98 C2 GOL B3003 A 503 TYR A 8 TYR~? 32.18 O2 GOL B3003 A 537 GLU A 36 GLU^? 32.45 C3 GOL B3003 coo 24.06 146.21 11.09 22.89 146.18 9.36 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 coo 15.91 140.69 8.32 15.71 143.39 9.13 -75.60 0.07 -12.75 -74.74 -0.75 -15.28 coo 16.65 144.44 13.24 18.34 145.22 12.33 -77.05 -4.23 -19.20 -78.34 -5.25 -20.55 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 1 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 135 ARG^? 18.21 O3 GOL B3003 A 451 GLU A 137 GLU^? 13.01 O3 GOL B3003 A 540 GLU A 94 GLU^? 12.44 O3 GOL B3003 coo 79.04 80.20 80.81 79.58 81.40 83.63 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo 81.34 87.29 87.22 82.36 86.09 88.61 -76.29 -23.51 -11.03 -77.57 -25.20 -11.05 coo 79.94 80.46 88.84 81.11 81.36 87.27 -69.86 -28.27 -14.01 -71.58 -27.29 -13.32 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 38 ARG^? 30.46 C3 GOL B3003 B 451 GLU A 43 GLU^? 29.98 C2 GOL B3003 B 540 GLU A 36 GLU^? 32.45 C3 GOL B3003 coo 82.21 41.07 119.14 83.95 40.66 116.59 -81.82 -5.43 -17.99 -82.24 -8.30 -19.04 coo 86.52 35.28 112.74 87.08 36.38 110.99 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 coo 83.38 41.19 112.55 85.47 40.59 112.72 -77.05 -4.23 -19.20 -78.34 -5.25 -20.55 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG A 135 ARG^? 18.21 O3 GOL B3003 B 451 GLU A 137 GLU^? 13.01 O3 GOL B3003 B 540 GLU A 94 GLU^? 12.44 O3 GOL B3003 coo 82.21 41.07 119.14 83.95 40.66 116.59 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo 86.52 35.28 112.74 87.08 36.38 110.99 -76.29 -23.51 -11.03 -77.57 -25.20 -11.05 coo 83.38 41.19 112.55 85.47 40.59 112.72 -69.86 -28.27 -14.01 -71.58 -27.29 -13.32 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG B 38 ARG^? 20.86 C1 GOL B3003 B 451 GLU B 43 GLU^? 18.78 O1 GOL B3003 B 540 GLU B 36 GLU^? 22.14 C1 GOL B3003 coo 82.21 41.07 119.14 83.95 40.66 116.59 -46.74 -35.40 4.40 -49.31 -36.38 5.75 coo 86.52 35.28 112.74 87.08 36.38 110.99 -52.23 -26.63 6.86 -51.71 -27.25 8.85 coo 83.38 41.19 112.55 85.47 40.59 112.72 -46.92 -30.82 5.73 -47.47 -32.26 7.22 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 3 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 104 ARG^? 31.23 C2 GOL B3003 183 LYS A 48 LYS.? 30.42 O2 GOL B3003 317 ARG B 89 ARG^? 19.99 O3 GOL B3003 coo 76.57 109.19 73.41 73.86 110.26 72.16 -70.27 -11.30 -22.73 -68.72 -9.08 -24.24 coo 82.09 117.51 66.37 80.60 114.32 71.44 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo 65.21 120.62 58.76 63.62 123.14 59.66 -63.05 -31.09 -16.52 -61.54 -30.22 -19.07 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 1 hits 1bib_c00 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 57 GLY.? 27.67 O2 GOL B3003 48 HIS A 55 HIS.? 23.22 O2 GOL B3003 99 ASP B 77 ASP~? 23.19 C1 GOL B3003 coo 12.38 5.55 24.25 13.27 5.59 24.39 -50.68 -19.34 -18.61 -51.28 -19.76 -18.45 coo 18.80 12.68 24.53 17.69 13.54 26.08 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 coo 17.07 18.51 26.62 16.67 17.07 28.09 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 1 hits 1bp2_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 38 ARG^? 30.46 C3 GOL B3003 A 128 GLU A 43 GLU^? 29.98 C2 GOL B3003 A 225 GLU A 36 GLU^? 32.45 C3 GOL B3003 coo 38.56 19.11 14.83 37.12 21.00 16.76 -81.82 -5.43 -17.99 -82.24 -8.30 -19.04 coo 36.48 24.43 22.02 36.86 26.34 21.13 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 coo 40.16 23.71 17.01 38.52 24.96 17.40 -77.05 -4.23 -19.20 -78.34 -5.25 -20.55 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG A 104 ARG^? 31.23 C2 GOL B3003 A 128 GLU A 36 GLU^? 32.45 C3 GOL B3003 A 225 GLU A 43 GLU^? 29.98 C2 GOL B3003 coo 38.56 19.11 14.83 37.12 21.00 16.76 -70.27 -11.30 -22.73 -68.72 -9.08 -24.24 coo 36.48 24.43 22.02 36.86 26.34 21.13 -77.05 -4.23 -19.20 -78.34 -5.25 -20.55 coo 40.16 23.71 17.01 38.52 24.96 17.40 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 ULMN 3 1bqc_c01 BETA-MANNANASE user 3 3 # 3 A 50 ARG B 38 ARG^? 20.86 C1 GOL B3003 A 128 GLU B 43 GLU^? 18.78 O1 GOL B3003 A 225 GLU B 36 GLU^? 22.14 C1 GOL B3003 coo 38.56 19.11 14.83 37.12 21.00 16.76 -46.74 -35.40 4.40 -49.31 -36.38 5.75 coo 36.48 24.43 22.02 36.86 26.34 21.13 -52.23 -26.63 6.86 -51.71 -27.25 8.85 coo 40.16 23.71 17.01 38.52 24.96 17.40 -46.92 -30.82 5.73 -47.47 -32.26 7.22 ULMN 3 1bqc_c01 BETA-MANNANASE user 4 3 # 4 A 50 ARG B 104 ARG^? 16.84 O1 GOL B3003 A 128 GLU B 36 GLU^? 22.14 C1 GOL B3003 A 225 GLU B 43 GLU^? 18.78 O1 GOL B3003 coo 38.56 19.11 14.83 37.12 21.00 16.76 -54.16 -24.27 10.34 -56.57 -25.03 12.16 coo 36.48 24.43 22.02 36.86 26.34 21.13 -46.92 -30.82 5.73 -47.47 -32.26 7.22 coo 40.16 23.71 17.01 38.52 24.96 17.40 -52.23 -26.63 6.86 -51.71 -27.25 8.85 1bqc_c01 source 1bqc BETA-MANNANASE : 4 hits 1bqc_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 46 PHE^? 23.53 O2 GOL B3003 A 205 ASP A 129 ASP.? 33.59 C2 GOL B3003 A 236 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 4.14 2.10 36.34 6.69 3.08 36.92 -62.08 -10.95 -15.59 -61.63 -13.70 -15.25 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 134 PHE^? 16.11 C2 GOL B3003 A 205 ASP A 129 ASP.? 33.59 C2 GOL B3003 A 236 LYS A 48 LYS.? 30.42 O2 GOL B3003 coo 4.14 2.10 36.34 6.69 3.08 36.92 -66.66 -20.84 -15.05 -67.17 -20.21 -12.35 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE B 46 PHE^? 16.98 O2 GOL B3003 A 205 ASP B 129 ASP.? 21.97 O1 GOL B3003 A 236 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 4.14 2.10 36.34 6.69 3.08 36.92 -55.24 -16.60 2.62 -58.07 -16.55 2.38 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -59.59 -18.37 15.65 -59.22 -18.41 17.77 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -67.78 -15.41 8.33 -71.72 -12.47 6.85 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE B 134 PHE^? 7.35 O2 GOL B3003 A 205 ASP B 129 ASP.? 21.97 O1 GOL B3003 A 236 LYS B 48 LYS.? 23.67 O2 GOL B3003 coo 4.14 2.10 36.34 6.69 3.08 36.92 -64.55 -22.36 2.54 -63.98 -22.76 -0.20 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -59.59 -18.37 15.65 -59.22 -18.41 17.77 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -56.50 -11.36 6.48 -60.31 -8.26 9.60 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 4 hits 1bs0_c01 naa= 3 ULMN 3 1bu7_c02 CYTOCHROME P450 user 1 3 # 1 A 268 THR A 92 THR^? 7.25 O3 GOL B3003 A 393 PHE A 134 PHE^? 16.11 C2 GOL B3003 A 400 CYH A 65 CYH~? 13.02 O2 GOL B3003 coo 45.81 71.19 43.26 47.70 70.19 43.25 -71.10 -25.35 -7.58 -71.95 -27.31 -7.64 coo 48.54 63.17 48.16 46.74 64.99 49.22 -66.66 -20.84 -15.05 -67.17 -20.21 -12.35 coo 53.76 64.39 46.87 52.06 66.55 47.33 -65.23 -17.87 -9.94 -64.55 -20.54 -9.18 ULMN 3 1bu7_c02 CYTOCHROME P450 user 2 3 # 2 A 268 THR B 92 THR^? -4.12 O3 GOL B3003s A 393 PHE B 134 PHE^? 7.35 O2 GOL B3003 A 400 CYH B 65 CYH~? 9.67 O2 GOL B3003 coo 45.81 71.19 43.26 47.70 70.19 43.25 -68.62 -27.37 -4.77 -70.50 -28.47 -4.70 coo 48.54 63.17 48.16 46.74 64.99 49.22 -64.55 -22.36 2.54 -63.98 -22.76 -0.20 coo 53.76 64.39 46.87 52.06 66.55 47.33 -61.86 -20.74 -2.77 -64.56 -20.53 -3.49 1bu7_c02 source 1bu7 CYTOCHROME P450 : 2 hits 1bu7_c02 naa= 3 ULMN 3 1bu7_c03 CYTOCHROME P450 user 1 3 # 1 B 268 THR A 92 THR^? 7.25 O3 GOL B3003 B 393 PHE A 134 PHE^? 16.11 C2 GOL B3003 B 400 CYH A 65 CYH~? 13.02 O2 GOL B3003 coo 37.20 116.32 52.00 35.18 117.07 52.13 -71.10 -25.35 -7.58 -71.95 -27.31 -7.64 coo 33.81 121.65 59.26 35.49 119.55 59.81 -66.66 -20.84 -15.05 -67.17 -20.21 -12.35 coo 28.79 121.15 57.00 30.51 118.99 56.70 -65.23 -17.87 -9.94 -64.55 -20.54 -9.18 ULMN 3 1bu7_c03 CYTOCHROME P450 user 2 3 # 2 B 268 THR B 92 THR^? -4.12 O3 GOL B3003s B 393 PHE B 134 PHE^? 7.35 O2 GOL B3003 B 400 CYH B 65 CYH~? 9.67 O2 GOL B3003 coo 37.20 116.32 52.00 35.18 117.07 52.13 -68.62 -27.37 -4.77 -70.50 -28.47 -4.70 coo 33.81 121.65 59.26 35.49 119.55 59.81 -64.55 -22.36 2.54 -63.98 -22.76 -0.20 coo 28.79 121.15 57.00 30.51 118.99 56.70 -61.86 -20.74 -2.77 -64.56 -20.53 -3.49 1bu7_c03 source 1bu7 CYTOCHROME P450 : 2 hits 1bu7_c03 naa= 3 ULMN 3 1c82_c00 HYALURONATE LYASE user 1 3 # 1 A 349 ASN A 66 ASN~? 18.56 O2 GOL B3003 A 399 HIS A 60 HIS~? 18.77 O2 GOL B3003 A 408 TYR B 26 TYR~? 20.48 O2 GOL B3003 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -55.97 -15.06 -9.69 -58.20 -13.79 -8.56 ULMN 3 1c82_c00 HYALURONATE LYASE user 2 3 # 2 A 349 ASN A 66 ASN~? 18.56 O2 GOL B3003 A 399 HIS B 60 HIS~? 17.21 O2 GOL B3003 A 408 TYR A 26 TYR~? 18.77 O2 GOL B3003 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -60.61 -11.36 -3.29 -59.04 -13.40 -4.41 ULMN 3 1c82_c00 HYALURONATE LYASE user 3 3 # 3 A 349 ASN B 66 ASN~? 17.08 O2 GOL B3003 A 399 HIS A 60 HIS~? 18.77 O2 GOL B3003 A 408 TYR B 26 TYR~? 20.48 O2 GOL B3003 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -55.97 -15.06 -9.69 -58.20 -13.79 -8.56 ULMN 3 1c82_c00 HYALURONATE LYASE user 4 3 # 4 A 349 ASN B 66 ASN~? 17.08 O2 GOL B3003 A 399 HIS B 60 HIS~? 17.21 O2 GOL B3003 A 408 TYR A 26 TYR~? 18.77 O2 GOL B3003 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -60.61 -11.36 -3.29 -59.04 -13.40 -4.41 1c82_c00 source 1c82 HYALURONATE LYASE : 4 hits 1c82_c00 naa= 3 ULMN 3 1c82_c02 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 60 HIS~? 18.77 O2 GOL B3003 A 408 TYR B 26 TYR~? 20.48 O2 GOL B3003 A 480 ARG B 50 ARG~? 28.73 O2 GOL B3003 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -55.97 -15.06 -9.69 -58.20 -13.79 -8.56 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -58.03 -1.48 1.92 -57.72 -1.86 -1.08 ULMN 3 1c82_c02 HYALURONATE LYASE user 2 3 # 2 A 399 HIS B 60 HIS~? 17.21 O2 GOL B3003 A 408 TYR A 26 TYR~? 18.77 O2 GOL B3003 A 480 ARG A 50 ARG~? 31.50 O2 GOL B3003 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -60.61 -11.36 -3.29 -59.04 -13.40 -4.41 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -46.97 -10.03 -14.88 -47.71 -8.54 -12.26 1c82_c02 source 1c82 HYALURONATE LYASE : 2 hits 1c82_c02 naa= 3 ULMN 3 1cb8_c00 CHONDROITINASE AC user 1 3 # 1 A 175 ASN A 66 ASN~? 18.56 O2 GOL B3003 A 225 HIS A 60 HIS~? 18.77 O2 GOL B3003 A 234 TYR B 26 TYR~? 20.48 O2 GOL B3003 coo 26.32 35.76 46.63 26.28 33.63 46.67 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 coo 27.04 28.61 41.75 26.86 28.65 43.84 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 21.80 30.48 43.67 23.70 29.06 45.12 -55.97 -15.06 -9.69 -58.20 -13.79 -8.56 ULMN 3 1cb8_c00 CHONDROITINASE AC user 2 3 # 2 A 175 ASN A 66 ASN~? 18.56 O2 GOL B3003 A 225 HIS B 60 HIS~? 17.21 O2 GOL B3003 A 234 TYR A 26 TYR~? 18.77 O2 GOL B3003 coo 26.32 35.76 46.63 26.28 33.63 46.67 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 coo 27.04 28.61 41.75 26.86 28.65 43.84 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 21.80 30.48 43.67 23.70 29.06 45.12 -60.61 -11.36 -3.29 -59.04 -13.40 -4.41 ULMN 3 1cb8_c00 CHONDROITINASE AC user 3 3 # 3 A 175 ASN B 66 ASN~? 17.08 O2 GOL B3003 A 225 HIS A 60 HIS~? 18.77 O2 GOL B3003 A 234 TYR B 26 TYR~? 20.48 O2 GOL B3003 coo 26.32 35.76 46.63 26.28 33.63 46.67 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 coo 27.04 28.61 41.75 26.86 28.65 43.84 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 21.80 30.48 43.67 23.70 29.06 45.12 -55.97 -15.06 -9.69 -58.20 -13.79 -8.56 ULMN 3 1cb8_c00 CHONDROITINASE AC user 4 3 # 4 A 175 ASN B 66 ASN~? 17.08 O2 GOL B3003 A 225 HIS B 60 HIS~? 17.21 O2 GOL B3003 A 234 TYR A 26 TYR~? 18.77 O2 GOL B3003 coo 26.32 35.76 46.63 26.28 33.63 46.67 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 coo 27.04 28.61 41.75 26.86 28.65 43.84 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 21.80 30.48 43.67 23.70 29.06 45.12 -60.61 -11.36 -3.29 -59.04 -13.40 -4.41 1cb8_c00 source 1cb8 CHONDROITINASE AC : 4 hits 1cb8_c00 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 40 GLY.? 26.28 C3 GOL B3003 A 228 SER A 79 SER~? 25.85 C3 GOL B3003 A 549 ASP A 77 ASP~? 25.15 O2 GOL B3003 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -82.58 -10.11 -13.61 -82.02 -9.61 -13.72 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -83.19 -7.52 -8.25 -82.08 -8.51 -10.20 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY B 40 GLY.? 18.22 C1 GOL B3003 A 228 SER B 79 SER~? 19.08 C1 GOL B3003 A 549 ASP B 77 ASP~? 23.19 C1 GOL B3003 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -51.69 -37.08 0.45 -51.33 -36.42 0.48 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -49.78 -37.37 -5.16 -50.88 -36.34 -3.25 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 2 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 40 GLY.? 26.28 C3 GOL B3003 B1228 SER A 79 SER~? 25.85 C3 GOL B3003 B1549 ASP A 77 ASP~? 25.15 O2 GOL B3003 coo 126.34 72.75 125.66 125.95 73.27 126.11 -82.58 -10.11 -13.61 -82.02 -9.61 -13.72 coo 131.65 74.68 129.41 130.31 72.73 128.82 -83.19 -7.52 -8.25 -82.08 -8.51 -10.20 coo 134.72 69.43 130.42 133.03 70.65 130.08 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY B 40 GLY.? 18.22 C1 GOL B3003 B1228 SER B 79 SER~? 19.08 C1 GOL B3003 B1549 ASP B 77 ASP~? 23.19 C1 GOL B3003 coo 126.34 72.75 125.66 125.95 73.27 126.11 -51.69 -37.08 0.45 -51.33 -36.42 0.48 coo 131.65 74.68 129.41 130.31 72.73 128.82 -49.78 -37.37 -5.16 -50.88 -36.34 -3.25 coo 134.72 69.43 130.42 133.03 70.65 130.08 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 2 hits 1cjy_c01 naa= 3 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 1 3 # 1 361 GLU A 69 GLU~? 14.08 O2 GOL B3003 447 HIS B 55 HIS.? 21.07 O2 GOL B3003 485 ASN B 54 ASN.? 18.51 O2 GOL B3003 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -68.84 -13.66 -5.25 -69.74 -15.00 -3.84 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -70.49 -6.63 0.68 -71.77 -8.29 0.64 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -66.66 -9.78 1.21 -66.97 -10.19 3.30 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 2 3 # 2 361 GLU B 69 GLU~? 14.08 O2 GOL B3003 447 HIS A 55 HIS.? 23.22 O2 GOL B3003 485 ASN A 54 ASN.? 22.89 O2 GOL B3003 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -57.32 -23.73 -7.47 -58.56 -24.80 -8.76 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -53.54 -20.89 -13.71 -53.93 -21.45 -15.71 1coy_c00 source 1coy CHOLESTEROL OXIDASE (E.C.1.1.3.6) COMPLEX WITH: 2 hits 1coy_c00 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 127 TYR^? 25.18 O3 GOL B3003 A 173 ASP A 129 ASP.? 33.59 C2 GOL B3003 C 48 ARG A 135 ARG^? 18.21 O3 GOL B3003 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 24.35 4.55 25.11 25.94 3.23 25.53 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR A 127 TYR^? 25.18 O3 GOL B3003 A 173 ASP A 130 ASP.? 32.43 C2 GOL B3003 C 48 ARG A 135 ARG^? 18.21 O3 GOL B3003 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 24.35 4.55 25.11 25.94 3.23 25.53 -68.90 -15.75 -28.47 -68.86 -13.69 -28.85 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR B 127 TYR^? 12.67 O1 GOL B3003 A 173 ASP B 130 ASP.? 19.87 O1 GOL B3003 C 48 ARG B 135 ARG^? -4.69 O1 GOL B3003s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 24.35 4.55 25.11 25.94 3.23 25.53 -58.56 -23.75 15.92 -56.48 -23.58 15.94 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -67.70 -29.08 5.06 -70.56 -28.22 5.84 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 135 ARG^? 18.21 O3 GOL B3003 C 101 TYR A 127 TYR^? 25.18 O3 GOL B3003 C 173 ASP A 129 ASP.? 33.59 C2 GOL B3003 coo 32.27 5.62 48.15 31.93 6.48 51.06 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo 29.64 3.64 57.39 31.22 5.14 55.65 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG A 135 ARG^? 18.21 O3 GOL B3003 C 101 TYR A 127 TYR^? 25.18 O3 GOL B3003 C 173 ASP A 130 ASP.? 32.43 C2 GOL B3003 coo 32.27 5.62 48.15 31.93 6.48 51.06 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo 29.64 3.64 57.39 31.22 5.14 55.65 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -68.90 -15.75 -28.47 -68.86 -13.69 -28.85 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG B 135 ARG^? -4.69 O1 GOL B3003s C 101 TYR B 127 TYR^? 12.67 O1 GOL B3003 C 173 ASP B 130 ASP.? 19.87 O1 GOL B3003 coo 32.27 5.62 48.15 31.93 6.48 51.06 -67.70 -29.08 5.06 -70.56 -28.22 5.84 coo 29.64 3.64 57.39 31.22 5.14 55.65 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -58.56 -23.75 15.92 -56.48 -23.58 15.94 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 135 ARG^? 18.21 O3 GOL B3003 D 101 TYR A 127 TYR^? 25.18 O3 GOL B3003 D 173 ASP A 130 ASP.? 32.43 C2 GOL B3003 coo 69.08 8.58 32.60 69.70 10.81 30.58 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo 71.77 11.86 24.26 70.23 12.22 26.56 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 71.60 6.14 19.25 70.26 6.87 20.69 -68.90 -15.75 -28.47 -68.86 -13.69 -28.85 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 104 ARG^? 16.84 O1 GOL B3003 D 101 TYR B 41 TYR^? 17.51 C1 GOL B3003 D 173 ASP B 108 ASP^? 13.79 O1 GOL B3003 coo 69.08 8.58 32.60 69.70 10.81 30.58 -54.16 -24.27 10.34 -56.57 -25.03 12.16 coo 71.77 11.86 24.26 70.23 12.22 26.56 -51.53 -33.23 4.97 -52.40 -31.33 6.90 coo 71.60 6.14 19.25 70.26 6.87 20.69 -57.59 -34.50 4.86 -57.32 -36.42 5.70 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG B 135 ARG^? -4.69 O1 GOL B3003s D 101 TYR B 127 TYR^? 12.67 O1 GOL B3003 D 173 ASP B 130 ASP.? 19.87 O1 GOL B3003 coo 69.08 8.58 32.60 69.70 10.81 30.58 -67.70 -29.08 5.06 -70.56 -28.22 5.84 coo 71.77 11.86 24.26 70.23 12.22 26.56 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 71.60 6.14 19.25 70.26 6.87 20.69 -58.56 -23.75 15.92 -56.48 -23.58 15.94 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 127 TYR^? 25.18 O3 GOL B3003 B 173 ASP A 129 ASP.? 33.59 C2 GOL B3003 D 48 ARG A 135 ARG^? 18.21 O3 GOL B3003 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR A 127 TYR^? 25.18 O3 GOL B3003 B 173 ASP A 130 ASP.? 32.43 C2 GOL B3003 D 48 ARG A 135 ARG^? 18.21 O3 GOL B3003 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -68.90 -15.75 -28.47 -68.86 -13.69 -28.85 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR B 127 TYR^? 12.67 O1 GOL B3003 B 173 ASP B 130 ASP.? 19.87 O1 GOL B3003 D 48 ARG B 135 ARG^? -4.69 O1 GOL B3003s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -58.56 -23.75 15.92 -56.48 -23.58 15.94 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -67.70 -29.08 5.06 -70.56 -28.22 5.84 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c03 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA A 24 ALA~? 22.09 O2 GOL B3003 A 74 ASN B 54 ASN.? 18.51 O2 GOL B3003 A 75 GLY B 57 GLY.? 22.76 O2 GOL B3003 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -65.41 -5.61 -1.70 -66.52 -6.57 -2.29 coo 1.20 66.40 122.20 2.03 64.53 121.46 -66.66 -9.78 1.21 -66.97 -10.19 3.30 coo 4.68 65.84 125.52 4.11 65.60 126.05 -65.09 -6.61 5.95 -65.49 -7.28 5.91 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA B 24 ALA~? 23.47 O2 GOL B3003 A 74 ASN A 54 ASN.? 22.89 O2 GOL B3003 A 75 GLY A 57 GLY.? 27.67 O2 GOL B3003 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -48.96 -19.03 -10.76 -49.14 -20.16 -9.73 coo 1.20 66.40 122.20 2.03 64.53 121.46 -53.54 -20.89 -13.71 -53.93 -21.45 -15.71 coo 4.68 65.84 125.52 4.11 65.60 126.05 -50.68 -19.34 -18.61 -51.28 -19.76 -18.45 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 24 ALA~? 22.09 O2 GOL B3003 B 74 ASN B 54 ASN.? 18.51 O2 GOL B3003 B 75 GLY B 57 GLY.? 22.76 O2 GOL B3003 coo 39.21 14.97 27.55 40.19 16.01 27.08 -65.41 -5.61 -1.70 -66.52 -6.57 -2.29 coo 43.06 12.94 25.74 42.26 11.81 27.44 -66.66 -9.78 1.21 -66.97 -10.19 3.30 coo 46.38 13.54 29.18 46.14 14.29 29.26 -65.09 -6.61 5.95 -65.49 -7.28 5.91 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 2 3 # 2 B 1 ALA B 24 ALA~? 23.47 O2 GOL B3003 B 74 ASN A 54 ASN.? 22.89 O2 GOL B3003 B 75 GLY A 57 GLY.? 27.67 O2 GOL B3003 coo 39.21 14.97 27.55 40.19 16.01 27.08 -48.96 -19.03 -10.76 -49.14 -20.16 -9.73 coo 43.06 12.94 25.74 42.26 11.81 27.44 -53.54 -20.89 -13.71 -53.93 -21.45 -15.71 coo 46.38 13.54 29.18 46.14 14.29 29.26 -50.68 -19.34 -18.61 -51.28 -19.76 -18.45 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 24 ALA~? 22.09 O2 GOL B3003 C 74 ASN B 54 ASN.? 18.51 O2 GOL B3003 C 75 GLY B 57 GLY.? 22.76 O2 GOL B3003 coo 16.14 15.08 36.63 15.28 14.65 37.81 -65.41 -5.61 -1.70 -66.52 -6.57 -2.29 coo 11.60 16.13 36.70 12.80 17.74 35.96 -66.66 -9.78 1.21 -66.97 -10.19 3.30 coo 10.99 19.23 40.32 11.50 18.77 40.74 -65.09 -6.61 5.95 -65.49 -7.28 5.91 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 2 3 # 2 C 1 ALA B 24 ALA~? 23.47 O2 GOL B3003 C 74 ASN A 54 ASN.? 22.89 O2 GOL B3003 C 75 GLY A 57 GLY.? 27.67 O2 GOL B3003 coo 16.14 15.08 36.63 15.28 14.65 37.81 -48.96 -19.03 -10.76 -49.14 -20.16 -9.73 coo 11.60 16.13 36.70 12.80 17.74 35.96 -53.54 -20.89 -13.71 -53.93 -21.45 -15.71 coo 10.99 19.23 40.32 11.50 18.77 40.74 -50.68 -19.34 -18.61 -51.28 -19.76 -18.45 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c06 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA A 24 ALA~? 22.09 O2 GOL B3003 D 74 ASN B 54 ASN.? 18.51 O2 GOL B3003 D 75 GLY B 57 GLY.? 22.76 O2 GOL B3003 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -65.41 -5.61 -1.70 -66.52 -6.57 -2.29 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -66.66 -9.78 1.21 -66.97 -10.19 3.30 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -65.09 -6.61 5.95 -65.49 -7.28 5.91 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 2 3 # 2 D 1 ALA B 24 ALA~? 23.47 O2 GOL B3003 D 74 ASN A 54 ASN.? 22.89 O2 GOL B3003 D 75 GLY A 57 GLY.? 27.67 O2 GOL B3003 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -48.96 -19.03 -10.76 -49.14 -20.16 -9.73 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -53.54 -20.89 -13.71 -53.93 -21.45 -15.71 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -50.68 -19.34 -18.61 -51.28 -19.76 -18.45 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c07 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR B 141 TYR^? 19.35 O3 GOL B3003 A 243 ASP A 129 ASP.? 33.59 C2 GOL B3003 A 272 LYS A 48 LYS.? 30.42 O2 GOL B3003 coo 2.03 68.31 21.46 0.66 68.36 23.90 -60.85 -36.38 -15.85 -61.05 -38.68 -17.49 coo 16.93 55.67 9.65 17.16 54.23 11.19 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 14.13 45.79 13.40 14.25 49.41 18.30 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 1 hits 1d7r_c02 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 51 GLU~? 30.75 O2 GOL B3003 A 226 THR B 58 THR.? 18.62 O2 GOL B3003 A 229 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 9.66 102.78 70.07 9.79 101.18 71.42 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 7.24 97.46 49.60 8.11 95.69 48.80 -64.53 -10.33 6.37 -66.50 -11.12 6.99 coo 10.53 97.56 43.71 9.33 93.71 47.17 -67.78 -15.41 8.33 -71.72 -12.47 6.85 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU B 51 GLU~? 27.77 O2 GOL B3003 A 226 THR A 58 THR.? 25.02 O2 GOL B3003 A 229 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 9.66 102.78 70.07 9.79 101.18 71.42 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 7.24 97.46 49.60 8.11 95.69 48.80 -54.47 -19.41 -19.06 -54.96 -21.49 -19.40 coo 10.53 97.56 43.71 9.33 93.71 47.17 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 51 GLU~? 30.75 O2 GOL B3003 B 226 THR B 58 THR.? 18.62 O2 GOL B3003 B 229 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 15.90 87.61 49.61 13.92 86.96 49.36 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 20.74 95.78 68.68 19.29 96.84 69.83 -64.53 -10.33 6.37 -66.50 -11.12 6.99 coo 22.32 101.61 71.64 17.89 98.63 71.55 -67.78 -15.41 8.33 -71.72 -12.47 6.85 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU B 51 GLU~? 27.77 O2 GOL B3003 B 226 THR A 58 THR.? 25.02 O2 GOL B3003 B 229 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 15.90 87.61 49.61 13.92 86.96 49.36 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 20.74 95.78 68.68 19.29 96.84 69.83 -54.47 -19.41 -19.06 -54.96 -21.49 -19.40 coo 22.32 101.61 71.64 17.89 98.63 71.55 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 51 GLU~? 30.75 O2 GOL B3003 C 226 THR B 58 THR.? 18.62 O2 GOL B3003 C 229 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 5.43 40.40 61.63 4.27 41.99 60.90 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 22.16 45.88 73.63 23.23 47.70 73.25 -64.53 -10.33 6.37 -66.50 -11.12 6.99 coo 28.90 45.91 73.55 25.22 49.72 72.97 -67.78 -15.41 8.33 -71.72 -12.47 6.85 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU B 51 GLU~? 27.77 O2 GOL B3003 C 226 THR A 58 THR.? 25.02 O2 GOL B3003 C 229 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 5.43 40.40 61.63 4.27 41.99 60.90 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 22.16 45.88 73.63 23.23 47.70 73.25 -54.47 -19.41 -19.06 -54.96 -21.49 -19.40 coo 28.90 45.91 73.55 25.22 49.72 72.97 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 51 GLU~? 30.75 O2 GOL B3003 D 226 THR B 58 THR.? 18.62 O2 GOL B3003 D 229 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 26.07 55.89 66.14 25.33 56.50 68.01 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 11.79 47.62 52.67 10.10 46.51 53.39 -64.53 -10.33 6.37 -66.50 -11.12 6.99 coo 10.05 41.79 49.80 7.94 44.71 53.76 -67.78 -15.41 8.33 -71.72 -12.47 6.85 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU B 51 GLU~? 27.77 O2 GOL B3003 D 226 THR A 58 THR.? 25.02 O2 GOL B3003 D 229 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 26.07 55.89 66.14 25.33 56.50 68.01 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 11.79 47.62 52.67 10.10 46.51 53.39 -54.47 -19.41 -19.06 -54.96 -21.49 -19.40 coo 10.05 41.79 49.80 7.94 44.71 53.76 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c07 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 127 TYR^? 25.18 O3 GOL B3003 A 138 ARG A 135 ARG^? 18.21 O3 GOL B3003 A 161 LYS A 131 LYS^? 32.30 O3 GOL B3003 coo 29.03 88.95 86.80 28.09 90.57 84.75 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 23.31 93.18 82.88 23.00 93.71 79.86 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo 33.83 91.15 88.62 31.07 91.06 83.02 -67.71 -19.76 -26.19 -66.60 -18.46 -30.92 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 1 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 127 TYR^? 25.18 O3 GOL B3003 B 138 ARG A 135 ARG^? 18.21 O3 GOL B3003 B 161 LYS A 131 LYS^? 32.30 O3 GOL B3003 coo 4.62 122.69 99.88 5.46 122.82 97.24 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 10.44 122.27 94.08 11.02 123.87 91.53 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo -0.17 119.75 99.65 2.51 123.83 95.70 -67.71 -19.76 -26.19 -66.60 -18.46 -30.92 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 1 hits 1dhp_c01 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 100 THR.? 28.52 C2 GOL B3003 A 45 THR A 58 THR.? 25.02 O2 GOL B3003 A 161 LYS A 131 LYS^? 32.30 O3 GOL B3003 coo 26.16 88.25 79.16 25.22 89.47 80.71 -57.44 -18.13 -23.10 -57.49 -19.81 -24.49 coo 27.73 89.90 76.08 29.24 91.46 75.95 -54.47 -19.41 -19.06 -54.96 -21.49 -19.40 coo 33.83 91.15 88.62 31.07 91.06 83.02 -67.71 -19.76 -26.19 -66.60 -18.46 -30.92 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR B 100 THR.? 19.71 O2 GOL B3003 A 45 THR B 58 THR.? 18.62 O2 GOL B3003 A 161 LYS B 131 LYS^? 20.21 O1 GOL B3003 coo 26.16 88.25 79.16 25.22 89.47 80.71 -62.76 -12.87 10.48 -64.20 -13.14 12.03 coo 27.73 89.90 76.08 29.24 91.46 75.95 -64.53 -10.33 6.37 -66.50 -11.12 6.99 coo 33.83 91.15 88.62 31.07 91.06 83.02 -62.86 -23.11 13.82 -62.51 -19.68 17.98 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 100 THR.? 28.52 C2 GOL B3003 B 45 THR A 58 THR.? 25.02 O2 GOL B3003 B 161 LYS A 131 LYS^? 32.30 O3 GOL B3003 coo 7.39 128.28 94.56 8.34 126.36 94.79 -57.44 -18.13 -23.10 -57.49 -19.81 -24.49 coo 5.75 129.25 91.25 4.29 128.16 90.07 -54.47 -19.41 -19.06 -54.96 -21.49 -19.40 coo -0.17 119.75 99.65 2.51 123.83 95.70 -67.71 -19.76 -26.19 -66.60 -18.46 -30.92 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR B 100 THR.? 19.71 O2 GOL B3003 B 45 THR B 58 THR.? 18.62 O2 GOL B3003 B 161 LYS B 131 LYS^? 20.21 O1 GOL B3003 coo 7.39 128.28 94.56 8.34 126.36 94.79 -62.76 -12.87 10.48 -64.20 -13.14 12.03 coo 5.75 129.25 91.25 4.29 128.16 90.07 -64.53 -10.33 6.37 -66.50 -11.12 6.99 coo -0.17 119.75 99.65 2.51 123.83 95.70 -62.86 -23.11 13.82 -62.51 -19.68 17.98 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c03 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 95 TYR^? 14.20 C2 GOL B3003 150 LYS A 98 LYS.? 25.35 C2 GOL B3003 186 ASN B 66 ASN~? 17.08 O2 GOL B3003 coo 32.88 50.55 24.33 31.89 51.78 26.65 -63.24 -25.54 -13.60 -63.09 -24.30 -11.10 coo 27.04 52.42 22.30 26.88 49.99 27.00 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 coo 36.98 50.30 37.29 35.85 50.29 35.50 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 95 TYR^? 14.20 C2 GOL B3003 150 LYS A 98 LYS.? 25.35 C2 GOL B3003 186 ASN B 119 ASN^? 14.64 O3 GOL B3003 coo 32.88 50.55 24.33 31.89 51.78 26.65 -63.24 -25.54 -13.60 -63.09 -24.30 -11.10 coo 27.04 52.42 22.30 26.88 49.99 27.00 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 coo 36.98 50.30 37.29 35.85 50.29 35.50 -64.01 -38.08 -11.10 -64.51 -37.27 -12.99 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR B 95 TYR^? 8.98 O2 GOL B3003 150 LYS B 98 LYS.? 17.45 O2 GOL B3003 186 ASN A 66 ASN~? 18.56 O2 GOL B3003 coo 32.88 50.55 24.33 31.89 51.78 26.65 -69.79 -19.57 1.35 -68.80 -19.30 -1.28 coo 27.04 52.42 22.30 26.88 49.99 27.00 -67.78 -15.41 8.33 -71.72 -12.47 6.85 coo 36.98 50.30 37.29 35.85 50.29 35.50 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR B 95 TYR^? 8.98 O2 GOL B3003 150 LYS B 98 LYS.? 17.45 O2 GOL B3003 186 ASN A 119 ASN^? 12.89 C3 GOL B3003 coo 32.88 50.55 24.33 31.89 51.78 26.65 -69.79 -19.57 1.35 -68.80 -19.30 -1.28 coo 27.04 52.42 22.30 26.88 49.99 27.00 -67.78 -15.41 8.33 -71.72 -12.47 6.85 coo 36.98 50.30 37.29 35.85 50.29 35.50 -82.94 -21.99 -1.71 -81.51 -22.43 -0.25 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 3 # 5 146 TYR B 95 TYR^? 8.98 O2 GOL B3003 150 LYS B 98 LYS.? 17.45 O2 GOL B3003 186 ASN B 66 ASN~? 17.08 O2 GOL B3003 coo 32.88 50.55 24.33 31.89 51.78 26.65 -69.79 -19.57 1.35 -68.80 -19.30 -1.28 coo 27.04 52.42 22.30 26.88 49.99 27.00 -67.78 -15.41 8.33 -71.72 -12.47 6.85 coo 36.98 50.30 37.29 35.85 50.29 35.50 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 5 hits 1dhr_c00 naa= 3 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 1 3 # 1 A 48 ALA A 24 ALA~? 22.09 O2 GOL B3003 A 52 HIS B 60 HIS~? 17.21 O2 GOL B3003 A 191 TRP A 86 TRP^? 20.33 O2 GOL B3003 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -65.41 -5.61 -1.70 -66.52 -6.57 -2.29 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -79.05 -9.51 -1.28 -75.45 -10.68 -2.38 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 2 3 # 2 A 48 ALA A 61 ALA~? 16.30 O2 GOL B3003 A 52 HIS A 60 HIS~? 18.77 O2 GOL B3003 A 191 TRP B 86 TRP^? 19.60 C1 GOL B3003 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -60.15 -20.89 -12.58 -60.06 -22.39 -12.11 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -52.11 -33.03 -11.80 -53.43 -29.51 -10.61 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 3 3 # 3 A 48 ALA B 24 ALA~? 23.47 O2 GOL B3003 A 52 HIS A 60 HIS~? 18.77 O2 GOL B3003 A 191 TRP B 86 TRP^? 19.60 C1 GOL B3003 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -48.96 -19.03 -10.76 -49.14 -20.16 -9.73 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -52.11 -33.03 -11.80 -53.43 -29.51 -10.61 1dj1_c00 source 1dj1 CYTOCHROME C PEROXIDASE : 3 hits 1dj1_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 48 LYS.? 30.42 O2 GOL B3003 B 215 LYS A 98 LYS.? 25.35 C2 GOL B3003 B 277 LYS A 131 LYS^? 32.30 O3 GOL B3003 coo 6.78 45.91 16.15 7.82 40.81 15.84 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo 17.88 38.77 19.81 16.38 34.23 17.24 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 coo 20.33 37.78 11.20 16.77 34.53 13.47 -67.71 -19.76 -26.19 -66.60 -18.46 -30.92 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS B 48 LYS.? 23.67 O2 GOL B3003 B 215 LYS B 98 LYS.? 17.45 O2 GOL B3003 B 277 LYS B 131 LYS^? 20.21 O1 GOL B3003 coo 6.78 45.91 16.15 7.82 40.81 15.84 -56.50 -11.36 6.48 -60.31 -8.26 9.60 coo 17.88 38.77 19.81 16.38 34.23 17.24 -67.78 -15.41 8.33 -71.72 -12.47 6.85 coo 20.33 37.78 11.20 16.77 34.53 13.47 -62.86 -23.11 13.82 -62.51 -19.68 17.98 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 2 hits 1e19_c01 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 127 TYR^? 25.18 O3 GOL B3003 A 40 ASP A 102 ASP.? 31.57 O2 GOL B3003 A 103 ASP A 129 ASP.? 33.59 C2 GOL B3003 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 127 TYR^? 12.67 O1 GOL B3003 A 40 ASP B 102 ASP.? 23.17 O2 GOL B3003 A 103 ASP B 129 ASP.? 21.97 O1 GOL B3003 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -59.59 -18.37 15.65 -59.22 -18.41 17.77 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 2 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 127 TYR^? 25.18 O3 GOL B3003 B 40 ASP A 102 ASP.? 31.57 O2 GOL B3003 B 103 ASP A 129 ASP.? 33.59 C2 GOL B3003 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 127 TYR^? 12.67 O1 GOL B3003 B 40 ASP B 102 ASP.? 23.17 O2 GOL B3003 B 103 ASP B 129 ASP.? 21.97 O1 GOL B3003 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -59.59 -18.37 15.65 -59.22 -18.41 17.77 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 2 hits 1e3v_c03 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 42 ALA^? 24.61 O2 GOL B3003 A 257 ALA A 71 ALA~? 21.52 O2 GOL B3003 A 328 ASP A 77 ASP~? 25.15 O2 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -75.69 -8.89 -14.89 -75.18 -9.08 -13.44 coo 43.22 26.73 5.37 41.81 27.09 5.79 -72.14 -10.92 -11.36 -71.97 -11.62 -12.73 coo 38.17 34.10 6.67 37.72 32.06 6.84 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 42 ALA^? 24.61 O2 GOL B3003 A 257 ALA A 72 ALA~? 17.50 O2 GOL B3003 A 328 ASP A 77 ASP~? 25.15 O2 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -75.69 -8.89 -14.89 -75.18 -9.08 -13.44 coo 43.22 26.73 5.37 41.81 27.09 5.79 -74.48 -13.14 -9.37 -74.19 -14.60 -8.89 coo 38.17 34.10 6.67 37.72 32.06 6.84 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 68 ALA~? 16.38 O2 GOL B3003 A 257 ALA A 71 ALA~? 21.52 O2 GOL B3003 A 328 ASP A 108 ASP^? 24.12 C3 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -69.22 -15.24 -11.24 -69.18 -16.81 -11.21 coo 43.22 26.73 5.37 41.81 27.09 5.79 -72.14 -10.92 -11.36 -71.97 -11.62 -12.73 coo 38.17 34.10 6.67 37.72 32.06 6.84 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 68 ALA~? 16.38 O2 GOL B3003 A 257 ALA A 72 ALA~? 17.50 O2 GOL B3003 A 328 ASP A 108 ASP^? 24.12 C3 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -69.22 -15.24 -11.24 -69.18 -16.81 -11.21 coo 43.22 26.73 5.37 41.81 27.09 5.79 -74.48 -13.14 -9.37 -74.19 -14.60 -8.89 coo 38.17 34.10 6.67 37.72 32.06 6.84 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA A 68 ALA~? 16.38 O2 GOL B3003 A 257 ALA A 105 ALA^? 21.96 O2 GOL B3003 A 328 ASP A 108 ASP^? 24.12 C3 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -69.22 -15.24 -11.24 -69.18 -16.81 -11.21 coo 43.22 26.73 5.37 41.81 27.09 5.79 -69.34 -13.50 -17.22 -68.78 -13.44 -15.72 coo 38.17 34.10 6.67 37.72 32.06 6.84 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA A 68 ALA~? 16.38 O2 GOL B3003 A 257 ALA A 136 ALA^? 13.82 C2 GOL B3003 A 328 ASP A 108 ASP^? 24.12 C3 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -69.22 -15.24 -11.24 -69.18 -16.81 -11.21 coo 43.22 26.73 5.37 41.81 27.09 5.79 -71.60 -21.85 -11.90 -70.79 -20.73 -11.21 coo 38.17 34.10 6.67 37.72 32.06 6.84 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA A 71 ALA~? 21.52 O2 GOL B3003 A 257 ALA A 42 ALA^? 24.61 O2 GOL B3003 A 328 ASP A 77 ASP~? 25.15 O2 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -72.14 -10.92 -11.36 -71.97 -11.62 -12.73 coo 43.22 26.73 5.37 41.81 27.09 5.79 -75.69 -8.89 -14.89 -75.18 -9.08 -13.44 coo 38.17 34.10 6.67 37.72 32.06 6.84 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA A 71 ALA~? 21.52 O2 GOL B3003 A 257 ALA A 42 ALA^? 24.61 O2 GOL B3003 A 328 ASP A 108 ASP^? 24.12 C3 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -72.14 -10.92 -11.36 -71.97 -11.62 -12.73 coo 43.22 26.73 5.37 41.81 27.09 5.79 -75.69 -8.89 -14.89 -75.18 -9.08 -13.44 coo 38.17 34.10 6.67 37.72 32.06 6.84 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA A 71 ALA~? 21.52 O2 GOL B3003 A 257 ALA A 72 ALA~? 17.50 O2 GOL B3003 A 328 ASP A 77 ASP~? 25.15 O2 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -72.14 -10.92 -11.36 -71.97 -11.62 -12.73 coo 43.22 26.73 5.37 41.81 27.09 5.79 -74.48 -13.14 -9.37 -74.19 -14.60 -8.89 coo 38.17 34.10 6.67 37.72 32.06 6.84 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA A 71 ALA~? 21.52 O2 GOL B3003 A 257 ALA A 72 ALA~? 17.50 O2 GOL B3003 A 328 ASP A 108 ASP^? 24.12 C3 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -72.14 -10.92 -11.36 -71.97 -11.62 -12.73 coo 43.22 26.73 5.37 41.81 27.09 5.79 -74.48 -13.14 -9.37 -74.19 -14.60 -8.89 coo 38.17 34.10 6.67 37.72 32.06 6.84 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA A 71 ALA~? 21.52 O2 GOL B3003 A 257 ALA A 105 ALA^? 21.96 O2 GOL B3003 A 328 ASP A 108 ASP^? 24.12 C3 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -72.14 -10.92 -11.36 -71.97 -11.62 -12.73 coo 43.22 26.73 5.37 41.81 27.09 5.79 -69.34 -13.50 -17.22 -68.78 -13.44 -15.72 coo 38.17 34.10 6.67 37.72 32.06 6.84 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA A 72 ALA~? 17.50 O2 GOL B3003 A 257 ALA A 42 ALA^? 24.61 O2 GOL B3003 A 328 ASP A 77 ASP~? 25.15 O2 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -74.48 -13.14 -9.37 -74.19 -14.60 -8.89 coo 43.22 26.73 5.37 41.81 27.09 5.79 -75.69 -8.89 -14.89 -75.18 -9.08 -13.44 coo 38.17 34.10 6.67 37.72 32.06 6.84 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA A 72 ALA~? 17.50 O2 GOL B3003 A 257 ALA A 42 ALA^? 24.61 O2 GOL B3003 A 328 ASP A 108 ASP^? 24.12 C3 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -74.48 -13.14 -9.37 -74.19 -14.60 -8.89 coo 43.22 26.73 5.37 41.81 27.09 5.79 -75.69 -8.89 -14.89 -75.18 -9.08 -13.44 coo 38.17 34.10 6.67 37.72 32.06 6.84 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 14 3 # 14 A 229 ALA A 72 ALA~? 17.50 O2 GOL B3003 A 257 ALA A 71 ALA~? 21.52 O2 GOL B3003 A 328 ASP A 77 ASP~? 25.15 O2 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -74.48 -13.14 -9.37 -74.19 -14.60 -8.89 coo 43.22 26.73 5.37 41.81 27.09 5.79 -72.14 -10.92 -11.36 -71.97 -11.62 -12.73 coo 38.17 34.10 6.67 37.72 32.06 6.84 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 15 3 # 15 A 229 ALA A 72 ALA~? 17.50 O2 GOL B3003 A 257 ALA A 71 ALA~? 21.52 O2 GOL B3003 A 328 ASP A 108 ASP^? 24.12 C3 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -74.48 -13.14 -9.37 -74.19 -14.60 -8.89 coo 43.22 26.73 5.37 41.81 27.09 5.79 -72.14 -10.92 -11.36 -71.97 -11.62 -12.73 coo 38.17 34.10 6.67 37.72 32.06 6.84 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 16 3 # 16 A 229 ALA A 97 ALA.? 23.38 O3 GOL B3003 A 257 ALA A 99 ALA.? 23.47 O2 GOL B3003 A 328 ASP A 129 ASP.? 33.59 C2 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -62.47 -25.33 -21.21 -63.01 -24.79 -22.57 coo 43.22 26.73 5.37 41.81 27.09 5.79 -59.96 -19.58 -20.71 -60.50 -18.86 -19.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 17 3 # 17 A 229 ALA A 105 ALA^? 21.96 O2 GOL B3003 A 257 ALA A 71 ALA~? 21.52 O2 GOL B3003 A 328 ASP A 108 ASP^? 24.12 C3 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -69.34 -13.50 -17.22 -68.78 -13.44 -15.72 coo 43.22 26.73 5.37 41.81 27.09 5.79 -72.14 -10.92 -11.36 -71.97 -11.62 -12.73 coo 38.17 34.10 6.67 37.72 32.06 6.84 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 18 3 # 18 A 229 ALA A 105 ALA^? 21.96 O2 GOL B3003 A 257 ALA A 126 ALA^? 20.93 C2 GOL B3003 A 328 ASP A 102 ASP.? 31.57 O2 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -69.34 -13.50 -17.22 -68.78 -13.44 -15.72 coo 43.22 26.73 5.37 41.81 27.09 5.79 -68.45 -17.28 -18.43 -67.26 -17.28 -17.43 coo 38.17 34.10 6.67 37.72 32.06 6.84 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 19 3 # 19 A 229 ALA A 105 ALA^? 21.96 O2 GOL B3003 A 257 ALA A 126 ALA^? 20.93 C2 GOL B3003 A 328 ASP A 108 ASP^? 24.12 C3 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -69.34 -13.50 -17.22 -68.78 -13.44 -15.72 coo 43.22 26.73 5.37 41.81 27.09 5.79 -68.45 -17.28 -18.43 -67.26 -17.28 -17.43 coo 38.17 34.10 6.67 37.72 32.06 6.84 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 20 3 # 20 A 229 ALA A 105 ALA^? 21.96 O2 GOL B3003 A 257 ALA A 126 ALA^? 20.93 C2 GOL B3003 A 328 ASP A 130 ASP.? 32.43 C2 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -69.34 -13.50 -17.22 -68.78 -13.44 -15.72 coo 43.22 26.73 5.37 41.81 27.09 5.79 -68.45 -17.28 -18.43 -67.26 -17.28 -17.43 coo 38.17 34.10 6.67 37.72 32.06 6.84 -68.90 -15.75 -28.47 -68.86 -13.69 -28.85 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 21 3 # 21 A 229 ALA A 126 ALA^? 20.93 C2 GOL B3003 A 257 ALA A 105 ALA^? 21.96 O2 GOL B3003 A 328 ASP A 102 ASP.? 31.57 O2 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -68.45 -17.28 -18.43 -67.26 -17.28 -17.43 coo 43.22 26.73 5.37 41.81 27.09 5.79 -69.34 -13.50 -17.22 -68.78 -13.44 -15.72 coo 38.17 34.10 6.67 37.72 32.06 6.84 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 22 3 # 22 A 229 ALA A 126 ALA^? 20.93 C2 GOL B3003 A 257 ALA A 105 ALA^? 21.96 O2 GOL B3003 A 328 ASP A 108 ASP^? 24.12 C3 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -68.45 -17.28 -18.43 -67.26 -17.28 -17.43 coo 43.22 26.73 5.37 41.81 27.09 5.79 -69.34 -13.50 -17.22 -68.78 -13.44 -15.72 coo 38.17 34.10 6.67 37.72 32.06 6.84 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 23 3 # 23 A 229 ALA B 42 ALA^? 16.63 C1 GOL B3003 A 257 ALA B 71 ALA~? 13.92 O2 GOL B3003 A 328 ASP B 77 ASP~? 23.19 C1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -51.52 -30.04 1.96 -51.81 -29.58 0.53 coo 43.22 26.73 5.37 41.81 27.09 5.79 -54.10 -26.79 -1.51 -54.86 -26.75 -0.19 coo 38.17 34.10 6.67 37.72 32.06 6.84 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 24 3 # 24 A 229 ALA B 42 ALA^? 16.63 C1 GOL B3003 A 257 ALA B 72 ALA~? 11.73 C1 GOL B3003 A 328 ASP B 77 ASP~? 23.19 C1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -51.52 -30.04 1.96 -51.81 -29.58 0.53 coo 43.22 26.73 5.37 41.81 27.09 5.79 -56.11 -29.30 -3.54 -57.59 -29.20 -3.91 coo 38.17 34.10 6.67 37.72 32.06 6.84 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 25 3 # 25 A 229 ALA B 67 ALA~? 13.93 O2 GOL B3003 A 257 ALA B 105 ALA^? 12.73 O2 GOL B3003 A 328 ASP B 102 ASP.? 23.17 O2 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -56.73 -21.14 -0.96 -57.02 -20.76 0.55 coo 43.22 26.73 5.37 41.81 27.09 5.79 -56.92 -24.43 4.67 -57.11 -23.87 3.22 coo 38.17 34.10 6.67 37.72 32.06 6.84 -54.64 -15.40 9.63 -53.71 -13.49 9.90 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 26 3 # 26 A 229 ALA B 68 ALA~? 9.46 O2 GOL B3003 A 257 ALA B 71 ALA~? 13.92 O2 GOL B3003 A 328 ASP B 108 ASP^? 13.79 O1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -58.71 -24.38 -1.50 -60.25 -24.49 -1.51 coo 43.22 26.73 5.37 41.81 27.09 5.79 -54.10 -26.79 -1.51 -54.86 -26.75 -0.19 coo 38.17 34.10 6.67 37.72 32.06 6.84 -57.59 -34.50 4.86 -57.32 -36.42 5.70 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 27 3 # 27 A 229 ALA B 68 ALA~? 9.46 O2 GOL B3003 A 257 ALA B 72 ALA~? 11.73 C1 GOL B3003 A 328 ASP B 108 ASP^? 13.79 O1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -58.71 -24.38 -1.50 -60.25 -24.49 -1.51 coo 43.22 26.73 5.37 41.81 27.09 5.79 -56.11 -29.30 -3.54 -57.59 -29.20 -3.91 coo 38.17 34.10 6.67 37.72 32.06 6.84 -57.59 -34.50 4.86 -57.32 -36.42 5.70 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 28 3 # 28 A 229 ALA B 68 ALA~? 9.46 O2 GOL B3003 A 257 ALA B 105 ALA^? 12.73 O2 GOL B3003 A 328 ASP B 108 ASP^? 13.79 O1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -58.71 -24.38 -1.50 -60.25 -24.49 -1.51 coo 43.22 26.73 5.37 41.81 27.09 5.79 -56.92 -24.43 4.67 -57.11 -23.87 3.22 coo 38.17 34.10 6.67 37.72 32.06 6.84 -57.59 -34.50 4.86 -57.32 -36.42 5.70 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 29 3 # 29 A 229 ALA B 71 ALA~? 13.92 O2 GOL B3003 A 257 ALA B 42 ALA^? 16.63 C1 GOL B3003 A 328 ASP B 77 ASP~? 23.19 C1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -54.10 -26.79 -1.51 -54.86 -26.75 -0.19 coo 43.22 26.73 5.37 41.81 27.09 5.79 -51.52 -30.04 1.96 -51.81 -29.58 0.53 coo 38.17 34.10 6.67 37.72 32.06 6.84 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 30 3 # 30 A 229 ALA B 71 ALA~? 13.92 O2 GOL B3003 A 257 ALA B 42 ALA^? 16.63 C1 GOL B3003 A 328 ASP B 108 ASP^? 13.79 O1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -54.10 -26.79 -1.51 -54.86 -26.75 -0.19 coo 43.22 26.73 5.37 41.81 27.09 5.79 -51.52 -30.04 1.96 -51.81 -29.58 0.53 coo 38.17 34.10 6.67 37.72 32.06 6.84 -57.59 -34.50 4.86 -57.32 -36.42 5.70 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 31 3 # 31 A 229 ALA B 71 ALA~? 13.92 O2 GOL B3003 A 257 ALA B 72 ALA~? 11.73 C1 GOL B3003 A 328 ASP B 77 ASP~? 23.19 C1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -54.10 -26.79 -1.51 -54.86 -26.75 -0.19 coo 43.22 26.73 5.37 41.81 27.09 5.79 -56.11 -29.30 -3.54 -57.59 -29.20 -3.91 coo 38.17 34.10 6.67 37.72 32.06 6.84 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 32 3 # 32 A 229 ALA B 71 ALA~? 13.92 O2 GOL B3003 A 257 ALA B 72 ALA~? 11.73 C1 GOL B3003 A 328 ASP B 108 ASP^? 13.79 O1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -54.10 -26.79 -1.51 -54.86 -26.75 -0.19 coo 43.22 26.73 5.37 41.81 27.09 5.79 -56.11 -29.30 -3.54 -57.59 -29.20 -3.91 coo 38.17 34.10 6.67 37.72 32.06 6.84 -57.59 -34.50 4.86 -57.32 -36.42 5.70 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 33 3 # 33 A 229 ALA B 71 ALA~? 13.92 O2 GOL B3003 A 257 ALA B 105 ALA^? 12.73 O2 GOL B3003 A 328 ASP B 108 ASP^? 13.79 O1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -54.10 -26.79 -1.51 -54.86 -26.75 -0.19 coo 43.22 26.73 5.37 41.81 27.09 5.79 -56.92 -24.43 4.67 -57.11 -23.87 3.22 coo 38.17 34.10 6.67 37.72 32.06 6.84 -57.59 -34.50 4.86 -57.32 -36.42 5.70 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 34 3 # 34 A 229 ALA B 72 ALA~? 11.73 C1 GOL B3003 A 257 ALA B 42 ALA^? 16.63 C1 GOL B3003 A 328 ASP B 77 ASP~? 23.19 C1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -56.11 -29.30 -3.54 -57.59 -29.20 -3.91 coo 43.22 26.73 5.37 41.81 27.09 5.79 -51.52 -30.04 1.96 -51.81 -29.58 0.53 coo 38.17 34.10 6.67 37.72 32.06 6.84 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 35 3 # 35 A 229 ALA B 72 ALA~? 11.73 C1 GOL B3003 A 257 ALA B 42 ALA^? 16.63 C1 GOL B3003 A 328 ASP B 108 ASP^? 13.79 O1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -56.11 -29.30 -3.54 -57.59 -29.20 -3.91 coo 43.22 26.73 5.37 41.81 27.09 5.79 -51.52 -30.04 1.96 -51.81 -29.58 0.53 coo 38.17 34.10 6.67 37.72 32.06 6.84 -57.59 -34.50 4.86 -57.32 -36.42 5.70 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 36 3 # 36 A 229 ALA B 72 ALA~? 11.73 C1 GOL B3003 A 257 ALA B 71 ALA~? 13.92 O2 GOL B3003 A 328 ASP B 77 ASP~? 23.19 C1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -56.11 -29.30 -3.54 -57.59 -29.20 -3.91 coo 43.22 26.73 5.37 41.81 27.09 5.79 -54.10 -26.79 -1.51 -54.86 -26.75 -0.19 coo 38.17 34.10 6.67 37.72 32.06 6.84 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 37 3 # 37 A 229 ALA B 72 ALA~? 11.73 C1 GOL B3003 A 257 ALA B 71 ALA~? 13.92 O2 GOL B3003 A 328 ASP B 108 ASP^? 13.79 O1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -56.11 -29.30 -3.54 -57.59 -29.20 -3.91 coo 43.22 26.73 5.37 41.81 27.09 5.79 -54.10 -26.79 -1.51 -54.86 -26.75 -0.19 coo 38.17 34.10 6.67 37.72 32.06 6.84 -57.59 -34.50 4.86 -57.32 -36.42 5.70 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 38 3 # 38 A 229 ALA B 97 ALA.? 13.42 O2 GOL B3003 A 257 ALA B 99 ALA.? 14.94 O2 GOL B3003 A 328 ASP B 129 ASP.? 21.97 O1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -69.29 -18.84 8.94 -68.60 -19.32 10.25 coo 43.22 26.73 5.37 41.81 27.09 5.79 -63.97 -15.58 8.13 -63.29 -16.06 6.87 coo 38.17 34.10 6.67 37.72 32.06 6.84 -59.59 -18.37 15.65 -59.22 -18.41 17.77 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 39 3 # 39 A 229 ALA B 105 ALA^? 12.73 O2 GOL B3003 A 257 ALA B 71 ALA~? 13.92 O2 GOL B3003 A 328 ASP B 108 ASP^? 13.79 O1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -56.92 -24.43 4.67 -57.11 -23.87 3.22 coo 43.22 26.73 5.37 41.81 27.09 5.79 -54.10 -26.79 -1.51 -54.86 -26.75 -0.19 coo 38.17 34.10 6.67 37.72 32.06 6.84 -57.59 -34.50 4.86 -57.32 -36.42 5.70 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 40 3 # 40 A 229 ALA B 105 ALA^? 12.73 O2 GOL B3003 A 257 ALA B 126 ALA^? 10.66 O2 GOL B3003 A 328 ASP B 130 ASP.? 19.87 O1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -56.92 -24.43 4.67 -57.11 -23.87 3.22 coo 43.22 26.73 5.37 41.81 27.09 5.79 -60.76 -23.74 5.87 -60.95 -22.56 4.85 coo 38.17 34.10 6.67 37.72 32.06 6.84 -58.56 -23.75 15.92 -56.48 -23.58 15.94 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 41 3 # 41 A 229 ALA B 126 ALA^? 10.66 O2 GOL B3003 A 257 ALA B 105 ALA^? 12.73 O2 GOL B3003 A 328 ASP B 102 ASP.? 23.17 O2 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -60.76 -23.74 5.87 -60.95 -22.56 4.85 coo 43.22 26.73 5.37 41.81 27.09 5.79 -56.92 -24.43 4.67 -57.11 -23.87 3.22 coo 38.17 34.10 6.67 37.72 32.06 6.84 -54.64 -15.40 9.63 -53.71 -13.49 9.90 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 42 3 # 42 A 229 ALA B 126 ALA^? 10.66 O2 GOL B3003 A 257 ALA B 105 ALA^? 12.73 O2 GOL B3003 A 328 ASP B 108 ASP^? 13.79 O1 GOL B3003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -60.76 -23.74 5.87 -60.95 -22.56 4.85 coo 43.22 26.73 5.37 41.81 27.09 5.79 -56.92 -24.43 4.67 -57.11 -23.87 3.22 coo 38.17 34.10 6.67 37.72 32.06 6.84 -57.59 -34.50 4.86 -57.32 -36.42 5.70 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 42 hits 1eo7_c00 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 48 LYS.? 30.42 O2 GOL B3003 A 193 GLU A 51 GLU~? 30.75 O2 GOL B3003 A 217 VAL A 52 VAL~? 24.69 O2 GOL B3003 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -54.95 -13.44 -13.36 -56.57 -12.17 -14.20 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS B 48 LYS.? 23.67 O2 GOL B3003 A 193 GLU B 51 GLU~? 27.77 O2 GOL B3003 A 217 VAL B 52 VAL~? 20.63 O2 GOL B3003 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -56.50 -11.36 6.48 -60.31 -8.26 9.60 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -58.91 -10.05 0.41 -57.27 -11.32 1.25 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 2 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 45 THR^? 29.40 O2 GOL B3003 A 159 LYS A 48 LYS.? 30.42 O2 GOL B3003 A 193 GLU A 51 GLU~? 30.75 O2 GOL B3003 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -65.94 -8.74 -18.36 -66.12 -7.40 -20.07 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 100 THR.? 28.52 C2 GOL B3003 A 159 LYS A 131 LYS^? 32.30 O3 GOL B3003 A 193 GLU A 43 GLU^? 29.98 C2 GOL B3003 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -57.44 -18.13 -23.10 -57.49 -19.81 -24.49 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -67.71 -19.76 -26.19 -66.60 -18.46 -30.92 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR B 45 THR^? 20.55 O2 GOL B3003 A 159 LYS B 48 LYS.? 23.67 O2 GOL B3003 A 193 GLU B 51 GLU~? 27.77 O2 GOL B3003 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -52.39 -20.27 5.23 -50.82 -20.45 6.75 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -56.50 -11.36 6.48 -60.31 -8.26 9.60 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR B 100 THR.? 19.71 O2 GOL B3003 A 159 LYS B 131 LYS^? 20.21 O1 GOL B3003 A 193 GLU B 43 GLU^? 18.78 O1 GOL B3003 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -62.76 -12.87 10.48 -64.20 -13.14 12.03 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -62.86 -23.11 13.82 -62.51 -19.68 17.98 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -52.23 -26.63 6.86 -51.71 -27.25 8.85 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 4 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 102 ASP.? 31.57 O2 GOL B3003 260 GLU A 43 GLU^? 29.98 C2 GOL B3003 370 TYR A 127 TYR^? 25.18 O3 GOL B3003 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP A 108 ASP^? 24.12 C3 GOL B3003 260 GLU A 43 GLU^? 29.98 C2 GOL B3003 370 TYR A 127 TYR^? 25.18 O3 GOL B3003 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP B 102 ASP.? 23.17 O2 GOL B3003 260 GLU B 43 GLU^? 18.78 O1 GOL B3003 370 TYR B 127 TYR^? 12.67 O1 GOL B3003 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -52.23 -26.63 6.86 -51.71 -27.25 8.85 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -59.88 -24.81 10.26 -60.45 -27.57 10.09 ULMN 3 1euu_c00 SIALIDASE user 4 3 # 4 92 ASP B 108 ASP^? 13.79 O1 GOL B3003 260 GLU B 43 GLU^? 18.78 O1 GOL B3003 370 TYR B 127 TYR^? 12.67 O1 GOL B3003 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -57.59 -34.50 4.86 -57.32 -36.42 5.70 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -52.23 -26.63 6.86 -51.71 -27.25 8.85 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -59.88 -24.81 10.26 -60.45 -27.57 10.09 1euu_c00 source 1euu SIALIDASE : 4 hits 1euu_c00 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 127 TYR^? 25.18 O3 GOL B3003 A 142 LEU A 64 LEU~? 19.16 O2 GOL B3003 A 165 LYS A 131 LYS^? 32.30 O3 GOL B3003 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -63.56 -18.28 -14.02 -62.68 -18.47 -15.97 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -67.71 -19.76 -26.19 -66.60 -18.46 -30.92 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 127 TYR^? 25.18 O3 GOL B3003 B 142 LEU A 64 LEU~? 19.16 O2 GOL B3003 B 165 LYS A 131 LYS^? 32.30 O3 GOL B3003 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -63.56 -18.28 -14.02 -62.68 -18.47 -15.97 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -67.71 -19.76 -26.19 -66.60 -18.46 -30.92 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 127 TYR^? 25.18 O3 GOL B3003 D 142 LEU A 64 LEU~? 19.16 O2 GOL B3003 D 165 LYS A 131 LYS^? 32.30 O3 GOL B3003 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -63.56 -18.28 -14.02 -62.68 -18.47 -15.97 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -67.71 -19.76 -26.19 -66.60 -18.46 -30.92 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c03 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 38 ARG^? 30.46 C3 GOL B3003 A 136 GLU A 43 GLU^? 29.98 C2 GOL B3003 A 246 GLU A 36 GLU^? 32.45 C3 GOL B3003 coo 13.48 30.30 107.06 11.75 30.99 109.44 -81.82 -5.43 -17.99 -82.24 -8.30 -19.04 coo 9.46 32.37 115.82 8.50 34.20 115.47 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 coo 11.99 34.33 109.92 10.08 34.19 110.77 -77.05 -4.23 -19.20 -78.34 -5.25 -20.55 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG A 104 ARG^? 31.23 C2 GOL B3003 A 136 GLU A 36 GLU^? 32.45 C3 GOL B3003 A 246 GLU A 43 GLU^? 29.98 C2 GOL B3003 coo 13.48 30.30 107.06 11.75 30.99 109.44 -70.27 -11.30 -22.73 -68.72 -9.08 -24.24 coo 9.46 32.37 115.82 8.50 34.20 115.47 -77.05 -4.23 -19.20 -78.34 -5.25 -20.55 coo 11.99 34.33 109.92 10.08 34.19 110.77 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG A 135 ARG^? 18.21 O3 GOL B3003 A 136 GLU A 137 GLU^? 13.01 O3 GOL B3003 A 246 GLU A 94 GLU^? 12.44 O3 GOL B3003 coo 13.48 30.30 107.06 11.75 30.99 109.44 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo 9.46 32.37 115.82 8.50 34.20 115.47 -76.29 -23.51 -11.03 -77.57 -25.20 -11.05 coo 11.99 34.33 109.92 10.08 34.19 110.77 -69.86 -28.27 -14.01 -71.58 -27.29 -13.32 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG B 38 ARG^? 20.86 C1 GOL B3003 A 136 GLU B 43 GLU^? 18.78 O1 GOL B3003 A 246 GLU B 36 GLU^? 22.14 C1 GOL B3003 coo 13.48 30.30 107.06 11.75 30.99 109.44 -46.74 -35.40 4.40 -49.31 -36.38 5.75 coo 9.46 32.37 115.82 8.50 34.20 115.47 -52.23 -26.63 6.86 -51.71 -27.25 8.85 coo 11.99 34.33 109.92 10.08 34.19 110.77 -46.92 -30.82 5.73 -47.47 -32.26 7.22 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG B 104 ARG^? 16.84 O1 GOL B3003 A 136 GLU B 36 GLU^? 22.14 C1 GOL B3003 A 246 GLU B 43 GLU^? 18.78 O1 GOL B3003 coo 13.48 30.30 107.06 11.75 30.99 109.44 -54.16 -24.27 10.34 -56.57 -25.03 12.16 coo 9.46 32.37 115.82 8.50 34.20 115.47 -46.92 -30.82 5.73 -47.47 -32.26 7.22 coo 11.99 34.33 109.92 10.08 34.19 110.77 -52.23 -26.63 6.86 -51.71 -27.25 8.85 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 5 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 38 ARG^? 30.46 C3 GOL B3003 A 136 GLU A 43 GLU^? 29.98 C2 GOL B3003 A 246 GLU A 36 GLU^? 32.45 C3 GOL B3003 coo 13.94 29.84 106.80 11.67 30.40 108.79 -81.82 -5.43 -17.99 -82.24 -8.30 -19.04 coo 9.52 31.97 115.23 8.45 33.74 114.72 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 coo 11.92 33.82 109.35 10.10 33.50 110.39 -77.05 -4.23 -19.20 -78.34 -5.25 -20.55 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG A 104 ARG^? 31.23 C2 GOL B3003 A 136 GLU A 36 GLU^? 32.45 C3 GOL B3003 A 246 GLU A 43 GLU^? 29.98 C2 GOL B3003 coo 13.94 29.84 106.80 11.67 30.40 108.79 -70.27 -11.30 -22.73 -68.72 -9.08 -24.24 coo 9.52 31.97 115.23 8.45 33.74 114.72 -77.05 -4.23 -19.20 -78.34 -5.25 -20.55 coo 11.92 33.82 109.35 10.10 33.50 110.39 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG A 135 ARG^? 18.21 O3 GOL B3003 A 136 GLU A 137 GLU^? 13.01 O3 GOL B3003 A 246 GLU A 94 GLU^? 12.44 O3 GOL B3003 coo 13.94 29.84 106.80 11.67 30.40 108.79 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo 9.52 31.97 115.23 8.45 33.74 114.72 -76.29 -23.51 -11.03 -77.57 -25.20 -11.05 coo 11.92 33.82 109.35 10.10 33.50 110.39 -69.86 -28.27 -14.01 -71.58 -27.29 -13.32 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG B 38 ARG^? 20.86 C1 GOL B3003 A 136 GLU B 43 GLU^? 18.78 O1 GOL B3003 A 246 GLU B 36 GLU^? 22.14 C1 GOL B3003 coo 13.94 29.84 106.80 11.67 30.40 108.79 -46.74 -35.40 4.40 -49.31 -36.38 5.75 coo 9.52 31.97 115.23 8.45 33.74 114.72 -52.23 -26.63 6.86 -51.71 -27.25 8.85 coo 11.92 33.82 109.35 10.10 33.50 110.39 -46.92 -30.82 5.73 -47.47 -32.26 7.22 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG B 104 ARG^? 16.84 O1 GOL B3003 A 136 GLU B 36 GLU^? 22.14 C1 GOL B3003 A 246 GLU B 43 GLU^? 18.78 O1 GOL B3003 coo 13.94 29.84 106.80 11.67 30.40 108.79 -54.16 -24.27 10.34 -56.57 -25.03 12.16 coo 9.52 31.97 115.23 8.45 33.74 114.72 -46.92 -30.82 5.73 -47.47 -32.26 7.22 coo 11.92 33.82 109.35 10.10 33.50 110.39 -52.23 -26.63 6.86 -51.71 -27.25 8.85 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 5 hits 1fob_c00 naa= 3 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 1 3 # 1 412 GLU A 69 GLU~? 14.08 O2 GOL B3003 516 HIS B 55 HIS.? 21.07 O2 GOL B3003 559 HIS B 60 HIS~? 17.21 O2 GOL B3003 coo 49.01 14.50 52.53 46.99 14.61 52.78 -68.84 -13.66 -5.25 -69.74 -15.00 -3.84 coo 41.59 7.83 54.15 41.16 9.87 53.87 -70.49 -6.63 0.68 -71.77 -8.29 0.64 coo 42.22 14.55 52.50 43.91 14.87 53.60 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 2 3 # 2 412 GLU B 69 GLU~? 14.08 O2 GOL B3003 516 HIS A 55 HIS.? 23.22 O2 GOL B3003 559 HIS A 60 HIS~? 18.77 O2 GOL B3003 coo 49.01 14.50 52.53 46.99 14.61 52.78 -57.32 -23.73 -7.47 -58.56 -24.80 -8.76 coo 41.59 7.83 54.15 41.16 9.87 53.87 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 coo 42.22 14.55 52.50 43.91 14.87 53.60 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 1gal_c00 source 1gal GLUCOSE OXIDASE (E.C.1.1.3.4) : 2 hits 1gal_c00 naa= 3 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 1 3 # 1 13 ASP B 77 ASP~? 23.19 C1 GOL B3003 41 HIS A 55 HIS.? 23.22 O2 GOL B3003 224 GLN B 3 GLN~? 29.70 C1 GOL B3003 coo -3.80 50.71 49.48 -5.59 51.85 49.27 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo -6.45 47.32 41.99 -8.32 46.87 42.83 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 coo -12.35 49.13 49.89 -13.38 48.89 48.03 -41.35 -31.53 -8.01 -40.73 -32.32 -9.92 1gim_c00 source 1gim ADENYLOSUCCINATE SYNTHETASE : 1 hits 1gim_c00 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 98 LYS.? 25.35 C2 GOL B3003 210 ARG A 50 ARG~? 31.50 O2 GOL B3003 225 ARG A 49 ARG~? 28.59 O2 GOL B3003 coo 17.51 28.50 73.42 17.24 23.02 75.86 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 coo 24.74 11.56 73.05 25.29 14.32 71.80 -46.97 -10.03 -14.88 -47.71 -8.54 -12.26 coo 27.81 15.44 77.10 25.66 16.50 75.19 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 1 hits 1gsa_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 46 PHE^? 23.53 O2 GOL B3003 A 298 ASP A 102 ASP.? 31.57 O2 GOL B3003 A 329 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -62.08 -10.95 -15.59 -61.63 -13.70 -15.25 coo 2.59 0.29 25.55 4.65 0.18 25.07 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 12.42 6.10 23.27 9.95 1.57 20.16 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE B 46 PHE^? 16.98 O2 GOL B3003 A 298 ASP B 102 ASP.? 23.17 O2 GOL B3003 A 329 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -55.24 -16.60 2.62 -58.07 -16.55 2.38 coo 2.59 0.29 25.55 4.65 0.18 25.07 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 12.42 6.10 23.27 9.95 1.57 20.16 -67.78 -15.41 8.33 -71.72 -12.47 6.85 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 46 PHE^? 23.53 O2 GOL B3003 B 298 ASP A 102 ASP.? 31.57 O2 GOL B3003 B 329 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -62.08 -10.95 -15.59 -61.63 -13.70 -15.25 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE B 46 PHE^? 16.98 O2 GOL B3003 B 298 ASP B 102 ASP.? 23.17 O2 GOL B3003 B 329 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -55.24 -16.60 2.62 -58.07 -16.55 2.38 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -67.78 -15.41 8.33 -71.72 -12.47 6.85 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 46 PHE^? 23.53 O2 GOL B3003 C 298 ASP A 102 ASP.? 31.57 O2 GOL B3003 C 329 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 17.41 60.57 64.39 18.40 58.12 65.34 -62.08 -10.95 -15.59 -61.63 -13.70 -15.25 coo 24.10 66.43 63.33 24.18 64.30 63.40 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 27.64 56.61 58.17 22.18 57.92 60.36 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE B 46 PHE^? 16.98 O2 GOL B3003 C 298 ASP B 102 ASP.? 23.17 O2 GOL B3003 C 329 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 17.41 60.57 64.39 18.40 58.12 65.34 -55.24 -16.60 2.62 -58.07 -16.55 2.38 coo 24.10 66.43 63.33 24.18 64.30 63.40 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 27.64 56.61 58.17 22.18 57.92 60.36 -67.78 -15.41 8.33 -71.72 -12.47 6.85 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 46 PHE^? 23.53 O2 GOL B3003 D 298 ASP A 102 ASP.? 31.57 O2 GOL B3003 D 329 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 35.44 53.35 83.81 35.65 54.53 81.28 -62.08 -10.95 -15.59 -61.63 -13.70 -15.25 coo 29.72 46.46 83.60 30.79 47.36 81.99 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 36.89 44.91 74.55 37.33 48.94 79.01 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE B 46 PHE^? 16.98 O2 GOL B3003 D 298 ASP B 102 ASP.? 23.17 O2 GOL B3003 D 329 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 35.44 53.35 83.81 35.65 54.53 81.28 -55.24 -16.60 2.62 -58.07 -16.55 2.38 coo 29.72 46.46 83.60 30.79 47.36 81.99 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 36.89 44.91 74.55 37.33 48.94 79.01 -67.78 -15.41 8.33 -71.72 -12.47 6.85 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c03 naa= 3 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 1 3 # 1 A 267 GLU A 43 GLU^? 29.98 C2 GOL B3003 A 369 ARG A 38 ARG^? 30.46 C3 GOL B3003 A 372 TYR A 41 TYR^? 27.98 C3 GOL B3003 coo 16.47 7.99 31.03 17.36 6.90 32.63 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 -81.82 -5.43 -17.99 -82.24 -8.30 -19.04 coo 16.01 4.58 27.39 13.82 5.38 28.94 -78.71 -9.58 -18.05 -76.83 -10.14 -20.07 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 2 3 # 2 A 267 GLU B 43 GLU^? 18.78 O1 GOL B3003 A 369 ARG B 38 ARG^? 20.86 C1 GOL B3003 A 372 TYR B 41 TYR^? 17.51 C1 GOL B3003 coo 16.47 7.99 31.03 17.36 6.90 32.63 -52.23 -26.63 6.86 -51.71 -27.25 8.85 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 -46.74 -35.40 4.40 -49.31 -36.38 5.75 coo 16.01 4.58 27.39 13.82 5.38 28.94 -51.53 -33.23 4.97 -52.40 -31.33 6.90 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 3 3 # 3 A 267 GLU B 94 GLU^? -3.92 C3 GOL B3003s A 369 ARG A 89 ARG^? 14.22 C3 GOL B3003 A 372 TYR B 95 TYR^? 8.98 O2 GOL B3003 coo 16.47 7.99 31.03 17.36 6.90 32.63 -71.89 -26.19 1.24 -72.67 -27.83 2.28 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 -77.20 -20.48 3.22 -78.65 -19.76 5.86 coo 16.01 4.58 27.39 13.82 5.38 28.94 -69.79 -19.57 1.35 -68.80 -19.30 -1.28 1i1e_c00 source 1i1e BOTULINUM NEUROTOXIN TYPE B : 3 hits 1i1e_c00 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 35 VAL^? 31.31 O2 GOL B3003 A 200 ASP A 102 ASP.? 31.57 O2 GOL B3003 A 226 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -71.16 -4.16 -19.26 -70.76 -5.47 -20.96 coo 24.51 43.28 11.18 25.17 44.50 9.58 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 52 VAL~? 24.69 O2 GOL B3003 A 200 ASP A 102 ASP.? 31.57 O2 GOL B3003 A 226 LYS A 131 LYS^? 32.30 O3 GOL B3003 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -54.95 -13.44 -13.36 -56.57 -12.17 -14.20 coo 24.51 43.28 11.18 25.17 44.50 9.58 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 -67.71 -19.76 -26.19 -66.60 -18.46 -30.92 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 121 VAL^? 13.88 C3 GOL B3003 A 200 ASP A 108 ASP^? 24.12 C3 GOL B3003 A 226 LYS A 131 LYS^? 32.30 O3 GOL B3003 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -80.07 -20.68 -7.43 -79.82 -22.80 -7.52 coo 24.51 43.28 11.18 25.17 44.50 9.58 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 coo 34.47 51.09 7.19 28.58 51.18 7.53 -67.71 -19.76 -26.19 -66.60 -18.46 -30.92 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL B 35 VAL^? 21.91 O2 GOL B3003 A 200 ASP B 102 ASP.? 23.17 O2 GOL B3003 A 226 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -47.49 -24.95 6.16 -48.73 -24.69 7.93 coo 24.51 43.28 11.18 25.17 44.50 9.58 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 -67.78 -15.41 8.33 -71.72 -12.47 6.85 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL B 52 VAL~? 20.63 O2 GOL B3003 A 200 ASP B 102 ASP.? 23.17 O2 GOL B3003 A 226 LYS B 131 LYS^? 20.21 O1 GOL B3003 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -58.91 -10.05 0.41 -57.27 -11.32 1.25 coo 24.51 43.28 11.18 25.17 44.50 9.58 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 -62.86 -23.11 13.82 -62.51 -19.68 17.98 1i29_c03 source 1i29 CSDB : 5 hits 1i29_c03 naa= 3 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 1 3 # 1 A 78 GLN A 33 GLN^? 32.15 O2 GOL B3003 A 79 PHE A 46 PHE^? 23.53 O2 GOL B3003 A 80 THR A 45 THR^? 29.40 O2 GOL B3003 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 -63.71 -3.20 -17.25 -63.44 -1.34 -16.21 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 -62.08 -10.95 -15.59 -61.63 -13.70 -15.25 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 -65.94 -8.74 -18.36 -66.12 -7.40 -20.07 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 2 3 # 2 A 78 GLN B 33 GLN^? 26.03 O2 GOL B3003 A 79 PHE B 46 PHE^? 16.98 O2 GOL B3003 A 80 THR B 45 THR^? 20.55 O2 GOL B3003 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 -46.83 -17.75 3.46 -45.11 -17.47 2.21 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 -55.24 -16.60 2.62 -58.07 -16.55 2.38 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 -52.39 -20.27 5.23 -50.82 -20.45 6.75 1j7g_c00 source 1j7g D-TYROSYL-TRNA(TYR) DEACYLASE : 2 hits 1j7g_c00 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 51 GLU~? 30.75 O2 GOL B3003 A 163 ARG A 49 ARG~? 28.59 O2 GOL B3003 A 222 ARG A 50 ARG~? 31.50 O2 GOL B3003 coo 51.27 81.34 48.31 51.67 80.79 50.28 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 48.06 78.22 50.94 48.51 78.27 53.98 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 coo 54.85 84.16 52.60 54.26 81.23 53.34 -46.97 -10.03 -14.88 -47.71 -8.54 -12.26 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU A 51 GLU~? 30.75 O2 GOL B3003 A 163 ARG A 50 ARG~? 31.50 O2 GOL B3003 A 222 ARG A 49 ARG~? 28.59 O2 GOL B3003 coo 51.27 81.34 48.31 51.67 80.79 50.28 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 48.06 78.22 50.94 48.51 78.27 53.98 -46.97 -10.03 -14.88 -47.71 -8.54 -12.26 coo 54.85 84.16 52.60 54.26 81.23 53.34 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 ULMN 3 1kim_c00 THYMIDINE KINASE user 3 3 # 3 A 83 GLU B 51 GLU~? 27.77 O2 GOL B3003 A 163 ARG B 49 ARG~? 25.16 O2 GOL B3003 A 222 ARG B 50 ARG~? 28.73 O2 GOL B3003 coo 51.27 81.34 48.31 51.67 80.79 50.28 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 48.06 78.22 50.94 48.51 78.27 53.98 -53.07 -8.80 2.19 -52.38 -9.24 -0.76 coo 54.85 84.16 52.60 54.26 81.23 53.34 -58.03 -1.48 1.92 -57.72 -1.86 -1.08 ULMN 3 1kim_c00 THYMIDINE KINASE user 4 3 # 4 A 83 GLU B 51 GLU~? 27.77 O2 GOL B3003 A 163 ARG B 50 ARG~? 28.73 O2 GOL B3003 A 222 ARG B 49 ARG~? 25.16 O2 GOL B3003 coo 51.27 81.34 48.31 51.67 80.79 50.28 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 48.06 78.22 50.94 48.51 78.27 53.98 -58.03 -1.48 1.92 -57.72 -1.86 -1.08 coo 54.85 84.16 52.60 54.26 81.23 53.34 -53.07 -8.80 2.19 -52.38 -9.24 -0.76 1kim_c00 source 1kim THYMIDINE KINASE : 4 hits 1kim_c00 naa= 3 ULMN 3 1lcb_c00 THYMIDYLATE SYNTHASE user 1 3 # 1 198 CYH A 65 CYH~? 13.02 O2 GOL B3003 229 ASN B 66 ASN~? 17.08 O2 GOL B3003 232 SER B 29 SER~? 20.53 O2 GOL B3003 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -65.23 -17.87 -9.94 -64.55 -20.54 -9.18 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 coo 7.03 45.16 -41.61 9.10 46.34 -42.68 -53.88 -12.25 -4.91 -55.74 -13.66 -5.75 ULMN 3 1lcb_c00 THYMIDYLATE SYNTHASE user 2 3 # 2 198 CYH B 65 CYH~? 9.67 O2 GOL B3003 229 ASN A 66 ASN~? 18.56 O2 GOL B3003 232 SER A 29 SER~? 21.65 O2 GOL B3003 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -61.86 -20.74 -2.77 -64.56 -20.53 -3.49 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 coo 7.03 45.16 -41.61 9.10 46.34 -42.68 -57.98 -8.49 -8.08 -58.97 -10.59 -7.24 1lcb_c00 source 1lcb THYMIDYLATE SYNTHASE : 2 hits 1lcb_c00 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG A 49 ARG~? 28.59 O2 GOL B3003 245 HIS A 60 HIS~? 18.77 O2 GOL B3003 343 THR A 58 THR.? 25.02 O2 GOL B3003 coo 18.11 85.25 41.19 18.04 83.33 43.59 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 coo 5.34 86.23 43.48 6.16 87.26 45.12 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 9.06 92.76 42.80 7.04 92.63 42.14 -54.47 -19.41 -19.06 -54.96 -21.49 -19.40 ULMN 3 1lci_c00 LUCIFERASE user 2 3 # 2 218 ARG A 50 ARG~? 31.50 O2 GOL B3003 245 HIS A 55 HIS.? 23.22 O2 GOL B3003 343 THR A 58 THR.? 25.02 O2 GOL B3003 coo 18.11 85.25 41.19 18.04 83.33 43.59 -46.97 -10.03 -14.88 -47.71 -8.54 -12.26 coo 5.34 86.23 43.48 6.16 87.26 45.12 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 coo 9.06 92.76 42.80 7.04 92.63 42.14 -54.47 -19.41 -19.06 -54.96 -21.49 -19.40 ULMN 3 1lci_c00 LUCIFERASE user 3 3 # 3 218 ARG A 50 ARG~? 31.50 O2 GOL B3003 245 HIS A 60 HIS~? 18.77 O2 GOL B3003 343 THR A 58 THR.? 25.02 O2 GOL B3003 coo 18.11 85.25 41.19 18.04 83.33 43.59 -46.97 -10.03 -14.88 -47.71 -8.54 -12.26 coo 5.34 86.23 43.48 6.16 87.26 45.12 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 9.06 92.76 42.80 7.04 92.63 42.14 -54.47 -19.41 -19.06 -54.96 -21.49 -19.40 ULMN 3 1lci_c00 LUCIFERASE user 4 3 # 4 218 ARG B 49 ARG~? 25.16 O2 GOL B3003 245 HIS B 60 HIS~? 17.21 O2 GOL B3003 343 THR B 58 THR.? 18.62 O2 GOL B3003 coo 18.11 85.25 41.19 18.04 83.33 43.59 -53.07 -8.80 2.19 -52.38 -9.24 -0.76 coo 5.34 86.23 43.48 6.16 87.26 45.12 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 9.06 92.76 42.80 7.04 92.63 42.14 -64.53 -10.33 6.37 -66.50 -11.12 6.99 ULMN 3 1lci_c00 LUCIFERASE user 5 3 # 5 218 ARG B 50 ARG~? 28.73 O2 GOL B3003 245 HIS B 55 HIS.? 21.07 O2 GOL B3003 343 THR B 58 THR.? 18.62 O2 GOL B3003 coo 18.11 85.25 41.19 18.04 83.33 43.59 -58.03 -1.48 1.92 -57.72 -1.86 -1.08 coo 5.34 86.23 43.48 6.16 87.26 45.12 -70.49 -6.63 0.68 -71.77 -8.29 0.64 coo 9.06 92.76 42.80 7.04 92.63 42.14 -64.53 -10.33 6.37 -66.50 -11.12 6.99 ULMN 3 1lci_c00 LUCIFERASE user 6 3 # 6 218 ARG B 50 ARG~? 28.73 O2 GOL B3003 245 HIS B 60 HIS~? 17.21 O2 GOL B3003 343 THR B 58 THR.? 18.62 O2 GOL B3003 coo 18.11 85.25 41.19 18.04 83.33 43.59 -58.03 -1.48 1.92 -57.72 -1.86 -1.08 coo 5.34 86.23 43.48 6.16 87.26 45.12 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 9.06 92.76 42.80 7.04 92.63 42.14 -64.53 -10.33 6.37 -66.50 -11.12 6.99 1lci_c00 source 1lci LUCIFERASE : 6 hits 1lci_c00 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 102 ASP.? 31.57 O2 GOL B3003 A 265 GLU A 36 GLU^? 32.45 C3 GOL B3003 A 369 ASP A 130 ASP.? 32.43 C2 GOL B3003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 17.36 23.57 72.04 18.68 21.92 71.98 -77.05 -4.23 -19.20 -78.34 -5.25 -20.55 coo 12.19 31.08 87.29 11.13 32.66 86.38 -68.90 -15.75 -28.47 -68.86 -13.69 -28.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 130 ASP.? 32.43 C2 GOL B3003 A 265 GLU A 36 GLU^? 32.45 C3 GOL B3003 A 369 ASP A 102 ASP.? 31.57 O2 GOL B3003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -68.90 -15.75 -28.47 -68.86 -13.69 -28.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 -77.05 -4.23 -19.20 -78.34 -5.25 -20.55 coo 12.19 31.08 87.29 11.13 32.66 86.38 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 102 ASP.? 23.17 O2 GOL B3003 A 265 GLU B 36 GLU^? 22.14 C1 GOL B3003 A 369 ASP B 130 ASP.? 19.87 O1 GOL B3003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 17.36 23.57 72.04 18.68 21.92 71.98 -46.92 -30.82 5.73 -47.47 -32.26 7.22 coo 12.19 31.08 87.29 11.13 32.66 86.38 -58.56 -23.75 15.92 -56.48 -23.58 15.94 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 130 ASP.? 19.87 O1 GOL B3003 A 265 GLU B 36 GLU^? 22.14 C1 GOL B3003 A 369 ASP B 102 ASP.? 23.17 O2 GOL B3003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -58.56 -23.75 15.92 -56.48 -23.58 15.94 coo 17.36 23.57 72.04 18.68 21.92 71.98 -46.92 -30.82 5.73 -47.47 -32.26 7.22 coo 12.19 31.08 87.29 11.13 32.66 86.38 -54.64 -15.40 9.63 -53.71 -13.49 9.90 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 4 hits 1m53_c05 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 49 ARG~? 28.59 O2 GOL B3003 229 SER A 29 SER~? 21.65 O2 GOL B3003 325 GLU A 51 GLU~? 30.75 O2 GOL B3003 coo 2.54 15.84 18.57 3.24 17.85 16.30 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 coo 10.17 13.48 15.92 9.61 15.76 15.27 -57.98 -8.49 -8.08 -58.97 -10.59 -7.24 coo 5.42 13.04 19.75 5.74 13.81 17.79 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG B 49 ARG~? 25.16 O2 GOL B3003 229 SER B 29 SER~? 20.53 O2 GOL B3003 325 GLU B 51 GLU~? 27.77 O2 GOL B3003 coo 2.54 15.84 18.57 3.24 17.85 16.30 -53.07 -8.80 2.19 -52.38 -9.24 -0.76 coo 10.17 13.48 15.92 9.61 15.76 15.27 -53.88 -12.25 -4.91 -55.74 -13.66 -5.75 coo 5.42 13.04 19.75 5.74 13.81 17.79 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 2 hits 1mbb_c00 naa= 3 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 1 3 # 1 92 SER A 143 SER^? 21.60 C3 GOL B3003 201 HIS A 84 HIS^? 26.32 C3 GOL B3003 250 GLN A 144 GLN^? 27.88 C3 GOL B3003 coo 38.34 0.72 11.82 37.33 1.15 14.05 -85.41 -13.56 3.43 -83.66 -13.28 5.07 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 -87.33 -9.64 0.04 -89.27 -10.38 -0.27 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 -89.71 -12.05 4.73 -91.56 -11.55 3.74 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 2 3 # 2 92 SER B 143 SER^? 23.77 O3 GOL B3003 201 HIS B 84 HIS^? 25.00 C1 GOL B3003 250 GLN B 144 GLN^? 30.53 O3 GOL B3003 coo 38.34 0.72 11.82 37.33 1.15 14.05 -55.84 -39.65 -16.71 -55.68 -37.87 -18.32 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 -51.82 -41.33 -13.55 -52.15 -43.40 -13.65 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 -51.37 -43.82 -18.42 -50.77 -43.69 -20.51 1mla_c00 source 1mla MALONYL-COENZYME A ACYL CARRIER PROTEIN TRANSA: 2 hits 1mla_c00 naa= 3 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 B 199 HIS B 55 HIS.? 21.07 O2 GOL B3003 B 246 HIS B 60 HIS~? 17.21 O2 GOL B3003 B 255 TYR B 95 TYR^? 8.98 O2 GOL B3003 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -70.49 -6.63 0.68 -71.77 -8.29 0.64 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -69.79 -19.57 1.35 -68.80 -19.30 -1.28 1mpy_c01 source 1mpy CATECHOL 2,3-DIOXYGENASE : 1 hits 1mpy_c01 naa= 3 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 C 199 HIS A 55 HIS.? 23.22 O2 GOL B3003 C 246 HIS A 60 HIS~? 18.77 O2 GOL B3003 C 255 TYR A 95 TYR^? 14.20 C2 GOL B3003 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -63.24 -25.54 -13.60 -63.09 -24.30 -11.10 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 C 199 HIS B 55 HIS.? 21.07 O2 GOL B3003 C 246 HIS B 60 HIS~? 17.21 O2 GOL B3003 C 255 TYR B 95 TYR^? 8.98 O2 GOL B3003 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -70.49 -6.63 0.68 -71.77 -8.29 0.64 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -69.79 -19.57 1.35 -68.80 -19.30 -1.28 1mpy_c02 source 1mpy CATECHOL 2,3-DIOXYGENASE : 2 hits 1mpy_c02 naa= 3 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 D 199 HIS B 55 HIS.? 21.07 O2 GOL B3003 D 246 HIS B 60 HIS~? 17.21 O2 GOL B3003 D 255 TYR B 95 TYR^? 8.98 O2 GOL B3003 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -70.49 -6.63 0.68 -71.77 -8.29 0.64 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -69.79 -19.57 1.35 -68.80 -19.30 -1.28 1mpy_c03 source 1mpy CATECHOL 2,3-DIOXYGENASE : 1 hits 1mpy_c03 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 73 GLY~? 19.36 O2 GOL B3003 A 501 ASP A 102 ASP.? 31.57 O2 GOL B3003 B 367 TYR B 127 TYR^? 12.67 O1 GOL B3003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -74.18 -11.03 -6.20 -74.35 -10.76 -6.94 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -59.88 -24.81 10.26 -60.45 -27.57 10.09 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY B 90 GLY^? 10.97 O3 GOL B3003 A 501 ASP A 130 ASP.? 32.43 C2 GOL B3003 B 367 TYR B 8 TYR~? 31.49 O2 GOL B3003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -65.64 -29.04 -10.85 -64.89 -29.16 -10.49 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -68.90 -15.75 -28.47 -68.86 -13.69 -28.85 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -39.51 -21.17 -4.48 -37.83 -20.64 -6.69 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 2 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 73 GLY~? 19.36 O2 GOL B3003 D 501 ASP A 102 ASP.? 31.57 O2 GOL B3003 E 367 TYR B 127 TYR^? 12.67 O1 GOL B3003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -74.18 -11.03 -6.20 -74.35 -10.76 -6.94 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -59.88 -24.81 10.26 -60.45 -27.57 10.09 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY B 73 GLY~? 15.91 C1 GOL B3003 D 501 ASP B 102 ASP.? 23.17 O2 GOL B3003 E 367 TYR A 127 TYR^? 25.18 O3 GOL B3003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -54.34 -28.77 -6.80 -53.98 -28.87 -6.06 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY B 90 GLY^? 10.97 O3 GOL B3003 D 501 ASP A 130 ASP.? 32.43 C2 GOL B3003 E 367 TYR B 8 TYR~? 31.49 O2 GOL B3003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -65.64 -29.04 -10.85 -64.89 -29.16 -10.49 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -68.90 -15.75 -28.47 -68.86 -13.69 -28.85 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -39.51 -21.17 -4.48 -37.83 -20.64 -6.69 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 3 hits 1mro_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 55 HIS.? 23.22 O2 GOL B3003 A 197 ASP B 77 ASP~? 23.19 C1 GOL B3003 A 223 ALA B 67 ALA~? 13.93 O2 GOL B3003 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -56.73 -21.14 -0.96 -57.02 -20.76 0.55 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 55 HIS.? 23.22 O2 GOL B3003 A 197 ASP B 77 ASP~? 23.19 C1 GOL B3003 A 223 ALA B 68 ALA~? 9.46 O2 GOL B3003 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -58.71 -24.38 -1.50 -60.25 -24.49 -1.51 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS B 55 HIS.? 21.07 O2 GOL B3003 A 197 ASP A 77 ASP~? 25.15 O2 GOL B3003 A 223 ALA A 67 ALA~? 20.70 O2 GOL B3003 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -70.49 -6.63 0.68 -71.77 -8.29 0.64 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -66.30 -12.87 -11.78 -65.83 -13.06 -13.25 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS B 55 HIS.? 21.07 O2 GOL B3003 A 197 ASP A 77 ASP~? 25.15 O2 GOL B3003 A 223 ALA A 68 ALA~? 16.38 O2 GOL B3003 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -70.49 -6.63 0.68 -71.77 -8.29 0.64 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -69.22 -15.24 -11.24 -69.18 -16.81 -11.21 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 4 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 55 HIS.? 23.22 O2 GOL B3003 B 197 ASP B 77 ASP~? 23.19 C1 GOL B3003 B 223 ALA B 67 ALA~? 13.93 O2 GOL B3003 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -56.73 -21.14 -0.96 -57.02 -20.76 0.55 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 55 HIS.? 23.22 O2 GOL B3003 B 197 ASP B 77 ASP~? 23.19 C1 GOL B3003 B 223 ALA B 68 ALA~? 9.46 O2 GOL B3003 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -58.71 -24.38 -1.50 -60.25 -24.49 -1.51 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS B 55 HIS.? 21.07 O2 GOL B3003 B 197 ASP A 77 ASP~? 25.15 O2 GOL B3003 B 223 ALA A 67 ALA~? 20.70 O2 GOL B3003 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -70.49 -6.63 0.68 -71.77 -8.29 0.64 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -66.30 -12.87 -11.78 -65.83 -13.06 -13.25 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS B 55 HIS.? 21.07 O2 GOL B3003 B 197 ASP A 77 ASP~? 25.15 O2 GOL B3003 B 223 ALA A 68 ALA~? 16.38 O2 GOL B3003 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -70.49 -6.63 0.68 -71.77 -8.29 0.64 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -69.22 -15.24 -11.24 -69.18 -16.81 -11.21 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 4 hits 1n2t_c03 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS A 60 HIS~? 18.77 O2 GOL B3003 A 290 LYS A 48 LYS.? 30.42 O2 GOL B3003 A 405 ARG A 50 ARG~? 31.50 O2 GOL B3003 coo 41.33 25.99 28.05 41.95 26.95 29.80 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 37.11 33.75 31.82 38.72 27.95 29.90 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo 42.28 27.98 41.30 43.16 28.14 38.35 -46.97 -10.03 -14.88 -47.71 -8.54 -12.26 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 2 3 # 2 A 264 HIS B 60 HIS~? 17.21 O2 GOL B3003 A 290 LYS B 48 LYS.? 23.67 O2 GOL B3003 A 405 ARG B 50 ARG~? 28.73 O2 GOL B3003 coo 41.33 25.99 28.05 41.95 26.95 29.80 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 37.11 33.75 31.82 38.72 27.95 29.90 -56.50 -11.36 6.48 -60.31 -8.26 9.60 coo 42.28 27.98 41.30 43.16 28.14 38.35 -58.03 -1.48 1.92 -57.72 -1.86 -1.08 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 2 hits 1nhx_c00 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 51 GLU~? 30.75 O2 GOL B3003 B 128 HIS A 60 HIS~? 18.77 O2 GOL B3003 C 263 HIS B 60 HIS~? 17.21 O2 GOL B3003 coo 6.12 5.94 82.00 7.16 6.32 83.81 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 12.51 16.35 80.99 13.16 14.90 82.37 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 11.58 14.94 93.26 12.25 14.03 91.50 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU B 51 GLU~? 27.77 O2 GOL B3003 B 128 HIS B 60 HIS~? 17.21 O2 GOL B3003 C 263 HIS A 60 HIS~? 18.77 O2 GOL B3003 coo 6.12 5.94 82.00 7.16 6.32 83.81 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 12.51 16.35 80.99 13.16 14.90 82.37 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 11.58 14.94 93.26 12.25 14.03 91.50 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 2 hits 1ni4_c00 naa= 3 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 1 3 # 1 191 HIS A 60 HIS~? 18.77 O2 GOL B3003 194 ASN B 66 ASN~? 17.08 O2 GOL B3003 196 TYR B 26 TYR~? 20.48 O2 GOL B3003 coo 40.21 70.60 24.49 39.36 69.94 22.74 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 39.62 68.39 19.02 38.50 66.72 19.87 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 coo 40.89 73.30 19.79 38.36 73.12 18.60 -55.97 -15.06 -9.69 -58.20 -13.79 -8.56 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 2 3 # 2 191 HIS B 60 HIS~? 17.21 O2 GOL B3003 194 ASN A 66 ASN~? 18.56 O2 GOL B3003 196 TYR A 26 TYR~? 18.77 O2 GOL B3003 coo 40.21 70.60 24.49 39.36 69.94 22.74 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 39.62 68.39 19.02 38.50 66.72 19.87 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 coo 40.89 73.30 19.79 38.36 73.12 18.60 -60.61 -11.36 -3.29 -59.04 -13.40 -4.41 1oya_c00 source 1oya OLD YELLOW ENZYME (OXIDIZED) (OYE) (E.C.1.6.99: 2 hits 1oya_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 97 ALA.? 23.38 O3 GOL B3003 A 126 LEU A 96 LEU.? 18.96 O3 GOL B3003 A 158 GLU A 94 GLU^? 12.44 O3 GOL B3003 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -62.47 -25.33 -21.21 -63.01 -24.79 -22.57 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -66.71 -25.98 -19.95 -68.65 -26.18 -19.02 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -69.86 -28.27 -14.01 -71.58 -27.29 -13.32 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA B 97 ALA.? 13.42 O2 GOL B3003 A 126 LEU B 96 LEU.? 8.01 O1 GOL B3003 A 158 GLU B 94 GLU^? -3.92 C3 GOL B3003s coo -2.29 37.66 144.73 -1.46 37.12 145.87 -69.29 -18.84 8.94 -68.60 -19.32 10.25 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -69.25 -23.10 7.64 -69.19 -25.11 6.81 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -71.89 -26.19 1.24 -72.67 -27.83 2.28 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 97 ALA.? 23.38 O3 GOL B3003 B 126 LEU A 96 LEU.? 18.96 O3 GOL B3003 B 158 GLU A 94 GLU^? 12.44 O3 GOL B3003 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -62.47 -25.33 -21.21 -63.01 -24.79 -22.57 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -66.71 -25.98 -19.95 -68.65 -26.18 -19.02 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -69.86 -28.27 -14.01 -71.58 -27.29 -13.32 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA B 97 ALA.? 13.42 O2 GOL B3003 B 126 LEU B 96 LEU.? 8.01 O1 GOL B3003 B 158 GLU B 94 GLU^? -3.92 C3 GOL B3003s coo -39.79 4.61 147.27 -39.61 5.56 148.47 -69.29 -18.84 8.94 -68.60 -19.32 10.25 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -69.25 -23.10 7.64 -69.19 -25.11 6.81 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -71.89 -26.19 1.24 -72.67 -27.83 2.28 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 97 ALA.? 23.38 O3 GOL B3003 C 126 LEU A 96 LEU.? 18.96 O3 GOL B3003 C 158 GLU A 94 GLU^? 12.44 O3 GOL B3003 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -62.47 -25.33 -21.21 -63.01 -24.79 -22.57 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -66.71 -25.98 -19.95 -68.65 -26.18 -19.02 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -69.86 -28.27 -14.01 -71.58 -27.29 -13.32 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA B 97 ALA.? 13.42 O2 GOL B3003 C 126 LEU B 96 LEU.? 8.01 O1 GOL B3003 C 158 GLU B 94 GLU^? -3.92 C3 GOL B3003s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -69.29 -18.84 8.94 -68.60 -19.32 10.25 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -69.25 -23.10 7.64 -69.19 -25.11 6.81 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -71.89 -26.19 1.24 -72.67 -27.83 2.28 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c02 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 29 SER~? 21.65 O2 GOL B3003 B 69 ALA A 63 ALA~? 20.48 O2 GOL B3003 B 241 ASN A 66 ASN~? 18.56 O2 GOL B3003 coo 13.24 41.94 33.13 13.08 39.54 33.17 -57.98 -8.49 -8.08 -58.97 -10.59 -7.24 coo 9.15 37.89 36.69 10.55 37.76 37.22 -60.50 -15.57 -11.23 -59.47 -15.15 -12.27 coo 10.91 43.03 38.47 11.81 41.82 36.93 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER B 29 SER~? 20.53 O2 GOL B3003 B 69 ALA B 63 ALA~? 16.33 O2 GOL B3003 B 241 ASN B 66 ASN~? 17.08 O2 GOL B3003 coo 13.24 41.94 33.13 13.08 39.54 33.17 -53.88 -12.25 -4.91 -55.74 -13.66 -5.75 coo 9.15 37.89 36.69 10.55 37.76 37.22 -60.28 -15.75 -1.57 -59.97 -14.61 -0.57 coo 10.91 43.03 38.47 11.81 41.82 36.93 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 2 hits 1pnl_c00 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 77 ASP~? 25.15 O2 GOL B3003 A 68 ALA A 78 ALA~? 27.37 O2 GOL B3003 A 72 LEU A 37 LEU^? 28.29 O2 GOL B3003 coo 46.76 7.59 18.65 45.27 6.01 18.52 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 coo 48.88 4.35 16.59 48.73 5.09 15.20 -80.19 -5.25 -7.66 -79.43 -5.02 -8.97 coo 53.89 6.25 15.09 52.88 7.92 14.14 -75.95 -3.96 -13.53 -76.20 -4.63 -11.46 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 113 ASP.? 26.51 C3 GOL B3003 A 68 ALA A 116 ALA.? 23.27 C3 GOL B3003 A 72 LEU A 120 LEU^? 18.74 C3 GOL B3003 coo 46.76 7.59 18.65 45.27 6.01 18.52 -89.97 -15.81 -8.87 -91.42 -14.61 -7.90 coo 48.88 4.35 16.59 48.73 5.09 15.20 -89.66 -15.03 -4.04 -89.44 -16.33 -4.88 coo 53.89 6.25 15.09 52.88 7.92 14.14 -82.90 -17.58 -5.43 -84.91 -16.72 -5.49 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP B 113 ASP.? 21.25 C1 GOL B3003 A 68 ALA B 116 ALA.? 20.24 O3 GOL B3003 A 72 LEU B 120 LEU^? 15.50 C1 GOL B3003 coo 46.76 7.59 18.65 45.27 6.01 18.52 -57.60 -44.90 -4.66 -56.48 -46.28 -5.79 coo 48.88 4.35 16.59 48.73 5.09 15.20 -56.62 -44.42 -9.71 -57.92 -44.57 -8.87 coo 53.89 6.25 15.09 52.88 7.92 14.14 -59.42 -37.97 -7.46 -58.18 -39.68 -7.96 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 3 hits 1q6l_c05 naa= 3 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 1 3 # 1 A 191 ASN A 119 ASN^? 12.89 C3 GOL B3003 A 239 ARG A 89 ARG^? 14.22 C3 GOL B3003 A 246 TYR A 141 TYR^? 17.22 C3 GOL B3003 coo 2.50 7.27 18.06 0.76 7.28 16.81 -82.94 -21.99 -1.71 -81.51 -22.43 -0.25 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -77.20 -20.48 3.22 -78.65 -19.76 5.86 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -81.76 -18.20 2.94 -84.02 -18.22 4.60 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 2 3 # 2 A 191 ASN B 119 ASN^? 14.64 O3 GOL B3003 A 239 ARG B 89 ARG^? 19.99 O3 GOL B3003 A 246 TYR B 141 TYR^? 19.35 O3 GOL B3003 coo 2.50 7.27 18.06 0.76 7.28 16.81 -64.01 -38.08 -11.10 -64.51 -37.27 -12.99 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -63.05 -31.09 -16.52 -61.54 -30.22 -19.07 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -60.85 -36.38 -15.85 -61.05 -38.68 -17.49 1qaz_c00 source 1qaz ALGINATE LYASE A1-III : 2 hits 1qaz_c00 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 A 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 A 261 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 55.48 26.51 40.65 55.39 23.99 39.43 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 48.87 29.19 44.63 49.10 27.34 43.63 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 47.58 17.35 41.83 51.40 20.85 40.83 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 127 TYR^? 12.67 O1 GOL B3003 A 236 ASP B 129 ASP.? 21.97 O1 GOL B3003 A 261 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 55.48 26.51 40.65 55.39 23.99 39.43 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 48.87 29.19 44.63 49.10 27.34 43.63 -59.59 -18.37 15.65 -59.22 -18.41 17.77 coo 47.58 17.35 41.83 51.40 20.85 40.83 -67.78 -15.41 8.33 -71.72 -12.47 6.85 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 B 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 B 261 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 127 TYR^? 12.67 O1 GOL B3003 B 236 ASP B 129 ASP.? 21.97 O1 GOL B3003 B 261 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -59.59 -18.37 15.65 -59.22 -18.41 17.77 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -67.78 -15.41 8.33 -71.72 -12.47 6.85 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 C 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 C 261 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 39.51 34.34 13.63 37.63 32.61 14.79 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 45.78 31.11 9.51 44.25 30.06 10.53 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 37.54 22.37 12.10 37.83 27.55 13.24 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR B 127 TYR^? 12.67 O1 GOL B3003 C 236 ASP B 129 ASP.? 21.97 O1 GOL B3003 C 261 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 39.51 34.34 13.63 37.63 32.61 14.79 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 45.78 31.11 9.51 44.25 30.06 10.53 -59.59 -18.37 15.65 -59.22 -18.41 17.77 coo 37.54 22.37 12.10 37.83 27.55 13.24 -67.78 -15.41 8.33 -71.72 -12.47 6.85 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 D 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 D 261 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR B 127 TYR^? 12.67 O1 GOL B3003 D 236 ASP B 129 ASP.? 21.97 O1 GOL B3003 D 261 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -59.59 -18.37 15.65 -59.22 -18.41 17.77 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -67.78 -15.41 8.33 -71.72 -12.47 6.85 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 E 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 E 261 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 127 TYR^? 12.67 O1 GOL B3003 E 236 ASP B 129 ASP.? 21.97 O1 GOL B3003 E 261 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -59.59 -18.37 15.65 -59.22 -18.41 17.77 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -67.78 -15.41 8.33 -71.72 -12.47 6.85 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 F 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 F 261 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 127 TYR^? 12.67 O1 GOL B3003 F 236 ASP B 129 ASP.? 21.97 O1 GOL B3003 F 261 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -59.59 -18.37 15.65 -59.22 -18.41 17.77 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -67.78 -15.41 8.33 -71.72 -12.47 6.85 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 G 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 G 261 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR B 127 TYR^? 12.67 O1 GOL B3003 G 236 ASP B 129 ASP.? 21.97 O1 GOL B3003 G 261 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -59.59 -18.37 15.65 -59.22 -18.41 17.77 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -67.78 -15.41 8.33 -71.72 -12.47 6.85 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 H 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 H 261 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR B 127 TYR^? 12.67 O1 GOL B3003 H 236 ASP B 129 ASP.? 21.97 O1 GOL B3003 H 261 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -59.59 -18.37 15.65 -59.22 -18.41 17.77 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -67.78 -15.41 8.33 -71.72 -12.47 6.85 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 135 ARG^? 18.21 O3 GOL B3003 C 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 C 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 coo 39.01 29.77 22.02 37.48 31.30 19.84 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo 39.51 34.34 13.63 37.63 32.61 14.79 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 45.78 31.11 9.51 44.25 30.06 10.53 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 135 ARG^? 18.21 O3 GOL B3003 D 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 D 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 A 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 C 110 ARG A 135 ARG^? 18.21 O3 GOL B3003 coo 55.48 26.51 40.65 55.39 23.99 39.43 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 48.87 29.19 44.63 49.10 27.34 43.63 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 52.39 23.42 32.10 54.51 23.27 34.29 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 B 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 D 110 ARG A 135 ARG^? 18.21 O3 GOL B3003 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 135 ARG^? 18.21 O3 GOL B3003 G 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 G 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 135 ARG^? 18.21 O3 GOL B3003 H 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 H 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 E 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 G 110 ARG A 135 ARG^? 18.21 O3 GOL B3003 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 127 TYR^? 25.18 O3 GOL B3003 F 236 ASP A 129 ASP.? 33.59 C2 GOL B3003 H 110 ARG A 135 ARG^? 18.21 O3 GOL B3003 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c23 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 102 ASP.? 31.57 O2 GOL B3003 A 261 ASP A 108 ASP^? 24.12 C3 GOL B3003 A 329 ASP A 130 ASP.? 32.43 C2 GOL B3003 coo 28.46 69.88 26.74 30.40 70.70 26.53 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 34.02 79.89 42.60 34.73 78.01 41.86 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 coo 37.87 70.12 31.80 36.61 69.74 30.15 -68.90 -15.75 -28.47 -68.86 -13.69 -28.85 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 102 ASP.? 23.17 O2 GOL B3003 A 261 ASP B 108 ASP^? 13.79 O1 GOL B3003 A 329 ASP B 130 ASP.? 19.87 O1 GOL B3003 coo 28.46 69.88 26.74 30.40 70.70 26.53 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 34.02 79.89 42.60 34.73 78.01 41.86 -57.59 -34.50 4.86 -57.32 -36.42 5.70 coo 37.87 70.12 31.80 36.61 69.74 30.15 -58.56 -23.75 15.92 -56.48 -23.58 15.94 1qho_c05 source 1qho ALPHA-AMYLASE : 2 hits 1qho_c05 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 55 HIS.? 23.22 O2 GOL B3003 A 646 ASP B 77 ASP~? 23.19 C1 GOL B3003 A 739 GLY B 21 GLY~? 27.73 O2 GOL B3003 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -46.44 -14.12 -8.07 -46.01 -14.74 -8.43 1qrz_c20 source 1qrz PLASMINOGEN : 1 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS A 55 HIS.? 23.22 O2 GOL B3003 B 646 ASP B 77 ASP~? 23.19 C1 GOL B3003 B 739 GLY B 21 GLY~? 27.73 O2 GOL B3003 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -46.44 -14.12 -8.07 -46.01 -14.74 -8.43 1qrz_c21 source 1qrz PLASMINOGEN : 1 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 55 HIS.? 23.22 O2 GOL B3003 C 646 ASP B 77 ASP~? 23.19 C1 GOL B3003 C 739 GLY B 21 GLY~? 27.73 O2 GOL B3003 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo 7.82 1.25 3.03 7.30 1.31 3.65 -46.44 -14.12 -8.07 -46.01 -14.74 -8.43 1qrz_c22 source 1qrz PLASMINOGEN : 1 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 55 HIS.? 23.22 O2 GOL B3003 D 646 ASP B 77 ASP~? 23.19 C1 GOL B3003 D 739 GLY B 21 GLY~? 27.73 O2 GOL B3003 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -46.44 -14.12 -8.07 -46.01 -14.74 -8.43 1qrz_c23 source 1qrz PLASMINOGEN : 1 hits 1qrz_c23 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 46 PHE^? 23.53 O2 GOL B3003 A 201 ASP A 102 ASP.? 31.57 O2 GOL B3003 A 227 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 23.39 49.81 32.16 21.33 51.68 32.26 -62.08 -10.95 -15.59 -61.63 -13.70 -15.25 coo 25.52 45.12 37.98 23.98 46.65 37.85 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 12.68 46.83 36.69 18.26 48.67 34.51 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE B 46 PHE^? 16.98 O2 GOL B3003 A 201 ASP B 102 ASP.? 23.17 O2 GOL B3003 A 227 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 23.39 49.81 32.16 21.33 51.68 32.26 -55.24 -16.60 2.62 -58.07 -16.55 2.38 coo 25.52 45.12 37.98 23.98 46.65 37.85 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 12.68 46.83 36.69 18.26 48.67 34.51 -67.78 -15.41 8.33 -71.72 -12.47 6.85 1qz9_c02 source 1qz9 KYNURENINASE : 2 hits 1qz9_c02 naa= 3 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 1 3 # 1 A 12 HIS A 60 HIS~? 18.77 O2 GOL B3003 A 41 LYS A 48 LYS.? 30.42 O2 GOL B3003 A 119 HIS A 55 HIS.? 23.22 O2 GOL B3003 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 2 3 # 2 A 12 HIS B 60 HIS~? 17.21 O2 GOL B3003 A 41 LYS B 48 LYS.? 23.67 O2 GOL B3003 A 119 HIS B 55 HIS.? 21.07 O2 GOL B3003 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -56.50 -11.36 6.48 -60.31 -8.26 9.60 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -70.49 -6.63 0.68 -71.77 -8.29 0.64 1rbn_c01 source 1rbn RIBONUCLEASE A (E.C.3.1.27.5) DERIVATIVE II CO: 2 hits 1rbn_c01 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 94 GLU^? 12.44 O3 GOL B3003 A 288 HIS B 60 HIS~? 17.21 O2 GOL B3003 A 329 LYS B 48 LYS.? 23.67 O2 GOL B3003 coo 29.27 18.78 14.99 27.16 18.62 14.76 -69.86 -28.27 -14.01 -71.58 -27.29 -13.32 coo 49.52 10.06 10.36 50.99 9.65 8.92 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 57.80 12.92 13.83 53.77 8.42 12.15 -56.50 -11.36 6.48 -60.31 -8.26 9.60 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU B 36 GLU^? 22.14 C1 GOL B3003 A 288 HIS A 60 HIS~? 18.77 O2 GOL B3003 A 329 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 29.27 18.78 14.99 27.16 18.62 14.76 -46.92 -30.82 5.73 -47.47 -32.26 7.22 coo 49.52 10.06 10.36 50.99 9.65 8.92 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 57.80 12.92 13.83 53.77 8.42 12.15 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU B 94 GLU^? -3.92 C3 GOL B3003s A 288 HIS A 60 HIS~? 18.77 O2 GOL B3003 A 329 LYS A 48 LYS.? 30.42 O2 GOL B3003 coo 29.27 18.78 14.99 27.16 18.62 14.76 -71.89 -26.19 1.24 -72.67 -27.83 2.28 coo 49.52 10.06 10.36 50.99 9.65 8.92 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 57.80 12.92 13.83 53.77 8.42 12.15 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 3 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 36 GLU^? 32.45 C3 GOL B3003 B 288 HIS B 60 HIS~? 17.21 O2 GOL B3003 B 329 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -77.05 -4.23 -19.20 -78.34 -5.25 -20.55 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -67.78 -15.41 8.33 -71.72 -12.47 6.85 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU A 94 GLU^? 12.44 O3 GOL B3003 B 288 HIS B 60 HIS~? 17.21 O2 GOL B3003 B 329 LYS B 48 LYS.? 23.67 O2 GOL B3003 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -69.86 -28.27 -14.01 -71.58 -27.29 -13.32 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -56.50 -11.36 6.48 -60.31 -8.26 9.60 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 B 137 GLU B 36 GLU^? 22.14 C1 GOL B3003 B 288 HIS A 60 HIS~? 18.77 O2 GOL B3003 B 329 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -46.92 -30.82 5.73 -47.47 -32.26 7.22 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 B 137 GLU B 94 GLU^? -3.92 C3 GOL B3003s B 288 HIS A 60 HIS~? 18.77 O2 GOL B3003 B 329 LYS A 48 LYS.? 30.42 O2 GOL B3003 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -71.89 -26.19 1.24 -72.67 -27.83 2.28 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 4 hits 1roz_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 102 ASP.? 31.57 O2 GOL B3003 595 GLU A 43 GLU^? 29.98 C2 GOL B3003 713 TYR A 127 TYR^? 25.18 O3 GOL B3003 coo 5.64 2.82 38.49 4.59 4.19 37.25 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 4.35 13.73 37.63 3.39 12.18 36.55 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 coo 3.76 10.25 31.38 3.16 9.87 34.10 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP A 108 ASP^? 24.12 C3 GOL B3003 595 GLU A 43 GLU^? 29.98 C2 GOL B3003 713 TYR A 127 TYR^? 25.18 O3 GOL B3003 coo 5.64 2.82 38.49 4.59 4.19 37.25 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 coo 4.35 13.73 37.63 3.39 12.18 36.55 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 coo 3.76 10.25 31.38 3.16 9.87 34.10 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 ULMN 3 1sll_c00 SIALIDASE L user 3 3 # 3 318 ASP B 102 ASP.? 23.17 O2 GOL B3003 595 GLU B 43 GLU^? 18.78 O1 GOL B3003 713 TYR B 127 TYR^? 12.67 O1 GOL B3003 coo 5.64 2.82 38.49 4.59 4.19 37.25 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 4.35 13.73 37.63 3.39 12.18 36.55 -52.23 -26.63 6.86 -51.71 -27.25 8.85 coo 3.76 10.25 31.38 3.16 9.87 34.10 -59.88 -24.81 10.26 -60.45 -27.57 10.09 ULMN 3 1sll_c00 SIALIDASE L user 4 3 # 4 318 ASP B 108 ASP^? 13.79 O1 GOL B3003 595 GLU B 43 GLU^? 18.78 O1 GOL B3003 713 TYR B 127 TYR^? 12.67 O1 GOL B3003 coo 5.64 2.82 38.49 4.59 4.19 37.25 -57.59 -34.50 4.86 -57.32 -36.42 5.70 coo 4.35 13.73 37.63 3.39 12.18 36.55 -52.23 -26.63 6.86 -51.71 -27.25 8.85 coo 3.76 10.25 31.38 3.16 9.87 34.10 -59.88 -24.81 10.26 -60.45 -27.57 10.09 1sll_c00 source 1sll SIALIDASE L : 4 hits 1sll_c00 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 102 ASP.? 31.57 O2 GOL B3003 E 168 LYS A 48 LYS.? 30.42 O2 GOL B3003 E 201 THR A 45 THR^? 29.40 O2 GOL B3003 coo 5.36 16.20 22.10 3.88 17.00 23.31 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 5.06 22.32 18.11 1.02 22.08 22.74 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -65.94 -8.74 -18.36 -66.12 -7.40 -20.07 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP A 102 ASP.? 31.57 O2 GOL B3003 E 168 LYS A 48 LYS.? 30.42 O2 GOL B3003 E 201 THR A 100 THR.? 28.52 C2 GOL B3003 coo 5.36 16.20 22.10 3.88 17.00 23.31 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 5.06 22.32 18.11 1.02 22.08 22.74 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -57.44 -18.13 -23.10 -57.49 -19.81 -24.49 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP B 102 ASP.? 23.17 O2 GOL B3003 E 168 LYS B 48 LYS.? 23.67 O2 GOL B3003 E 201 THR B 45 THR^? 20.55 O2 GOL B3003 coo 5.36 16.20 22.10 3.88 17.00 23.31 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 5.06 22.32 18.11 1.02 22.08 22.74 -56.50 -11.36 6.48 -60.31 -8.26 9.60 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -52.39 -20.27 5.23 -50.82 -20.45 6.75 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP B 102 ASP.? 23.17 O2 GOL B3003 E 168 LYS B 48 LYS.? 23.67 O2 GOL B3003 E 201 THR B 100 THR.? 19.71 O2 GOL B3003 coo 5.36 16.20 22.10 3.88 17.00 23.31 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 5.06 22.32 18.11 1.02 22.08 22.74 -56.50 -11.36 6.48 -60.31 -8.26 9.60 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -62.76 -12.87 10.48 -64.20 -13.14 12.03 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 4 hits 1stc_c02 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 60 HIS~? 18.77 O2 GOL B3003 B 80 GLU B 69 GLU~? 14.08 O2 GOL B3003 B 223 ARG A 38 ARG^? 30.46 C3 GOL B3003 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -57.32 -23.73 -7.47 -58.56 -24.80 -8.76 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -81.82 -5.43 -17.99 -82.24 -8.30 -19.04 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS A 60 HIS~? 18.77 O2 GOL B3003 B 80 GLU B 69 GLU~? 14.08 O2 GOL B3003 B 223 ARG A 85 ARG^? 23.00 O2 GOL B3003 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -57.32 -23.73 -7.47 -58.56 -24.80 -8.76 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -81.56 -10.21 5.97 -79.12 -9.20 7.55 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS B 60 HIS~? 17.21 O2 GOL B3003 B 80 GLU A 69 GLU~? 14.08 O2 GOL B3003 B 223 ARG B 38 ARG^? 20.86 C1 GOL B3003 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -68.84 -13.66 -5.25 -69.74 -15.00 -3.84 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -46.74 -35.40 4.40 -49.31 -36.38 5.75 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 3 hits 1t0u_c01 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 129 ASP.? 33.59 C2 GOL B3003 218 GLU B 94 GLU^? -3.92 C3 GOL B3003s 329 ASP A 102 ASP.? 31.57 O2 GOL B3003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo 70.09 11.71 8.46 70.56 12.89 6.77 -71.89 -26.19 1.24 -72.67 -27.83 2.28 coo 59.16 37.82 13.95 57.63 37.03 15.12 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 130 ASP.? 32.43 C2 GOL B3003 218 GLU B 94 GLU^? -3.92 C3 GOL B3003s 329 ASP A 102 ASP.? 31.57 O2 GOL B3003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -68.90 -15.75 -28.47 -68.86 -13.69 -28.85 coo 70.09 11.71 8.46 70.56 12.89 6.77 -71.89 -26.19 1.24 -72.67 -27.83 2.28 coo 59.16 37.82 13.95 57.63 37.03 15.12 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 2 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 102 ASP.? 31.57 O2 GOL B3003 242 GLU B 51 GLU~? 27.77 O2 GOL B3003 329 ASP A 129 ASP.? 33.59 C2 GOL B3003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 30.42 34.74 5.00 29.09 35.09 3.38 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 59.16 37.82 13.95 57.63 37.03 15.12 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 1 hits 1uok_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 54 ASN.? 22.89 O2 GOL B3003 457 GLY B 73 GLY~? 15.91 C1 GOL B3003 459 GLU B 69 GLU~? 14.08 O2 GOL B3003 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -53.54 -20.89 -13.71 -53.93 -21.45 -15.71 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -54.34 -28.77 -6.80 -53.98 -28.87 -6.06 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -57.32 -23.73 -7.47 -58.56 -24.80 -8.76 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN B 54 ASN.? 18.51 O2 GOL B3003 457 GLY A 73 GLY~? 19.36 O2 GOL B3003 459 GLU A 69 GLU~? 14.08 O2 GOL B3003 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -66.66 -9.78 1.21 -66.97 -10.19 3.30 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -74.18 -11.03 -6.20 -74.35 -10.76 -6.94 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -68.84 -13.66 -5.25 -69.74 -15.00 -3.84 1vom_c00 source 1vom MYOSIN : 2 hits 1vom_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 42 ALA^? 24.61 O2 GOL B3003 B 182 GLY A 109 GLY.? 23.16 C3 GOL B3003 B 183 GLY A 40 GLY.? 26.28 C3 GOL B3003 coo 38.36-101.47-135.52 39.62-101.29-136.35 -75.69 -8.89 -14.89 -75.18 -9.08 -13.44 coo 41.93-102.35-126.87 41.52-101.89-126.30 -81.76 -14.10 -13.80 -81.87 -14.07 -14.63 coo 38.37-101.99-128.11 38.63-102.24-127.37 -82.58 -10.11 -13.61 -82.02 -9.61 -13.72 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA A 72 ALA~? 17.50 O2 GOL B3003 B 182 GLY A 40 GLY.? 26.28 C3 GOL B3003 B 183 GLY A 109 GLY.? 23.16 C3 GOL B3003 coo 38.36-101.47-135.52 39.62-101.29-136.35 -74.48 -13.14 -9.37 -74.19 -14.60 -8.89 coo 41.93-102.35-126.87 41.52-101.89-126.30 -82.58 -10.11 -13.61 -82.02 -9.61 -13.72 coo 38.37-101.99-128.11 38.63-102.24-127.37 -81.76 -14.10 -13.80 -81.87 -14.07 -14.63 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA A 78 ALA~? 27.37 O2 GOL B3003 B 182 GLY A 109 GLY.? 23.16 C3 GOL B3003 B 183 GLY A 40 GLY.? 26.28 C3 GOL B3003 coo 38.36-101.47-135.52 39.62-101.29-136.35 -80.19 -5.25 -7.66 -79.43 -5.02 -8.97 coo 41.93-102.35-126.87 41.52-101.89-126.30 -81.76 -14.10 -13.80 -81.87 -14.07 -14.63 coo 38.37-101.99-128.11 38.63-102.24-127.37 -82.58 -10.11 -13.61 -82.02 -9.61 -13.72 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 420 ALA A 107 ALA^? 21.32 C3 GOL B3003 B 182 GLY A 40 GLY.? 26.28 C3 GOL B3003 B 183 GLY A 109 GLY.? 23.16 C3 GOL B3003 coo 38.36-101.47-135.52 39.62-101.29-136.35 -75.48 -14.01 -14.53 -75.39 -13.19 -13.26 coo 41.93-102.35-126.87 41.52-101.89-126.30 -82.58 -10.11 -13.61 -82.02 -9.61 -13.72 coo 38.37-101.99-128.11 38.63-102.24-127.37 -81.76 -14.10 -13.80 -81.87 -14.07 -14.63 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 420 ALA B 42 ALA^? 16.63 C1 GOL B3003 B 182 GLY B 109 GLY.? 14.31 C1 GOL B3003 B 183 GLY B 40 GLY.? 18.22 C1 GOL B3003 coo 38.36-101.47-135.52 39.62-101.29-136.35 -51.52 -30.04 1.96 -51.81 -29.58 0.53 coo 41.93-102.35-126.87 41.52-101.89-126.30 -55.85 -36.69 0.89 -55.67 -36.92 1.66 coo 38.37-101.99-128.11 38.63-102.24-127.37 -51.69 -37.08 0.45 -51.33 -36.42 0.48 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 420 ALA B 72 ALA~? 11.73 C1 GOL B3003 B 182 GLY B 40 GLY.? 18.22 C1 GOL B3003 B 183 GLY B 109 GLY.? 14.31 C1 GOL B3003 coo 38.36-101.47-135.52 39.62-101.29-136.35 -56.11 -29.30 -3.54 -57.59 -29.20 -3.91 coo 41.93-102.35-126.87 41.52-101.89-126.30 -51.69 -37.08 0.45 -51.33 -36.42 0.48 coo 38.37-101.99-128.11 38.63-102.24-127.37 -55.85 -36.69 0.89 -55.67 -36.92 1.66 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 420 ALA B 78 ALA~? 21.69 C1 GOL B3003 B 182 GLY B 109 GLY.? 14.31 C1 GOL B3003 B 183 GLY B 40 GLY.? 18.22 C1 GOL B3003 coo 38.36-101.47-135.52 39.62-101.29-136.35 -47.73 -34.19 -5.55 -47.56 -33.49 -4.17 coo 41.93-102.35-126.87 41.52-101.89-126.30 -55.85 -36.69 0.89 -55.67 -36.92 1.66 coo 38.37-101.99-128.11 38.63-102.24-127.37 -51.69 -37.08 0.45 -51.33 -36.42 0.48 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 8 3 # 8 A 420 ALA B 107 ALA^? 12.35 C1 GOL B3003 B 182 GLY B 40 GLY.? 18.22 C1 GOL B3003 B 183 GLY B 109 GLY.? 14.31 C1 GOL B3003 coo 38.36-101.47-135.52 39.62-101.29-136.35 -56.66 -30.69 2.14 -56.09 -30.29 0.69 coo 41.93-102.35-126.87 41.52-101.89-126.30 -51.69 -37.08 0.45 -51.33 -36.42 0.48 coo 38.37-101.99-128.11 38.63-102.24-127.37 -55.85 -36.69 0.89 -55.67 -36.92 1.66 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 8 hits 1xny_c01 naa= 3 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 1 3 # 1 A 243 THR B 92 THR^? -4.12 O3 GOL B3003s A 345 PHE A 134 PHE^? 16.11 C2 GOL B3003 A 352 CYH A 65 CYH~? 13.02 O2 GOL B3003 coo 9.58 21.79 21.50 11.25 23.03 20.90 -68.62 -27.37 -4.77 -70.50 -28.47 -4.70 coo 19.40 19.75 18.58 17.39 17.81 18.80 -66.66 -20.84 -15.05 -67.17 -20.21 -12.35 coo 21.57 22.52 22.79 19.20 21.13 23.26 -65.23 -17.87 -9.94 -64.55 -20.54 -9.18 1xqd_c02 source 1xqd CYTOCHROME P450 55A1 : 1 hits 1xqd_c02 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 28 ALA~? 26.48 O2 GOL B3003 B 126 ARG A 49 ARG~? 28.59 O2 GOL B3003 B 138 GLU B 51 GLU~? 27.77 O2 GOL B3003 coo 2.11 4.00 19.31 3.14 4.86 19.99 -60.51 -5.63 -7.65 -59.95 -4.44 -6.84 coo 2.45 5.53 11.28 3.59 7.56 13.29 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 coo 6.10 2.00 25.24 6.12 1.84 23.13 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA A 126 ALA^? 20.93 C2 GOL B3003 B 126 ARG A 135 ARG^? 18.21 O3 GOL B3003 B 138 GLU A 43 GLU^? 29.98 C2 GOL B3003 coo 2.11 4.00 19.31 3.14 4.86 19.99 -68.45 -17.28 -18.43 -67.26 -17.28 -17.43 coo 2.45 5.53 11.28 3.59 7.56 13.29 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo 6.10 2.00 25.24 6.12 1.84 23.13 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA B 28 ALA~? 25.21 O2 GOL B3003 B 126 ARG B 49 ARG~? 25.16 O2 GOL B3003 B 138 GLU A 51 GLU~? 30.75 O2 GOL B3003 coo 2.11 4.00 19.31 3.14 4.86 19.99 -50.56 -14.10 -5.27 -49.55 -13.34 -6.21 coo 2.45 5.53 11.28 3.59 7.56 13.29 -53.07 -8.80 2.19 -52.38 -9.24 -0.76 coo 6.10 2.00 25.24 6.12 1.84 23.13 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA B 126 ALA^? 10.66 O2 GOL B3003 B 126 ARG B 135 ARG^? -4.69 O1 GOL B3003s B 138 GLU B 43 GLU^? 18.78 O1 GOL B3003 coo 2.11 4.00 19.31 3.14 4.86 19.99 -60.76 -23.74 5.87 -60.95 -22.56 4.85 coo 2.45 5.53 11.28 3.59 7.56 13.29 -67.70 -29.08 5.06 -70.56 -28.22 5.84 coo 6.10 2.00 25.24 6.12 1.84 23.13 -52.23 -26.63 6.86 -51.71 -27.25 8.85 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 28 ALA~? 26.48 O2 GOL B3003 C 126 ARG A 49 ARG~? 28.59 O2 GOL B3003 C 138 GLU B 51 GLU~? 27.77 O2 GOL B3003 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -60.51 -5.63 -7.65 -59.95 -4.44 -6.84 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA A 126 ALA^? 20.93 C2 GOL B3003 C 126 ARG A 135 ARG^? 18.21 O3 GOL B3003 C 138 GLU A 43 GLU^? 29.98 C2 GOL B3003 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -68.45 -17.28 -18.43 -67.26 -17.28 -17.43 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA B 28 ALA~? 25.21 O2 GOL B3003 C 126 ARG B 49 ARG~? 25.16 O2 GOL B3003 C 138 GLU A 51 GLU~? 30.75 O2 GOL B3003 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -50.56 -14.10 -5.27 -49.55 -13.34 -6.21 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -53.07 -8.80 2.19 -52.38 -9.24 -0.76 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 C 124 ALA B 126 ALA^? 10.66 O2 GOL B3003 C 126 ARG B 135 ARG^? -4.69 O1 GOL B3003s C 138 GLU B 43 GLU^? 18.78 O1 GOL B3003 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -60.76 -23.74 5.87 -60.95 -22.56 4.85 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -67.70 -29.08 5.06 -70.56 -28.22 5.84 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -52.23 -26.63 6.86 -51.71 -27.25 8.85 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 28 ALA~? 26.48 O2 GOL B3003 D 126 ARG A 49 ARG~? 28.59 O2 GOL B3003 D 138 GLU B 51 GLU~? 27.77 O2 GOL B3003 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -60.51 -5.63 -7.65 -59.95 -4.44 -6.84 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 coo 6.23 0.50 57.10 5.93 0.72 59.19 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA A 126 ALA^? 20.93 C2 GOL B3003 D 126 ARG A 135 ARG^? 18.21 O3 GOL B3003 D 138 GLU A 43 GLU^? 29.98 C2 GOL B3003 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -68.45 -17.28 -18.43 -67.26 -17.28 -17.43 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo 6.23 0.50 57.10 5.93 0.72 59.19 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA B 28 ALA~? 25.21 O2 GOL B3003 D 126 ARG B 49 ARG~? 25.16 O2 GOL B3003 D 138 GLU A 51 GLU~? 30.75 O2 GOL B3003 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -50.56 -14.10 -5.27 -49.55 -13.34 -6.21 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -53.07 -8.80 2.19 -52.38 -9.24 -0.76 coo 6.23 0.50 57.10 5.93 0.72 59.19 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 D 124 ALA B 126 ALA^? 10.66 O2 GOL B3003 D 126 ARG B 135 ARG^? -4.69 O1 GOL B3003s D 138 GLU B 43 GLU^? 18.78 O1 GOL B3003 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -60.76 -23.74 5.87 -60.95 -22.56 4.85 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -67.70 -29.08 5.06 -70.56 -28.22 5.84 coo 6.23 0.50 57.10 5.93 0.72 59.19 -52.23 -26.63 6.86 -51.71 -27.25 8.85 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 28 ALA~? 26.48 O2 GOL B3003 E 126 ARG A 49 ARG~? 28.59 O2 GOL B3003 E 138 GLU B 51 GLU~? 27.77 O2 GOL B3003 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -60.51 -5.63 -7.65 -59.95 -4.44 -6.84 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA A 126 ALA^? 20.93 C2 GOL B3003 E 126 ARG A 135 ARG^? 18.21 O3 GOL B3003 E 138 GLU A 43 GLU^? 29.98 C2 GOL B3003 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -68.45 -17.28 -18.43 -67.26 -17.28 -17.43 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA B 28 ALA~? 25.21 O2 GOL B3003 E 126 ARG B 49 ARG~? 25.16 O2 GOL B3003 E 138 GLU A 51 GLU~? 30.75 O2 GOL B3003 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -50.56 -14.10 -5.27 -49.55 -13.34 -6.21 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -53.07 -8.80 2.19 -52.38 -9.24 -0.76 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA B 126 ALA^? 10.66 O2 GOL B3003 E 126 ARG B 135 ARG^? -4.69 O1 GOL B3003s E 138 GLU B 43 GLU^? 18.78 O1 GOL B3003 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -60.76 -23.74 5.87 -60.95 -22.56 4.85 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -67.70 -29.08 5.06 -70.56 -28.22 5.84 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -52.23 -26.63 6.86 -51.71 -27.25 8.85 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 28 ALA~? 26.48 O2 GOL B3003 F 126 ARG A 49 ARG~? 28.59 O2 GOL B3003 F 138 GLU B 51 GLU~? 27.77 O2 GOL B3003 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -60.51 -5.63 -7.65 -59.95 -4.44 -6.84 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA A 126 ALA^? 20.93 C2 GOL B3003 F 126 ARG A 135 ARG^? 18.21 O3 GOL B3003 F 138 GLU A 43 GLU^? 29.98 C2 GOL B3003 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -68.45 -17.28 -18.43 -67.26 -17.28 -17.43 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -72.69 -24.14 -18.27 -75.50 -25.33 -18.16 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -72.20 -9.07 -19.89 -72.87 -8.59 -21.86 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA B 28 ALA~? 25.21 O2 GOL B3003 F 126 ARG B 49 ARG~? 25.16 O2 GOL B3003 F 138 GLU A 51 GLU~? 30.75 O2 GOL B3003 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -50.56 -14.10 -5.27 -49.55 -13.34 -6.21 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -53.07 -8.80 2.19 -52.38 -9.24 -0.76 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 F 124 ALA B 126 ALA^? 10.66 O2 GOL B3003 F 126 ARG B 135 ARG^? -4.69 O1 GOL B3003s F 138 GLU B 43 GLU^? 18.78 O1 GOL B3003 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -60.76 -23.74 5.87 -60.95 -22.56 4.85 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -67.70 -29.08 5.06 -70.56 -28.22 5.84 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -52.23 -26.63 6.86 -51.71 -27.25 8.85 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c11 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 102 ASP.? 31.57 O2 GOL B3003 A 371 LYS A 48 LYS.? 30.42 O2 GOL B3003 A 407 THR A 100 THR.? 28.52 C2 GOL B3003 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -57.44 -18.13 -23.10 -57.49 -19.81 -24.49 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP B 102 ASP.? 23.17 O2 GOL B3003 A 371 LYS B 48 LYS.? 23.67 O2 GOL B3003 A 407 THR B 100 THR.? 19.71 O2 GOL B3003 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -56.50 -11.36 6.48 -60.31 -8.26 9.60 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -62.76 -12.87 10.48 -64.20 -13.14 12.03 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 2 hits 1zrz_c02 naa= 3 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 A 105 ASN A 54 ASN.? 22.89 O2 GOL B3003 A 106 PRO B 25 PRO~? 26.24 O2 GOL B3003 A 108 TYR B 26 TYR~? 20.48 O2 GOL B3003 coo 34.91 38.94 20.48 33.53 38.20 19.00 -53.54 -20.89 -13.71 -53.93 -21.45 -15.71 coo 36.18 33.51 20.99 37.11 35.33 20.14 -48.78 -15.23 -12.71 -49.67 -16.00 -10.82 coo 33.01 33.46 15.68 31.96 34.97 17.80 -55.97 -15.06 -9.69 -58.20 -13.79 -8.56 2adm_c00 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 1 hits 2adm_c00 naa= 3 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 B 105 ASN A 54 ASN.? 22.89 O2 GOL B3003 B 106 PRO B 25 PRO~? 26.24 O2 GOL B3003 B 108 TYR B 26 TYR~? 20.48 O2 GOL B3003 coo 5.98 38.14 46.94 7.30 38.92 45.46 -53.54 -20.89 -13.71 -53.93 -21.45 -15.71 coo 4.66 43.53 47.47 3.74 41.73 46.59 -48.78 -15.23 -12.71 -49.67 -16.00 -10.82 coo 7.86 43.80 42.15 8.87 42.26 44.27 -55.97 -15.06 -9.69 -58.20 -13.79 -8.56 2adm_c01 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 1 hits 2adm_c01 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 84 HIS^? 26.32 C3 GOL B3003 B 163 ALA A 145 ALA.? 27.91 O2 GOL B3003 B 182 SER A 143 SER^? 21.60 C3 GOL B3003 coo 30.42 1.98 4.36 29.07 0.41 4.68 -87.33 -9.64 0.04 -89.27 -10.38 -0.27 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -85.55 -7.97 6.43 -85.19 -6.58 5.88 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -85.41 -13.56 3.43 -83.66 -13.28 5.07 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS B 84 HIS^? 25.00 C1 GOL B3003 B 163 ALA B 145 ALA.? 27.34 O3 GOL B3003 B 182 SER B 143 SER^? 23.77 O3 GOL B3003 coo 30.42 1.98 4.36 29.07 0.41 4.68 -51.82 -41.33 -13.55 -52.15 -43.40 -13.65 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -51.38 -39.24 -20.18 -52.48 -38.18 -20.28 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -55.84 -39.65 -16.71 -55.68 -37.87 -18.32 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 2 hits 2bhg_c02 naa= 3 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 1 3 # 1 65 THR A 92 THR^? 7.25 O3 GOL B3003 242 CYH A 65 CYH~? 13.02 O2 GOL B3003 270 PHE A 134 PHE^? 16.11 C2 GOL B3003 coo 12.97 28.35 3.84 11.81 28.07 2.09 -71.10 -25.35 -7.58 -71.95 -27.31 -7.64 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 -65.23 -17.87 -9.94 -64.55 -20.54 -9.18 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 -66.66 -20.84 -15.05 -67.17 -20.21 -12.35 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 2 3 # 2 65 THR B 92 THR^? -4.12 O3 GOL B3003s 242 CYH B 65 CYH~? 9.67 O2 GOL B3003 270 PHE B 134 PHE^? 7.35 O2 GOL B3003 coo 12.97 28.35 3.84 11.81 28.07 2.09 -68.62 -27.37 -4.77 -70.50 -28.47 -4.70 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 -61.86 -20.74 -2.77 -64.56 -20.53 -3.49 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 -64.55 -22.36 2.54 -63.98 -22.76 -0.20 2cnd_c01 source 2cnd NADH-DEPENDENT NITRATE REDUCTASE (CYTOCHROME B: 2 hits 2cnd_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 51 GLU~? 30.75 O2 GOL B3003 A 156 GLU B 51 GLU~? 27.77 O2 GOL B3003 A 194 ASN A 66 ASN~? 18.56 O2 GOL B3003 coo 74.14 15.91 8.55 72.08 15.36 8.63 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 67.47 20.07 1.34 65.99 20.06 2.88 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 67.44 25.26 13.91 67.54 23.65 15.28 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 51 GLU~? 30.75 O2 GOL B3003 A 156 GLU B 51 GLU~? 27.77 O2 GOL B3003 A 194 ASN B 66 ASN~? 17.08 O2 GOL B3003 coo 74.14 15.91 8.55 72.08 15.36 8.63 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 67.47 20.07 1.34 65.99 20.06 2.88 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 67.44 25.26 13.91 67.54 23.65 15.28 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU B 51 GLU~? 27.77 O2 GOL B3003 A 156 GLU A 51 GLU~? 30.75 O2 GOL B3003 A 194 ASN A 66 ASN~? 18.56 O2 GOL B3003 coo 74.14 15.91 8.55 72.08 15.36 8.63 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 67.47 20.07 1.34 65.99 20.06 2.88 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 67.44 25.26 13.91 67.54 23.65 15.28 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU B 51 GLU~? 27.77 O2 GOL B3003 A 156 GLU A 51 GLU~? 30.75 O2 GOL B3003 A 194 ASN B 66 ASN~? 17.08 O2 GOL B3003 coo 74.14 15.91 8.55 72.08 15.36 8.63 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 67.47 20.07 1.34 65.99 20.06 2.88 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 67.44 25.26 13.91 67.54 23.65 15.28 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 2dbt_c00 source 2dbt CHITINASE C : 4 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 51 GLU~? 30.75 O2 GOL B3003 B 156 GLU B 51 GLU~? 27.77 O2 GOL B3003 B 194 ASN A 66 ASN~? 18.56 O2 GOL B3003 coo 45.64 63.11 17.20 47.48 62.43 16.45 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 54.43 67.89 19.82 55.62 67.90 18.07 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 49.79 70.75 7.78 50.10 68.90 6.86 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 51 GLU~? 30.75 O2 GOL B3003 B 156 GLU B 51 GLU~? 27.77 O2 GOL B3003 B 194 ASN B 66 ASN~? 17.08 O2 GOL B3003 coo 45.64 63.11 17.20 47.48 62.43 16.45 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 54.43 67.89 19.82 55.62 67.90 18.07 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 49.79 70.75 7.78 50.10 68.90 6.86 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU B 51 GLU~? 27.77 O2 GOL B3003 B 156 GLU A 51 GLU~? 30.75 O2 GOL B3003 B 194 ASN A 66 ASN~? 18.56 O2 GOL B3003 coo 45.64 63.11 17.20 47.48 62.43 16.45 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 54.43 67.89 19.82 55.62 67.90 18.07 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 49.79 70.75 7.78 50.10 68.90 6.86 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU B 51 GLU~? 27.77 O2 GOL B3003 B 156 GLU A 51 GLU~? 30.75 O2 GOL B3003 B 194 ASN B 66 ASN~? 17.08 O2 GOL B3003 coo 45.64 63.11 17.20 47.48 62.43 16.45 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 54.43 67.89 19.82 55.62 67.90 18.07 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 49.79 70.75 7.78 50.10 68.90 6.86 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 2dbt_c01 source 2dbt CHITINASE C : 4 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 51 GLU~? 30.75 O2 GOL B3003 C 156 GLU B 51 GLU~? 27.77 O2 GOL B3003 C 194 ASN A 66 ASN~? 18.56 O2 GOL B3003 coo 41.23 29.31 13.28 43.03 29.85 12.29 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 44.75 23.09 5.51 46.77 22.91 6.12 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 49.75 21.00 18.12 50.45 23.02 18.26 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 51 GLU~? 30.75 O2 GOL B3003 C 156 GLU B 51 GLU~? 27.77 O2 GOL B3003 C 194 ASN B 66 ASN~? 17.08 O2 GOL B3003 coo 41.23 29.31 13.28 43.03 29.85 12.29 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 44.75 23.09 5.51 46.77 22.91 6.12 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 49.75 21.00 18.12 50.45 23.02 18.26 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU B 51 GLU~? 27.77 O2 GOL B3003 C 156 GLU A 51 GLU~? 30.75 O2 GOL B3003 C 194 ASN A 66 ASN~? 18.56 O2 GOL B3003 coo 41.23 29.31 13.28 43.03 29.85 12.29 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 44.75 23.09 5.51 46.77 22.91 6.12 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 49.75 21.00 18.12 50.45 23.02 18.26 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU B 51 GLU~? 27.77 O2 GOL B3003 C 156 GLU A 51 GLU~? 30.75 O2 GOL B3003 C 194 ASN B 66 ASN~? 17.08 O2 GOL B3003 coo 41.23 29.31 13.28 43.03 29.85 12.29 -54.82 -5.72 -1.14 -53.66 -5.02 0.53 coo 44.75 23.09 5.51 46.77 22.91 6.12 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 coo 49.75 21.00 18.12 50.45 23.02 18.26 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 2dbt_c02 source 2dbt CHITINASE C : 4 hits 2dbt_c02 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 127 TYR^? 25.18 O3 GOL B3003 A 245 ASP A 102 ASP.? 31.57 O2 GOL B3003 A 273 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR A 127 TYR^? 25.18 O3 GOL B3003 A 245 ASP A 129 ASP.? 33.59 C2 GOL B3003 A 273 LYS A 48 LYS.? 30.42 O2 GOL B3003 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR A 127 TYR^? 25.18 O3 GOL B3003 A 245 ASP A 129 ASP.? 33.59 C2 GOL B3003 A 273 LYS A 98 LYS.? 25.35 C2 GOL B3003 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -63.45 -16.24 -28.50 -63.51 -15.82 -30.61 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 150 TYR B 127 TYR^? 12.67 O1 GOL B3003 A 245 ASP B 102 ASP.? 23.17 O2 GOL B3003 A 273 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -67.78 -15.41 8.33 -71.72 -12.47 6.85 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 150 TYR B 127 TYR^? 12.67 O1 GOL B3003 A 245 ASP B 129 ASP.? 21.97 O1 GOL B3003 A 273 LYS B 48 LYS.? 23.67 O2 GOL B3003 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -59.59 -18.37 15.65 -59.22 -18.41 17.77 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -56.50 -11.36 6.48 -60.31 -8.26 9.60 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 150 TYR B 127 TYR^? 12.67 O1 GOL B3003 A 245 ASP B 129 ASP.? 21.97 O1 GOL B3003 A 273 LYS B 98 LYS.? 17.45 O2 GOL B3003 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -59.59 -18.37 15.65 -59.22 -18.41 17.77 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -67.78 -15.41 8.33 -71.72 -12.47 6.85 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 6 hits 2gsa_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE B 46 PHE^? 16.98 O2 GOL B3003 A 245 ASP B 102 ASP.? 23.17 O2 GOL B3003 A 273 LYS B 131 LYS^? 20.21 O1 GOL B3003 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -55.24 -16.60 2.62 -58.07 -16.55 2.38 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -62.86 -23.11 13.82 -62.51 -19.68 17.98 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 1 hits 2gsa_c04 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS A 60 HIS~? 18.77 O2 GOL B3003 A 341 GLU B 69 GLU~? 14.08 O2 GOL B3003 A 356 HIS A 55 HIS.? 23.22 O2 GOL B3003 coo 121.00 36.37 19.26 121.57 38.37 19.56 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 125.72 32.70 19.75 124.44 34.16 18.84 -57.32 -23.73 -7.47 -58.56 -24.80 -8.76 coo 124.34 41.73 25.55 123.79 42.60 23.72 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 A 311 HIS B 60 HIS~? 17.21 O2 GOL B3003 A 341 GLU A 69 GLU~? 14.08 O2 GOL B3003 A 356 HIS B 55 HIS.? 21.07 O2 GOL B3003 coo 121.00 36.37 19.26 121.57 38.37 19.56 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 125.72 32.70 19.75 124.44 34.16 18.84 -68.84 -13.66 -5.25 -69.74 -15.00 -3.84 coo 124.34 41.73 25.55 123.79 42.60 23.72 -70.49 -6.63 0.68 -71.77 -8.29 0.64 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 2 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS A 60 HIS~? 18.77 O2 GOL B3003 B 341 GLU B 69 GLU~? 14.08 O2 GOL B3003 B 356 HIS A 55 HIS.? 23.22 O2 GOL B3003 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -57.32 -23.73 -7.47 -58.56 -24.80 -8.76 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 B 311 HIS B 60 HIS~? 17.21 O2 GOL B3003 B 341 GLU A 69 GLU~? 14.08 O2 GOL B3003 B 356 HIS B 55 HIS.? 21.07 O2 GOL B3003 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -68.84 -13.66 -5.25 -69.74 -15.00 -3.84 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -70.49 -6.63 0.68 -71.77 -8.29 0.64 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 2 hits 2isd_c01 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 102 ASP.? 31.57 O2 GOL B3003 A 151 LYS A 48 LYS.? 30.42 O2 GOL B3003 A 186 THR A 45 THR^? 29.40 O2 GOL B3003 coo 41.42 17.90 44.98 43.39 18.36 45.61 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 45.75 16.58 39.61 47.43 18.26 45.54 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo 45.88 23.02 44.72 46.99 21.16 44.68 -65.94 -8.74 -18.36 -66.12 -7.40 -20.07 ULMN 3 2phk_c02 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 102 ASP.? 31.57 O2 GOL B3003 A 151 LYS A 48 LYS.? 30.42 O2 GOL B3003 A 186 THR A 100 THR.? 28.52 C2 GOL B3003 coo 41.42 17.90 44.98 43.39 18.36 45.61 -61.05 -10.44 -22.64 -59.33 -9.21 -22.90 coo 45.75 16.58 39.61 47.43 18.26 45.54 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo 45.88 23.02 44.72 46.99 21.16 44.68 -57.44 -18.13 -23.10 -57.49 -19.81 -24.49 ULMN 3 2phk_c02 MC-PEPTIDE user 3 3 # 3 A 149 ASP B 102 ASP.? 23.17 O2 GOL B3003 A 151 LYS B 48 LYS.? 23.67 O2 GOL B3003 A 186 THR B 45 THR^? 20.55 O2 GOL B3003 coo 41.42 17.90 44.98 43.39 18.36 45.61 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 45.75 16.58 39.61 47.43 18.26 45.54 -56.50 -11.36 6.48 -60.31 -8.26 9.60 coo 45.88 23.02 44.72 46.99 21.16 44.68 -52.39 -20.27 5.23 -50.82 -20.45 6.75 ULMN 3 2phk_c02 MC-PEPTIDE user 4 3 # 4 A 149 ASP B 102 ASP.? 23.17 O2 GOL B3003 A 151 LYS B 48 LYS.? 23.67 O2 GOL B3003 A 186 THR B 100 THR.? 19.71 O2 GOL B3003 coo 41.42 17.90 44.98 43.39 18.36 45.61 -54.64 -15.40 9.63 -53.71 -13.49 9.90 coo 45.75 16.58 39.61 47.43 18.26 45.54 -56.50 -11.36 6.48 -60.31 -8.26 9.60 coo 45.88 23.02 44.72 46.99 21.16 44.68 -62.76 -12.87 10.48 -64.20 -13.14 12.03 2phk_c02 source 2phk MC-PEPTIDE : 4 hits 2phk_c02 naa= 3 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 1 3 # 1 A 12 HIS A 60 HIS~? 18.77 O2 GOL B3003 A 40 LYS A 48 LYS.? 30.42 O2 GOL B3003 A 116 HIS A 55 HIS.? 23.22 O2 GOL B3003 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 18.50 3.53 20.10 16.17 2.61 14.41 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo 14.70 6.01 5.61 14.27 7.69 6.78 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 2 3 # 2 A 12 HIS B 60 HIS~? 17.21 O2 GOL B3003 A 40 LYS B 48 LYS.? 23.67 O2 GOL B3003 A 116 HIS B 55 HIS.? 21.07 O2 GOL B3003 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 18.50 3.53 20.10 16.17 2.61 14.41 -56.50 -11.36 6.48 -60.31 -8.26 9.60 coo 14.70 6.01 5.61 14.27 7.69 6.78 -70.49 -6.63 0.68 -71.77 -8.29 0.64 2rnf_c02 source 2rnf RIBONUCLEASE 4 : 2 hits 2rnf_c02 naa= 3 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 1 3 # 1 B 12 HIS A 60 HIS~? 18.77 O2 GOL B3003 B 40 LYS A 48 LYS.? 30.42 O2 GOL B3003 B 116 HIS A 55 HIS.? 23.22 O2 GOL B3003 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 2 3 # 2 B 12 HIS B 60 HIS~? 17.21 O2 GOL B3003 B 40 LYS B 48 LYS.? 23.67 O2 GOL B3003 B 116 HIS B 55 HIS.? 21.07 O2 GOL B3003 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -56.50 -11.36 6.48 -60.31 -8.26 9.60 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -70.49 -6.63 0.68 -71.77 -8.29 0.64 2rnf_c03 source 2rnf RIBONUCLEASE 4 : 2 hits 2rnf_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 108 ASP^? 24.12 C3 GOL B3003 166 GLY B 90 GLY^? 10.97 O3 GOL B3003 169 GLU B 69 GLU~? 14.08 O2 GOL B3003 coo 8.28 6.87 1.62 10.08 5.77 1.34 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -65.64 -29.04 -10.85 -64.89 -29.16 -10.49 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -57.32 -23.73 -7.47 -58.56 -24.80 -8.76 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 108 ASP^? 24.12 C3 GOL B3003 166 GLY B 90 GLY^? 10.97 O3 GOL B3003 169 GLU B 137 GLU^? -3.87 C1 GOL B3003s coo 8.28 6.87 1.62 10.08 5.77 1.34 -78.85 -16.17 -16.99 -80.64 -16.31 -18.13 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -65.64 -29.04 -10.85 -64.89 -29.16 -10.49 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -66.03 -32.19 -1.28 -67.80 -33.35 -1.11 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP B 77 ASP~? 23.19 C1 GOL B3003 166 GLY B 21 GLY~? 27.73 O2 GOL B3003 169 GLU A 51 GLU~? 30.75 O2 GOL B3003 coo 8.28 6.87 1.62 10.08 5.77 1.34 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -46.44 -14.12 -8.07 -46.01 -14.74 -8.43 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -51.78 -8.42 -12.00 -51.29 -7.32 -13.75 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 3 hits 2tdt_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 49 ARG~? 28.59 O2 GOL B3003 B 130 SER B 29 SER~? 20.53 O2 GOL B3003 B 159 LYS A 48 LYS.? 30.42 O2 GOL B3003 coo 58.72 31.58 20.45 60.80 29.39 20.94 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 coo 61.66 35.17 10.39 61.29 34.14 12.56 -53.88 -12.25 -4.91 -55.74 -13.66 -5.75 coo 65.38 28.77 21.17 63.49 28.03 16.12 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG B 49 ARG~? 25.16 O2 GOL B3003 B 130 SER A 29 SER~? 21.65 O2 GOL B3003 B 159 LYS B 48 LYS.? 23.67 O2 GOL B3003 coo 58.72 31.58 20.45 60.80 29.39 20.94 -53.07 -8.80 2.19 -52.38 -9.24 -0.76 coo 61.66 35.17 10.39 61.29 34.14 12.56 -57.98 -8.49 -8.08 -58.97 -10.59 -7.24 coo 65.38 28.77 21.17 63.49 28.03 16.12 -56.50 -11.36 6.48 -60.31 -8.26 9.60 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 2 hits 2tps_c01 naa= 3 ULMN 3 5cox_c04 CYCLOOXYGENASE-2 user 1 3 # 1 A 203 GLN A 144 GLN^? 27.88 C3 GOL B3003 A 207 HIS A 84 HIS^? 26.32 C3 GOL B3003 A 385 TYR A 141 TYR^? 17.22 C3 GOL B3003 coo 23.69 37.92 6.66 22.22 39.29 5.97 -89.71 -12.05 4.73 -91.56 -11.55 3.74 coo 27.49 36.78 4.86 25.87 35.83 3.93 -87.33 -9.64 0.04 -89.27 -10.38 -0.27 coo 25.45 28.28 7.33 26.01 28.57 10.04 -81.76 -18.20 2.94 -84.02 -18.22 4.60 5cox_c04 source 5cox CYCLOOXYGENASE-2 : 1 hits 5cox_c04 naa= 3 ULMN 3 5cox_c05 CYCLOOXYGENASE-2 user 1 3 # 1 B 203 GLN A 144 GLN^? 27.88 C3 GOL B3003 B 207 HIS A 84 HIS^? 26.32 C3 GOL B3003 B 385 TYR A 141 TYR^? 17.22 C3 GOL B3003 coo 71.73 24.29 -6.07 73.27 24.95 -7.36 -89.71 -12.05 4.73 -91.56 -11.55 3.74 coo 67.92 26.15 -5.01 69.53 27.05 -4.02 -87.33 -9.64 0.04 -89.27 -10.38 -0.27 coo 69.83 23.77 3.61 69.22 21.05 3.32 -81.76 -18.20 2.94 -84.02 -18.22 4.60 5cox_c05 source 5cox CYCLOOXYGENASE-2 : 1 hits 5cox_c05 naa= 3 ULMN 3 5cox_c06 CYCLOOXYGENASE-2 user 1 3 # 1 C 203 GLN A 144 GLN^? 27.88 C3 GOL B3003 C 207 HIS A 84 HIS^? 26.32 C3 GOL B3003 C 385 TYR A 141 TYR^? 17.22 C3 GOL B3003 coo 60.00 28.49 66.40 61.43 27.08 65.71 -89.71 -12.05 4.73 -91.56 -11.55 3.74 coo 56.23 29.81 64.65 57.85 30.66 63.63 -87.33 -9.64 0.04 -89.27 -10.38 -0.27 coo 58.74 38.31 66.76 58.24 38.12 69.50 -81.76 -18.20 2.94 -84.02 -18.22 4.60 5cox_c06 source 5cox CYCLOOXYGENASE-2 : 1 hits 5cox_c06 naa= 3 ULMN 3 5cox_c07 CYCLOOXYGENASE-2 user 1 3 # 1 D 203 GLN A 144 GLN^? 27.88 C3 GOL B3003 D 207 HIS A 84 HIS^? 26.32 C3 GOL B3003 D 385 TYR A 141 TYR^? 17.22 C3 GOL B3003 coo 12.27 43.90 54.45 10.71 43.30 53.17 -89.71 -12.05 4.73 -91.56 -11.55 3.74 coo 16.03 41.92 55.47 14.38 41.13 56.50 -87.33 -9.64 0.04 -89.27 -10.38 -0.27 coo 14.46 44.71 64.03 15.12 47.37 63.64 -81.76 -18.20 2.94 -84.02 -18.22 4.60 5cox_c07 source 5cox CYCLOOXYGENASE-2 : 1 hits 5cox_c07 naa= 3 ULMN 3 5rsa_c01 RIBONUCLEASE A user 1 3 # 1 12 HIS A 60 HIS~? 18.77 O2 GOL B3003 41 LYS A 48 LYS.? 30.42 O2 GOL B3003 119 HIS A 55 HIS.? 23.22 O2 GOL B3003 coo 28.18 18.67 11.43 28.83 17.39 9.89 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 25.33 8.32 6.30 27.86 13.90 7.82 -56.76 -11.66 -19.53 -52.91 -14.72 -21.77 coo 33.68 19.99 5.35 34.98 18.36 5.19 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 ULMN 3 5rsa_c01 RIBONUCLEASE A user 2 3 # 2 12 HIS A 60 HIS~? 18.77 O2 GOL B3003 41 LYS A 98 LYS.? 25.35 C2 GOL B3003 119 HIS A 55 HIS.? 23.22 O2 GOL B3003 coo 28.18 18.67 11.43 28.83 17.39 9.89 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 25.33 8.32 6.30 27.86 13.90 7.82 -59.30 -23.35 -20.70 -55.99 -27.63 -21.80 coo 33.68 19.99 5.35 34.98 18.36 5.19 -49.42 -24.27 -12.90 -50.43 -26.10 -13.02 ULMN 3 5rsa_c01 RIBONUCLEASE A user 3 3 # 3 12 HIS B 60 HIS~? 17.21 O2 GOL B3003 41 LYS B 48 LYS.? 23.67 O2 GOL B3003 119 HIS B 55 HIS.? 21.07 O2 GOL B3003 coo 28.18 18.67 11.43 28.83 17.39 9.89 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 25.33 8.32 6.30 27.86 13.90 7.82 -56.50 -11.36 6.48 -60.31 -8.26 9.60 coo 33.68 19.99 5.35 34.98 18.36 5.19 -70.49 -6.63 0.68 -71.77 -8.29 0.64 5rsa_c01 source 5rsa RIBONUCLEASE A : 3 hits 5rsa_c01 naa= 3 ULMN 3 8pch_c00 CATHEPSIN H user 1 3 # 1 A 25 CYH A 65 CYH~? 13.02 O2 GOL B3003 A 159 HIS A 60 HIS~? 18.77 O2 GOL B3003 A 175 ASN B 66 ASN~? 17.08 O2 GOL B3003 coo 17.05 13.18 22.45 14.62 11.74 22.22 -65.23 -17.87 -9.94 -64.55 -20.54 -9.18 coo 11.41 9.68 19.45 11.30 7.64 19.91 -56.16 -18.99 -11.07 -55.68 -20.08 -9.33 coo 18.02 12.10 14.04 16.52 11.22 15.25 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 ULMN 3 8pch_c00 CATHEPSIN H user 2 3 # 2 A 25 CYH B 65 CYH~? 9.67 O2 GOL B3003 A 159 HIS B 60 HIS~? 17.21 O2 GOL B3003 A 175 ASN A 66 ASN~? 18.56 O2 GOL B3003 coo 17.05 13.18 22.45 14.62 11.74 22.22 -61.86 -20.74 -2.77 -64.56 -20.53 -3.49 coo 11.41 9.68 19.45 11.30 7.64 19.91 -64.32 -12.04 -1.58 -65.47 -11.63 -3.29 coo 18.02 12.10 14.04 16.52 11.22 15.25 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 8pch_c00 source 8pch CATHEPSIN H : 2 hits 8pch_c00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 54 ASN.? 22.89 O2 GOL B3003 coo 5.80 63.03 55.85 5.52 65.03 56.45 -53.54 -20.89 -13.71 -53.93 -21.45 -15.71 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 66 ASN~? 18.56 O2 GOL B3003 coo 5.80 63.03 55.85 5.52 65.03 56.45 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 119 ASN^? 12.89 C3 GOL B3003 coo 5.80 63.03 55.85 5.52 65.03 56.45 -82.94 -21.99 -1.71 -81.51 -22.43 -0.25 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN B 54 ASN.? 18.51 O2 GOL B3003 coo 5.80 63.03 55.85 5.52 65.03 56.45 -66.66 -9.78 1.21 -66.97 -10.19 3.30 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN B 66 ASN~? 17.08 O2 GOL B3003 coo 5.80 63.03 55.85 5.52 65.03 56.45 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN B 119 ASN^? 14.64 O3 GOL B3003 coo 5.80 63.03 55.85 5.52 65.03 56.45 -64.01 -38.08 -11.10 -64.51 -37.27 -12.99 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 6 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR A 26 TYR~? 18.77 O2 GOL B3003 A 112 PHE B 46 PHE^? 16.98 O2 GOL B3003 A 140 ASN B 66 ASN~? 17.08 O2 GOL B3003 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -60.61 -11.36 -3.29 -59.04 -13.40 -4.41 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -55.24 -16.60 2.62 -58.07 -16.55 2.38 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -57.95 -18.20 -4.13 -56.70 -17.92 -5.88 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR B 26 TYR~? 20.48 O2 GOL B3003 A 112 PHE A 46 PHE^? 23.53 O2 GOL B3003 A 140 ASN A 66 ASN~? 18.56 O2 GOL B3003 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -55.97 -15.06 -9.69 -58.20 -13.79 -8.56 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -62.08 -10.95 -15.59 -61.63 -13.70 -15.25 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -63.22 -13.63 -8.63 -62.98 -12.29 -6.92 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 2 hits 1o8s_p00 naa= 3 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 49 ARG~? 28.59 O2 GOL B3003 A 188 TYR B 26 TYR~? 20.48 O2 GOL B3003 A 190 SER A 29 SER~? 21.65 O2 GOL B3003 coo 37.69 7.64 13.51 38.82 8.84 16.11 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 coo 47.14 12.10 13.73 48.75 12.33 16.01 -55.97 -15.06 -9.69 -58.20 -13.79 -8.56 coo 43.77 6.93 15.46 45.49 7.21 17.11 -57.98 -8.49 -8.08 -58.97 -10.59 -7.24 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG A 85 ARG^? 23.00 O2 GOL B3003 A 188 TYR A 141 TYR^? 17.22 C3 GOL B3003 A 190 SER A 143 SER^? 21.60 C3 GOL B3003 coo 37.69 7.64 13.51 38.82 8.84 16.11 -81.56 -10.21 5.97 -79.12 -9.20 7.55 coo 47.14 12.10 13.73 48.75 12.33 16.01 -81.76 -18.20 2.94 -84.02 -18.22 4.60 coo 43.77 6.93 15.46 45.49 7.21 17.11 -85.41 -13.56 3.43 -83.66 -13.28 5.07 ULMN 3 2p3i_p00 VP4 user 3 3 # 3 A 101 ARG B 49 ARG~? 25.16 O2 GOL B3003 A 188 TYR A 26 TYR~? 18.77 O2 GOL B3003 A 190 SER B 29 SER~? 20.53 O2 GOL B3003 coo 37.69 7.64 13.51 38.82 8.84 16.11 -53.07 -8.80 2.19 -52.38 -9.24 -0.76 coo 47.14 12.10 13.73 48.75 12.33 16.01 -60.61 -11.36 -3.29 -59.04 -13.40 -4.41 coo 43.77 6.93 15.46 45.49 7.21 17.11 -53.88 -12.25 -4.91 -55.74 -13.66 -5.75 ULMN 3 2p3i_p00 VP4 user 4 3 # 4 A 101 ARG B 85 ARG^? 26.71 C1 GOL B3003 A 188 TYR B 141 TYR^? 19.35 O3 GOL B3003 A 190 SER B 143 SER^? 23.77 O3 GOL B3003 coo 37.69 7.64 13.51 38.82 8.84 16.11 -53.06 -34.97 -19.15 -50.61 -33.06 -19.14 coo 47.14 12.10 13.73 48.75 12.33 16.01 -60.85 -36.38 -15.85 -61.05 -38.68 -17.49 coo 43.77 6.93 15.46 45.49 7.21 17.11 -55.84 -39.65 -16.71 -55.68 -37.87 -18.32 2p3i_p00 source 2p3i VP4 : 4 hits 2p3i_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 89 ARG^? 14.22 C3 GOL B3003 B 6 THR A 139 THR^? 10.61 C3 GOL B3003 B 8 THR A 92 THR^? 7.25 O3 GOL B3003 coo 40.52 16.08 100.90 37.97 16.41 102.60 -77.20 -20.48 3.22 -78.65 -19.76 5.86 coo 36.11 13.64 95.03 34.54 14.86 95.91 -77.27 -20.52 -4.07 -78.06 -22.45 -3.46 coo 32.72 8.05 92.39 31.25 9.11 91.35 -71.10 -25.35 -7.58 -71.95 -27.31 -7.64 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG B 89 ARG^? 19.99 O3 GOL B3003 B 6 THR B 139 THR^? 10.14 O3 GOL B3003 B 8 THR B 92 THR^? -4.12 O3 GOL B3003s coo 40.52 16.08 100.90 37.97 16.41 102.60 -63.05 -31.09 -16.52 -61.54 -30.22 -19.07 coo 36.11 13.64 95.03 34.54 14.86 95.91 -63.14 -32.85 -8.52 -64.94 -33.87 -9.09 coo 32.72 8.05 92.39 31.25 9.11 91.35 -68.62 -27.37 -4.77 -70.50 -28.47 -4.70 1b01_d00 source 1b01 GENE REGULATION/DNA : 2 hits 1b01_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 26 TYR~? 18.77 O2 GOL B3003 I 306 VAL B 59 VAL.? 17.31 O2 GOL B3003 I 308 VAL B 103 VAL^? 15.92 O2 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -60.61 -11.36 -3.29 -59.04 -13.40 -4.41 coo 23.55 29.53 9.81 23.15 27.39 10.24 -62.39 -12.60 4.19 -60.56 -13.73 4.56 coo 16.43 30.18 9.35 15.05 30.67 11.01 -57.09 -18.47 7.28 -58.71 -18.37 5.78 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 41 TYR^? 27.98 C3 GOL B3003 I 306 VAL A 106 VAL^? 24.38 C3 GOL B3003 I 308 VAL A 44 VAL^? 25.69 O2 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -78.71 -9.58 -18.05 -76.83 -10.14 -20.07 coo 23.55 29.53 9.81 23.15 27.39 10.24 -73.14 -13.53 -17.51 -74.10 -13.26 -19.48 coo 16.43 30.18 9.35 15.05 30.67 11.01 -69.20 -8.28 -16.49 -68.87 -7.96 -14.34 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 41 TYR^? 27.98 C3 GOL B3003 I 306 VAL A 106 VAL^? 24.38 C3 GOL B3003 I 308 VAL A 124 VAL^? 18.29 C3 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -78.71 -9.58 -18.05 -76.83 -10.14 -20.07 coo 23.55 29.53 9.81 23.15 27.39 10.24 -73.14 -13.53 -17.51 -74.10 -13.26 -19.48 coo 16.43 30.18 9.35 15.05 30.67 11.01 -73.66 -17.90 -14.34 -72.42 -16.48 -13.14 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 41 TYR^? 27.98 C3 GOL B3003 I 306 VAL A 106 VAL^? 24.38 C3 GOL B3003 I 308 VAL A 125 VAL^? 20.57 O3 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -78.71 -9.58 -18.05 -76.83 -10.14 -20.07 coo 23.55 29.53 9.81 23.15 27.39 10.24 -73.14 -13.53 -17.51 -74.10 -13.26 -19.48 coo 16.43 30.18 9.35 15.05 30.67 11.01 -71.82 -18.77 -17.54 -72.70 -19.96 -19.23 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 95 TYR^? 14.20 C2 GOL B3003 I 306 VAL A 93 VAL^? 11.20 C2 GOL B3003 I 308 VAL A 124 VAL^? 18.29 C3 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -63.24 -25.54 -13.60 -63.09 -24.30 -11.10 coo 23.55 29.53 9.81 23.15 27.39 10.24 -68.96 -24.72 -10.68 -67.35 -23.43 -9.82 coo 16.43 30.18 9.35 15.05 30.67 11.01 -73.66 -17.90 -14.34 -72.42 -16.48 -13.14 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR A 95 TYR^? 14.20 C2 GOL B3003 I 306 VAL A 93 VAL^? 11.20 C2 GOL B3003 I 308 VAL B 93 VAL^? 4.96 O2 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -63.24 -25.54 -13.60 -63.09 -24.30 -11.10 coo 23.55 29.53 9.81 23.15 27.39 10.24 -68.96 -24.72 -10.68 -67.35 -23.43 -9.82 coo 16.43 30.18 9.35 15.05 30.67 11.01 -68.21 -25.14 -1.74 -67.19 -23.40 -2.69 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR A 95 TYR^? 14.20 C2 GOL B3003 I 306 VAL A 133 VAL^? 22.41 C2 GOL B3003 I 308 VAL A 125 VAL^? 20.57 O3 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -63.24 -25.54 -13.60 -63.09 -24.30 -11.10 coo 23.55 29.53 9.81 23.15 27.39 10.24 -65.57 -22.09 -20.65 -64.21 -20.33 -20.97 coo 16.43 30.18 9.35 15.05 30.67 11.01 -71.82 -18.77 -17.54 -72.70 -19.96 -19.23 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR A 127 TYR^? 25.18 O3 GOL B3003 I 306 VAL A 103 VAL^? 24.95 O2 GOL B3003 I 308 VAL A 44 VAL^? 25.69 O2 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 23.55 29.53 9.81 23.15 27.39 10.24 -63.67 -13.20 -20.14 -63.37 -14.69 -18.50 coo 16.43 30.18 9.35 15.05 30.67 11.01 -69.20 -8.28 -16.49 -68.87 -7.96 -14.34 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR A 127 TYR^? 25.18 O3 GOL B3003 I 306 VAL A 106 VAL^? 24.38 C3 GOL B3003 I 308 VAL A 44 VAL^? 25.69 O2 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 23.55 29.53 9.81 23.15 27.39 10.24 -73.14 -13.53 -17.51 -74.10 -13.26 -19.48 coo 16.43 30.18 9.35 15.05 30.67 11.01 -69.20 -8.28 -16.49 -68.87 -7.96 -14.34 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR A 127 TYR^? 25.18 O3 GOL B3003 I 306 VAL A 106 VAL^? 24.38 C3 GOL B3003 I 308 VAL A 124 VAL^? 18.29 C3 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -69.75 -16.83 -22.82 -72.40 -17.69 -22.32 coo 23.55 29.53 9.81 23.15 27.39 10.24 -73.14 -13.53 -17.51 -74.10 -13.26 -19.48 coo 16.43 30.18 9.35 15.05 30.67 11.01 -73.66 -17.90 -14.34 -72.42 -16.48 -13.14 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR B 26 TYR~? 20.48 O2 GOL B3003 I 306 VAL A 59 VAL.? 23.86 O2 GOL B3003 I 308 VAL A 103 VAL^? 24.95 O2 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -55.97 -15.06 -9.69 -58.20 -13.79 -8.56 coo 23.55 29.53 9.81 23.15 27.39 10.24 -57.00 -17.39 -16.99 -58.36 -15.72 -17.41 coo 16.43 30.18 9.35 15.05 30.67 11.01 -63.67 -13.20 -20.14 -63.37 -14.69 -18.50 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR B 41 TYR^? 17.51 C1 GOL B3003 I 306 VAL B 106 VAL^? 13.40 O1 GOL B3003 I 308 VAL B 44 VAL^? 17.14 O2 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -51.53 -33.23 4.97 -52.40 -31.33 6.90 coo 23.55 29.53 9.81 23.15 27.39 10.24 -56.41 -28.17 4.97 -56.06 -29.06 6.96 coo 16.43 30.18 9.35 15.05 30.67 11.01 -51.87 -23.52 3.39 -52.82 -23.61 1.38 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 13 3 # 13 I 303 TYR B 41 TYR^? 17.51 C1 GOL B3003 I 306 VAL B 106 VAL^? 13.40 O1 GOL B3003 I 308 VAL B 124 VAL^? 8.51 C1 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -51.53 -33.23 4.97 -52.40 -31.33 6.90 coo 23.55 29.53 9.81 23.15 27.39 10.24 -56.41 -28.17 4.97 -56.06 -29.06 6.96 coo 16.43 30.18 9.35 15.05 30.67 11.01 -60.71 -28.98 1.81 -59.51 -27.58 0.58 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 14 3 # 14 I 303 TYR B 41 TYR^? 17.51 C1 GOL B3003 I 306 VAL B 106 VAL^? 13.40 O1 GOL B3003 I 308 VAL B 125 VAL^? 8.01 O1 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -51.53 -33.23 4.97 -52.40 -31.33 6.90 coo 23.55 29.53 9.81 23.15 27.39 10.24 -56.41 -28.17 4.97 -56.06 -29.06 6.96 coo 16.43 30.18 9.35 15.05 30.67 11.01 -61.77 -27.32 5.05 -62.87 -28.37 6.61 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 15 3 # 15 I 303 TYR B 95 TYR^? 8.98 O2 GOL B3003 I 306 VAL B 93 VAL^? 4.96 O2 GOL B3003 I 308 VAL A 93 VAL^? 11.20 C2 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -69.79 -19.57 1.35 -68.80 -19.30 -1.28 coo 23.55 29.53 9.81 23.15 27.39 10.24 -68.21 -25.14 -1.74 -67.19 -23.40 -2.69 coo 16.43 30.18 9.35 15.05 30.67 11.01 -68.96 -24.72 -10.68 -67.35 -23.43 -9.82 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 16 3 # 16 I 303 TYR B 95 TYR^? 8.98 O2 GOL B3003 I 306 VAL B 93 VAL^? 4.96 O2 GOL B3003 I 308 VAL B 124 VAL^? 8.51 C1 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -69.79 -19.57 1.35 -68.80 -19.30 -1.28 coo 23.55 29.53 9.81 23.15 27.39 10.24 -68.21 -25.14 -1.74 -67.19 -23.40 -2.69 coo 16.43 30.18 9.35 15.05 30.67 11.01 -60.71 -28.98 1.81 -59.51 -27.58 0.58 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 17 3 # 17 I 303 TYR B 95 TYR^? 8.98 O2 GOL B3003 I 306 VAL B 133 VAL^? 11.78 O2 GOL B3003 I 308 VAL B 125 VAL^? 8.01 O1 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -69.79 -19.57 1.35 -68.80 -19.30 -1.28 coo 23.55 29.53 9.81 23.15 27.39 10.24 -65.64 -21.43 8.27 -64.02 -19.95 8.55 coo 16.43 30.18 9.35 15.05 30.67 11.01 -61.77 -27.32 5.05 -62.87 -28.37 6.61 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 18 3 # 18 I 303 TYR B 127 TYR^? 12.67 O1 GOL B3003 I 306 VAL B 103 VAL^? 15.92 O2 GOL B3003 I 308 VAL B 44 VAL^? 17.14 O2 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 -57.09 -18.47 7.28 -58.71 -18.37 5.78 coo 16.43 30.18 9.35 15.05 30.67 11.01 -51.87 -23.52 3.39 -52.82 -23.61 1.38 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 19 3 # 19 I 303 TYR B 127 TYR^? 12.67 O1 GOL B3003 I 306 VAL B 106 VAL^? 13.40 O1 GOL B3003 I 308 VAL B 44 VAL^? 17.14 O2 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 -56.41 -28.17 4.97 -56.06 -29.06 6.96 coo 16.43 30.18 9.35 15.05 30.67 11.01 -51.87 -23.52 3.39 -52.82 -23.61 1.38 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 20 3 # 20 I 303 TYR B 127 TYR^? 12.67 O1 GOL B3003 I 306 VAL B 106 VAL^? 13.40 O1 GOL B3003 I 308 VAL B 124 VAL^? 8.51 C1 GOL B3003 coo 26.18 35.24 6.87 24.33 35.18 8.97 -59.88 -24.81 10.26 -60.45 -27.57 10.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 -56.41 -28.17 4.97 -56.06 -29.06 6.96 coo 16.43 30.18 9.35 15.05 30.67 11.01 -60.71 -28.98 1.81 -59.51 -27.58 0.58 1cqt_d00 source 1cqt GENE REGULATION/DNA : 20 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 13 PRO~? 34.52 O2 GOL B3003 A 272 LEU A 37 LEU^? 28.29 O2 GOL B3003 A 276 ARG A 38 ARG^? 30.46 C3 GOL B3003 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -71.54 1.30 -17.85 -71.30 1.66 -15.61 coo 10.97 0.43 16.73 11.31 2.11 18.06 -75.95 -3.96 -13.53 -76.20 -4.63 -11.46 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -81.82 -5.43 -17.99 -82.24 -8.30 -19.04 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 132 PRO^? 24.10 O3 GOL B3003 A 272 LEU A 96 LEU.? 18.96 O3 GOL B3003 A 276 ARG B 89 ARG^? 19.99 O3 GOL B3003 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -70.06 -22.70 -23.94 -68.60 -21.00 -23.48 coo 10.97 0.43 16.73 11.31 2.11 18.06 -66.71 -25.98 -19.95 -68.65 -26.18 -19.02 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -63.05 -31.09 -16.52 -61.54 -30.22 -19.07 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO B 25 PRO~? 26.24 O2 GOL B3003 A 272 LEU A 53 LEU~? 27.25 O2 GOL B3003 A 276 ARG A 49 ARG~? 28.59 O2 GOL B3003 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -48.78 -15.23 -12.71 -49.67 -16.00 -10.82 coo 10.97 0.43 16.73 11.31 2.11 18.06 -51.66 -16.03 -15.68 -51.70 -15.21 -17.69 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 1emh_d00 source 1emh HYDROLASE/DNA : 3 hits 1emh_d00 naa= 3 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 19 ARG B 135 ARG^? -4.69 O1 GOL B3003s A 30 THR B 100 THR.? 19.71 O2 GOL B3003 A 34 VAL B 128 VAL^? 16.88 O2 GOL B3003 A 38 LYS B 131 LYS^? 20.21 O1 GOL B3003 coo 30.09 31.19 5.41 30.53 28.24 4.72 -67.70 -29.08 5.06 -70.56 -28.22 5.84 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -62.76 -12.87 10.48 -64.20 -13.14 12.03 coo 18.16 36.88 2.14 19.60 35.97 0.73 -60.08 -19.17 11.25 -60.69 -17.14 10.61 coo 16.75 32.35 6.21 21.42 30.93 2.22 -62.86 -23.11 13.82 -62.51 -19.68 17.98 1mnm_d00 source 1mnm TRANSCRIPTION/DNA : 1 hits 1mnm_d00 naa= 4 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 29 SER~? 21.65 O2 GOL B3003 E 5 VAL B 52 VAL~? 20.63 O2 GOL B3003 E 7 ARG B 49 ARG~? 25.16 O2 GOL B3003 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -57.98 -8.49 -8.08 -58.97 -10.59 -7.24 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -58.91 -10.05 0.41 -57.27 -11.32 1.25 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -53.07 -8.80 2.19 -52.38 -9.24 -0.76 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER B 29 SER~? 20.53 O2 GOL B3003 E 5 VAL A 52 VAL~? 24.69 O2 GOL B3003 E 7 ARG A 49 ARG~? 28.59 O2 GOL B3003 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -53.88 -12.25 -4.91 -55.74 -13.66 -5.75 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -54.95 -13.44 -13.36 -56.57 -12.17 -14.20 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -54.84 -7.52 -15.58 -55.31 -6.71 -12.63 2bsq_d00 source 2bsq TRANSCRIPTION : 2 hits 2bsq_d00 naa= 3 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 1 3 # 1 A 101 VAL A 93 VAL^? 11.20 C2 GOL B3003 A 102 PHE A 134 PHE^? 16.11 C2 GOL B3003 A 169 CYH B 65 CYH~? 9.67 O2 GOL B3003 coo -0.48 2.03 12.21 0.64 0.32 12.97 -68.96 -24.72 -10.68 -67.35 -23.43 -9.82 coo 0.51 5.20 15.97 0.26 4.09 18.50 -66.66 -20.84 -15.05 -67.17 -20.21 -12.35 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 -61.86 -20.74 -2.77 -64.56 -20.53 -3.49 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 2 3 # 2 A 101 VAL B 44 VAL^? 17.14 O2 GOL B3003 A 102 PHE B 34 PHE^? 20.39 O2 GOL B3003 A 169 CYH B 65 CYH~? 9.67 O2 GOL B3003 coo -0.48 2.03 12.21 0.64 0.32 12.97 -51.87 -23.52 3.39 -52.82 -23.61 1.38 coo 0.51 5.20 15.97 0.26 4.09 18.50 -47.81 -24.83 0.44 -49.34 -25.35 -1.86 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 -61.86 -20.74 -2.77 -64.56 -20.53 -3.49 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 3 3 # 3 A 101 VAL B 93 VAL^? 4.96 O2 GOL B3003 A 102 PHE B 134 PHE^? 7.35 O2 GOL B3003 A 169 CYH A 65 CYH~? 13.02 O2 GOL B3003 coo -0.48 2.03 12.21 0.64 0.32 12.97 -68.21 -25.14 -1.74 -67.19 -23.40 -2.69 coo 0.51 5.20 15.97 0.26 4.09 18.50 -64.55 -22.36 2.54 -63.98 -22.76 -0.20 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 -65.23 -17.87 -9.94 -64.55 -20.54 -9.18 3s57_d00 source 3s57 OXIDOREDUCTASE/DNA : 3 hits 3s57_d00 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER B 2 SER~? 23.90 C1 GOL B3003 A 166 PHE B 16 PHE~? 24.89 O2 GOL B3003 A 182 PHE B 27 PHE~? 18.68 O2 GOL B3003 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -45.76 -29.24 -6.32 -45.70 -31.69 -6.64 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -44.05 -19.66 -1.11 -46.34 -21.01 -2.06 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -52.51 -19.71 -6.57 -53.86 -22.07 -7.24 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER B 2 SER~? 23.90 C1 GOL B3003 A 166 PHE B 34 PHE^? 20.39 O2 GOL B3003 A 182 PHE B 27 PHE~? 18.68 O2 GOL B3003 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -45.76 -29.24 -6.32 -45.70 -31.69 -6.64 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -47.81 -24.83 0.44 -49.34 -25.35 -1.86 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -52.51 -19.71 -6.57 -53.86 -22.07 -7.24 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER B 17 SER~? 27.40 O2 GOL B3003 A 166 PHE B 27 PHE~? 18.68 O2 GOL B3003 A 182 PHE B 46 PHE^? 16.98 O2 GOL B3003 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -44.33 -15.07 -2.31 -45.17 -14.31 -0.14 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -52.51 -19.71 -6.57 -53.86 -22.07 -7.24 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -55.24 -16.60 2.62 -58.07 -16.55 2.38 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 3 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER B 2 SER~? 23.90 C1 GOL B3003 B 166 PHE B 34 PHE^? 20.39 O2 GOL B3003 B 182 PHE B 27 PHE~? 18.68 O2 GOL B3003 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -45.76 -29.24 -6.32 -45.70 -31.69 -6.64 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -47.81 -24.83 0.44 -49.34 -25.35 -1.86 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -52.51 -19.71 -6.57 -53.86 -22.07 -7.24 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 1 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER B 2 SER~? 23.90 C1 GOL B3003 C 166 PHE B 16 PHE~? 24.89 O2 GOL B3003 C 182 PHE B 27 PHE~? 18.68 O2 GOL B3003 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -45.76 -29.24 -6.32 -45.70 -31.69 -6.64 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -44.05 -19.66 -1.11 -46.34 -21.01 -2.06 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -52.51 -19.71 -6.57 -53.86 -22.07 -7.24 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER B 2 SER~? 23.90 C1 GOL B3003 C 166 PHE B 34 PHE^? 20.39 O2 GOL B3003 C 182 PHE B 27 PHE~? 18.68 O2 GOL B3003 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -45.76 -29.24 -6.32 -45.70 -31.69 -6.64 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -47.81 -24.83 0.44 -49.34 -25.35 -1.86 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -52.51 -19.71 -6.57 -53.86 -22.07 -7.24 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER B 17 SER~? 27.40 O2 GOL B3003 C 166 PHE B 27 PHE~? 18.68 O2 GOL B3003 C 182 PHE B 46 PHE^? 16.98 O2 GOL B3003 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -44.33 -15.07 -2.31 -45.17 -14.31 -0.14 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -52.51 -19.71 -6.57 -53.86 -22.07 -7.24 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -55.24 -16.60 2.62 -58.07 -16.55 2.38 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 3 hits 2r11_o02 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 69 GLU~? 14.08 O2 GOL B3003 A 44 ASP A 77 ASP~? 25.15 O2 GOL B3003 A 50 THR A 74 THR~? 23.62 O2 GOL B3003 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -68.84 -13.66 -5.25 -69.74 -15.00 -3.84 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -74.75 -7.69 -7.82 -73.00 -7.15 -9.02 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU A 69 GLU~? 14.08 O2 GOL B3003 A 44 ASP A 77 ASP~? 25.15 O2 GOL B3003 A 50 THR A 76 THR~? 19.90 C3 GOL B3003 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -68.84 -13.66 -5.25 -69.74 -15.00 -3.84 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -79.24 -10.45 -6.71 -79.02 -12.26 -5.50 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU B 69 GLU~? 14.08 O2 GOL B3003 A 44 ASP B 77 ASP~? 23.19 C1 GOL B3003 A 50 THR B 74 THR~? 19.81 C1 GOL B3003 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -57.32 -23.73 -7.47 -58.56 -24.80 -8.76 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -50.84 -28.83 -5.36 -49.48 -27.31 -4.66 ULMN 3 3hde_o00 LYSOZYME user 4 3 # 4 A 35 GLU B 69 GLU~? 14.08 O2 GOL B3003 A 44 ASP B 77 ASP~? 23.19 C1 GOL B3003 A 50 THR B 76 THR~? 16.19 C1 GOL B3003 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -57.32 -23.73 -7.47 -58.56 -24.80 -8.76 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -53.03 -33.68 -6.46 -54.89 -33.59 -7.55 3hde_o00 source 3HDE LYSOZYME : 4 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 69 GLU~? 14.08 O2 GOL B3003 B 44 ASP A 77 ASP~? 25.15 O2 GOL B3003 B 50 THR A 76 THR~? 19.90 C3 GOL B3003 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -68.84 -13.66 -5.25 -69.74 -15.00 -3.84 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -79.24 -10.45 -6.71 -79.02 -12.26 -5.50 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU B 69 GLU~? 14.08 O2 GOL B3003 B 44 ASP B 77 ASP~? 23.19 C1 GOL B3003 B 50 THR B 76 THR~? 16.19 C1 GOL B3003 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -57.32 -23.73 -7.47 -58.56 -24.80 -8.76 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -53.03 -33.68 -6.46 -54.89 -33.59 -7.55 3hde_o01 source 3HDE LYSOZYME : 2 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 69 GLU~? 14.08 O2 GOL B3003 C 44 ASP A 77 ASP~? 25.15 O2 GOL B3003 C 50 THR A 76 THR~? 19.90 C3 GOL B3003 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -68.84 -13.66 -5.25 -69.74 -15.00 -3.84 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -77.49 -6.59 -4.33 -77.82 -5.17 -2.79 coo 25.48 4.87 1.60 23.90 4.95 0.15 -79.24 -10.45 -6.71 -79.02 -12.26 -5.50 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU B 69 GLU~? 14.08 O2 GOL B3003 C 44 ASP B 77 ASP~? 23.19 C1 GOL B3003 C 50 THR B 76 THR~? 16.19 C1 GOL B3003 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -57.32 -23.73 -7.47 -58.56 -24.80 -8.76 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -49.36 -31.35 -8.61 -47.85 -31.24 -10.09 coo 25.48 4.87 1.60 23.90 4.95 0.15 -53.03 -33.68 -6.46 -54.89 -33.59 -7.55 3hde_o02 source 3HDE LYSOZYME : 2 hits 3hde_o02 naa= 3 ULMN 3 4dqk_o00 BIFUNCTIONAL P-450/NADPH-P450 REDUCTuser 1 3 # 1 A 966 SER A 143 SER^? 21.60 C3 GOL B3003 A 967 ARG A 85 ARG^? 23.00 O2 GOL B3003 A 975 TYR A 141 TYR^? 17.22 C3 GOL B3003 coo 82.02 40.88 31.11 79.88 41.56 30.18 -85.41 -13.56 3.43 -83.66 -13.28 5.07 coo 78.94 44.79 33.75 77.86 47.56 32.82 -81.56 -10.21 5.97 -79.12 -9.20 7.55 coo 83.57 40.86 25.45 83.15 43.18 26.91 -81.76 -18.20 2.94 -84.02 -18.22 4.60 ULMN 3 4dqk_o00 BIFUNCTIONAL P-450/NADPH-P450 REDUCTuser 2 3 # 2 A 966 SER B 143 SER^? 23.77 O3 GOL B3003 A 967 ARG B 85 ARG^? 26.71 C1 GOL B3003 A 975 TYR B 141 TYR^? 19.35 O3 GOL B3003 coo 82.02 40.88 31.11 79.88 41.56 30.18 -55.84 -39.65 -16.71 -55.68 -37.87 -18.32 coo 78.94 44.79 33.75 77.86 47.56 32.82 -53.06 -34.97 -19.15 -50.61 -33.06 -19.14 coo 83.57 40.86 25.45 83.15 43.18 26.91 -60.85 -36.38 -15.85 -61.05 -38.68 -17.49 4dqk_o00 source 4DQK BIFUNCTIONAL P-450/NADPH-P450 REDUCTASE : 2 hits 4dqk_o00 naa= 3